id	sid	tid	token	lemma	pos
iajs-3610	1	1	227	227	NUM
iajs-3610	1	2	©	©	ADP
iajs-3610	1	3	2025	2025	NUM
iajs-3610	1	4	the	the	DET
iajs-3610	1	5	author(s	author(s	NOUN
iajs-3610	1	6	)	)	PUNCT
iajs-3610	1	7	.	.	PUNCT
iajs-3610	2	1	published	publish	VERB
iajs-3610	2	2	by	by	ADP
iajs-3610	2	3	college	college	NOUN
iajs-3610	2	4	of	of	ADP
iajs-3610	2	5	education	education	NOUN
iajs-3610	2	6	for	for	ADP
iajs-3610	2	7	pure	pure	ADJ
iajs-3610	2	8	science	science	NOUN
iajs-3610	2	9	(	(	PUNCT
iajs-3610	2	10	ibn	ibn	PROPN
iajs-3610	2	11	al	al	PROPN
iajs-3610	2	12	-	-	PUNCT
iajs-3610	2	13	haitham	haitham	PROPN
iajs-3610	2	14	)	)	PUNCT
iajs-3610	2	15	,	,	PUNCT
iajs-3610	2	16	university	university	NOUN
iajs-3610	2	17	of	of	ADP
iajs-3610	2	18	baghdad	baghdad	PROPN
iajs-3610	2	19	.	.	PUNCT
iajs-3610	3	1	this	this	PRON
iajs-3610	3	2	is	be	AUX
iajs-3610	3	3	an	an	DET
iajs-3610	3	4	open	open	ADJ
iajs-3610	3	5	-	-	PUNCT
iajs-3610	3	6	access	access	NOUN
iajs-3610	3	7	article	article	NOUN
iajs-3610	3	8	distributed	distribute	VERB
iajs-3610	3	9	under	under	ADP
iajs-3610	3	10	the	the	DET
iajs-3610	3	11	terms	term	NOUN
iajs-3610	3	12	of	of	ADP
iajs-3610	3	13	the	the	DET
iajs-3610	3	14	creative	creative	ADJ
iajs-3610	3	15	commons	common	NOUN
iajs-3610	3	16	attribution	attribution	NOUN
iajs-3610	3	17	4.0	4.0	NUM
iajs-3610	3	18	international	international	ADJ
iajs-3610	3	19	license	license	NOUN
iajs-3610	3	20	assessment	assessment	NOUN
iajs-3610	3	21	of	of	ADP
iajs-3610	3	22	serum	serum	NOUN
iajs-3610	3	23	angiotensin	angiotensin	NOUN
iajs-3610	3	24	converting	convert	VERB
iajs-3610	3	25	enzyme	enzyme	NOUN
iajs-3610	3	26	2	2	NUM
iajs-3610	3	27	and	and	CCONJ
iajs-3610	3	28	urine	urine	NOUN
iajs-3610	3	29	albumin	albumin	NOUN
iajs-3610	3	30	to	to	ADP
iajs-3610	3	31	creatinine	creatinine	NOUN
iajs-3610	3	32	ratio	ratio	NOUN
iajs-3610	3	33	as	as	ADP
iajs-3610	3	34	early	early	ADJ
iajs-3610	3	35	detection	detection	NOUN
iajs-3610	3	36	of	of	ADP
iajs-3610	3	37	diabetic	diabetic	ADJ
iajs-3610	3	38	nephropathy	nephropathy	NOUN
iajs-3610	3	39	sarah	sarah	PROPN
iajs-3610	3	40	sattar	sattar	PROPN
iajs-3610	3	41	jabbar	jabbar	PROPN
iajs-3610	3	42	1	1	NUM
iajs-3610	3	43	*	*	PUNCT
iajs-3610	3	44	and	and	CCONJ
iajs-3610	3	45	sanad	sanad	NOUN
iajs-3610	4	1	baqir	baqir	PROPN
iajs-3610	4	2	mahammed	mahammed	ADJ
iajs-3610	4	3	2	2	NUM
iajs-3610	4	4	1,2	1,2	NUM
iajs-3610	4	5	department	department	NOUN
iajs-3610	4	6	of	of	ADP
iajs-3610	4	7	chemistry	chemistry	NOUN
iajs-3610	4	8	,	,	PUNCT
iajs-3610	4	9	college	college	NOUN
iajs-3610	4	10	of	of	ADP
iajs-3610	4	11	science	science	NOUN
iajs-3610	4	12	for	for	ADP
iajs-3610	4	13	women	woman	NOUN
iajs-3610	4	14	,	,	PUNCT
iajs-3610	4	15	university	university	NOUN
iajs-3610	4	16	of	of	ADP
iajs-3610	4	17	baghdad	baghdad	PROPN
iajs-3610	4	18	,	,	PUNCT
iajs-3610	4	19	baghdad	baghdad	PROPN
iajs-3610	4	20	,	,	PUNCT
iajs-3610	4	21	iraq	iraq	PROPN
iajs-3610	4	22	.	.	PUNCT
iajs-3610	5	1	*	*	PUNCT
iajs-3610	5	2	corresponding	correspond	VERB
iajs-3610	5	3	author	author	NOUN
iajs-3610	5	4	.	.	PUNCT
iajs-3610	6	1	received	receive	VERB
iajs-3610	6	2	:	:	PUNCT
iajs-3610	6	3	6	6	NUM
iajs-3610	6	4	november	november	PROPN
iajs-3610	6	5	2023	2023	NUM
iajs-3610	6	6	accepted	accept	VERB
iajs-3610	6	7	:	:	PUNCT
iajs-3610	6	8	2	2	NUM
iajs-3610	6	9	january	january	NOUN
iajs-3610	6	10	2024	2024	NUM
iajs-3610	6	11	published	publish	VERB
iajs-3610	6	12	:	:	PUNCT
iajs-3610	6	13	20	20	NUM
iajs-3610	6	14	july	july	PROPN
iajs-3610	6	15	2025	2025	NUM
iajs-3610	6	16	doi.org/10.30526/38.3.3610	doi.org/10.30526/38.3.3610	VERB
iajs-3610	6	17	abstract	abstract	ADJ
iajs-3610	6	18	diabetic	diabetic	ADJ
iajs-3610	6	19	nephropathy	nephropathy	NOUN
iajs-3610	6	20	(	(	PUNCT
iajs-3610	6	21	dn	dn	NOUN
iajs-3610	6	22	)	)	PUNCT
iajs-3610	6	23	is	be	AUX
iajs-3610	6	24	a	a	DET
iajs-3610	6	25	chronic	chronic	ADJ
iajs-3610	6	26	disease	disease	NOUN
iajs-3610	6	27	manifested	manifest	VERB
iajs-3610	6	28	by	by	ADP
iajs-3610	6	29	a	a	DET
iajs-3610	6	30	decreased	decrease	VERB
iajs-3610	6	31	glomerular	glomerular	ADJ
iajs-3610	6	32	filtration	filtration	NOUN
iajs-3610	6	33	rate	rate	NOUN
iajs-3610	6	34	(	(	PUNCT
iajs-3610	6	35	gfr	gfr	NOUN
iajs-3610	6	36	)	)	PUNCT
iajs-3610	6	37	that	that	PRON
iajs-3610	6	38	leads	lead	VERB
iajs-3610	6	39	to	to	ADP
iajs-3610	6	40	the	the	DET
iajs-3610	6	41	progression	progression	NOUN
iajs-3610	6	42	of	of	ADP
iajs-3610	6	43	kidney	kidney	NOUN
iajs-3610	6	44	failure	failure	NOUN
iajs-3610	6	45	and	and	CCONJ
iajs-3610	6	46	increased	increase	VERB
iajs-3610	6	47	incidence	incidence	NOUN
iajs-3610	6	48	of	of	ADP
iajs-3610	6	49	mortality	mortality	NOUN
iajs-3610	6	50	and	and	CCONJ
iajs-3610	6	51	cardiovascular	cardiovascular	ADJ
iajs-3610	6	52	complications	complication	NOUN
iajs-3610	6	53	.	.	PUNCT
iajs-3610	7	1	type	type	NOUN
iajs-3610	7	2	2	2	NUM
iajs-3610	7	3	diabetes	diabetes	NOUN
iajs-3610	7	4	mellitus	mellitus	NOUN
iajs-3610	7	5	(	(	PUNCT
iajs-3610	7	6	t2	t2	NOUN
iajs-3610	7	7	dm	dm	PROPN
iajs-3610	7	8	)	)	PUNCT
iajs-3610	7	9	is	be	AUX
iajs-3610	7	10	a	a	DET
iajs-3610	7	11	metabolic	metabolic	NOUN
iajs-3610	7	12	disorder	disorder	NOUN
iajs-3610	7	13	that	that	PRON
iajs-3610	7	14	affects	affect	VERB
iajs-3610	7	15	multiple	multiple	ADJ
iajs-3610	7	16	organs	organ	NOUN
iajs-3610	7	17	,	,	PUNCT
iajs-3610	7	18	including	include	VERB
iajs-3610	7	19	the	the	DET
iajs-3610	7	20	pancreas	pancrea	NOUN
iajs-3610	7	21	,	,	PUNCT
iajs-3610	7	22	as	as	ADV
iajs-3610	7	23	well	well	ADV
iajs-3610	7	24	as	as	ADP
iajs-3610	7	25	the	the	DET
iajs-3610	7	26	kidneys	kidney	NOUN
iajs-3610	7	27	,	,	PUNCT
iajs-3610	7	28	liver	liver	NOUN
iajs-3610	7	29	,	,	PUNCT
iajs-3610	7	30	brain	brain	NOUN
iajs-3610	7	31	,	,	PUNCT
iajs-3610	7	32	and	and	CCONJ
iajs-3610	7	33	eyes	eye	NOUN
iajs-3610	7	34	.	.	PUNCT
iajs-3610	8	1	angiotensin	angiotensin	NOUN
iajs-3610	8	2	-	-	PUNCT
iajs-3610	8	3	converting	convert	VERB
iajs-3610	8	4	enzyme	enzyme	NOUN
iajs-3610	8	5	2	2	NUM
iajs-3610	8	6	(	(	PUNCT
iajs-3610	8	7	ace2	ace2	PROPN
iajs-3610	8	8	)	)	PUNCT
iajs-3610	8	9	is	be	AUX
iajs-3610	8	10	a	a	DET
iajs-3610	8	11	component	component	NOUN
iajs-3610	8	12	of	of	ADP
iajs-3610	8	13	the	the	DET
iajs-3610	8	14	reninangiotensin	reninangiotensin	NOUN
iajs-3610	8	15	system	system	NOUN
iajs-3610	8	16	,	,	PUNCT
iajs-3610	8	17	which	which	PRON
iajs-3610	8	18	is	be	AUX
iajs-3610	8	19	highly	highly	ADV
iajs-3610	8	20	expressed	express	VERB
iajs-3610	8	21	in	in	ADP
iajs-3610	8	22	renal	renal	ADJ
iajs-3610	8	23	tubular	tubular	ADJ
iajs-3610	8	24	epithelial	epithelial	ADJ
iajs-3610	8	25	cells	cell	NOUN
iajs-3610	8	26	.	.	PUNCT
iajs-3610	9	1	this	this	DET
iajs-3610	9	2	study	study	NOUN
iajs-3610	9	3	aims	aim	VERB
iajs-3610	9	4	to	to	PART
iajs-3610	9	5	measure	measure	VERB
iajs-3610	9	6	ace2	ace2	NOUN
iajs-3610	9	7	and	and	CCONJ
iajs-3610	9	8	the	the	DET
iajs-3610	9	9	urine	urine	NOUN
iajs-3610	9	10	albumin	albumin	NOUN
iajs-3610	9	11	-	-	PUNCT
iajs-3610	9	12	to	to	ADP
iajs-3610	9	13	-	-	PUNCT
iajs-3610	9	14	creatinine	creatinine	NOUN
iajs-3610	9	15	ratio	ratio	NOUN
iajs-3610	9	16	(	(	PUNCT
iajs-3610	9	17	acr	acr	PROPN
iajs-3610	9	18	)	)	PUNCT
iajs-3610	9	19	as	as	ADP
iajs-3610	9	20	early	early	ADJ
iajs-3610	9	21	detection	detection	NOUN
iajs-3610	9	22	markers	marker	NOUN
iajs-3610	9	23	for	for	ADP
iajs-3610	9	24	dn	dn	PROPN
iajs-3610	9	25	among	among	ADP
iajs-3610	9	26	t2	t2	NOUN
iajs-3610	9	27	dm	dm	PROPN
iajs-3610	9	28	patients	patient	NOUN
iajs-3610	9	29	.	.	PUNCT
iajs-3610	10	1	the	the	DET
iajs-3610	10	2	sample	sample	NOUN
iajs-3610	10	3	size	size	NOUN
iajs-3610	10	4	consisted	consist	VERB
iajs-3610	10	5	of	of	ADP
iajs-3610	10	6	135	135	NUM
iajs-3610	10	7	individuals	individual	NOUN
iajs-3610	10	8	,	,	PUNCT
iajs-3610	10	9	who	who	PRON
iajs-3610	10	10	were	be	AUX
iajs-3610	10	11	divided	divide	VERB
iajs-3610	10	12	into	into	ADP
iajs-3610	10	13	three	three	NUM
iajs-3610	10	14	groups	group	NOUN
iajs-3610	10	15	based	base	VERB
iajs-3610	10	16	on	on	ADP
iajs-3610	10	17	acr	acr	PROPN
iajs-3610	10	18	criteria	criterion	NOUN
iajs-3610	10	19	:	:	PUNCT
iajs-3610	10	20	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	10	21	,	,	PUNCT
iajs-3610	10	22	microalbuminuria	microalbuminuria	PROPN
iajs-3610	10	23	,	,	PUNCT
iajs-3610	10	24	and	and	CCONJ
iajs-3610	10	25	normoalbuminuria	normoalbuminuria	VERB
iajs-3610	10	26	,	,	PUNCT
iajs-3610	10	27	with	with	ADP
iajs-3610	10	28	healthy	healthy	ADJ
iajs-3610	10	29	subjects	subject	NOUN
iajs-3610	10	30	as	as	ADP
iajs-3610	10	31	the	the	DET
iajs-3610	10	32	control	control	NOUN
iajs-3610	10	33	group	group	NOUN
iajs-3610	10	34	.	.	PUNCT
iajs-3610	11	1	they	they	PRON
iajs-3610	11	2	were	be	AUX
iajs-3610	11	3	intended	intend	VERB
iajs-3610	11	4	for	for	AUX
iajs-3610	11	5	telafer	telafer	VERB
iajs-3610	11	6	hospital	hospital	NOUN
iajs-3610	11	7	in	in	ADP
iajs-3610	11	8	mosul	mosul	PROPN
iajs-3610	11	9	city	city	PROPN
iajs-3610	11	10	.	.	PUNCT
iajs-3610	12	1	the	the	DET
iajs-3610	12	2	data	datum	NOUN
iajs-3610	12	3	showed	show	VERB
iajs-3610	12	4	significant	significant	ADJ
iajs-3610	12	5	differences	difference	NOUN
iajs-3610	12	6	between	between	ADP
iajs-3610	12	7	patient	patient	ADJ
iajs-3610	12	8	groups	group	NOUN
iajs-3610	12	9	and	and	CCONJ
iajs-3610	12	10	the	the	DET
iajs-3610	12	11	control	control	NOUN
iajs-3610	12	12	group	group	NOUN
iajs-3610	12	13	for	for	ADP
iajs-3610	12	14	glycemic	glycemic	ADJ
iajs-3610	12	15	,	,	PUNCT
iajs-3610	12	16	lipid	lipid	NOUN
iajs-3610	12	17	profile	profile	NOUN
iajs-3610	12	18	,	,	PUNCT
iajs-3610	12	19	and	and	CCONJ
iajs-3610	12	20	kidney	kidney	NOUN
iajs-3610	12	21	function	function	NOUN
iajs-3610	12	22	tests	test	NOUN
iajs-3610	12	23	.	.	PUNCT
iajs-3610	13	1	additionally	additionally	ADV
iajs-3610	13	2	,	,	PUNCT
iajs-3610	13	3	the	the	DET
iajs-3610	13	4	results	result	NOUN
iajs-3610	13	5	revealed	reveal	VERB
iajs-3610	13	6	a	a	DET
iajs-3610	13	7	significant	significant	ADJ
iajs-3610	13	8	association	association	NOUN
iajs-3610	13	9	between	between	ADP
iajs-3610	13	10	serum	serum	NOUN
iajs-3610	13	11	glycemic	glycemic	ADJ
iajs-3610	13	12	levels	level	NOUN
iajs-3610	13	13	,	,	PUNCT
iajs-3610	13	14	lipid	lipid	NOUN
iajs-3610	13	15	profiles	profile	NOUN
iajs-3610	13	16	,	,	PUNCT
iajs-3610	13	17	kidney	kidney	NOUN
iajs-3610	13	18	function	function	NOUN
iajs-3610	13	19	tests	test	NOUN
iajs-3610	13	20	,	,	PUNCT
iajs-3610	13	21	and	and	CCONJ
iajs-3610	13	22	ace2	ace2	PROPN
iajs-3610	13	23	and	and	CCONJ
iajs-3610	13	24	dn	dn	NOUN
iajs-3610	13	25	in	in	ADP
iajs-3610	13	26	t2	t2	NOUN
iajs-3610	13	27	dm	dm	PROPN
iajs-3610	13	28	patients	patient	NOUN
iajs-3610	13	29	.	.	PUNCT
iajs-3610	14	1	based	base	VERB
iajs-3610	14	2	on	on	ADP
iajs-3610	14	3	the	the	DET
iajs-3610	14	4	current	current	ADJ
iajs-3610	14	5	data	datum	NOUN
iajs-3610	14	6	,	,	PUNCT
iajs-3610	14	7	it	it	PRON
iajs-3610	14	8	can	can	AUX
iajs-3610	14	9	be	be	AUX
iajs-3610	14	10	concluded	conclude	VERB
iajs-3610	14	11	that	that	SCONJ
iajs-3610	14	12	acr	acr	PROPN
iajs-3610	14	13	and	and	CCONJ
iajs-3610	14	14	ace2	ace2	PROPN
iajs-3610	14	15	play	play	VERB
iajs-3610	14	16	a	a	DET
iajs-3610	14	17	crucial	crucial	ADJ
iajs-3610	14	18	protective	protective	ADJ
iajs-3610	14	19	role	role	NOUN
iajs-3610	14	20	in	in	ADP
iajs-3610	14	21	preventing	prevent	VERB
iajs-3610	14	22	progressive	progressive	ADJ
iajs-3610	14	23	renal	renal	ADJ
iajs-3610	14	24	damage	damage	NOUN
iajs-3610	14	25	,	,	PUNCT
iajs-3610	14	26	which	which	PRON
iajs-3610	14	27	is	be	AUX
iajs-3610	14	28	a	a	DET
iajs-3610	14	29	valuable	valuable	ADJ
iajs-3610	14	30	indicator	indicator	NOUN
iajs-3610	14	31	for	for	ADP
iajs-3610	14	32	the	the	DET
iajs-3610	14	33	early	early	ADJ
iajs-3610	14	34	detection	detection	NOUN
iajs-3610	14	35	of	of	ADP
iajs-3610	14	36	dn	dn	PROPN
iajs-3610	14	37	.	.	PUNCT
iajs-3610	15	1	keywords	keyword	NOUN
iajs-3610	15	2	:	:	PUNCT
iajs-3610	15	3	albuminuria	albuminuria	NOUN
iajs-3610	15	4	,	,	PUNCT
iajs-3610	15	5	albumin	albumin	NOUN
iajs-3610	15	6	to	to	ADP
iajs-3610	15	7	creatinine	creatinine	NOUN
iajs-3610	15	8	ratio	ratio	NOUN
iajs-3610	15	9	,	,	PUNCT
iajs-3610	15	10	angiotensin	angiotensin	NOUN
iajs-3610	15	11	converting	convert	VERB
iajs-3610	15	12	enzyme-2	enzyme-2	PROPN
iajs-3610	15	13	,	,	PUNCT
iajs-3610	15	14	diabetic	diabetic	ADJ
iajs-3610	15	15	nephropathy	nephropathy	NOUN
iajs-3610	15	16	,	,	PUNCT
iajs-3610	15	17	type	type	NOUN
iajs-3610	15	18	2	2	NUM
iajs-3610	15	19	diabetes	diabetes	NOUN
iajs-3610	15	20	mellitus	mellitus	NOUN
iajs-3610	15	21	,	,	PUNCT
iajs-3610	15	22	1	1	X
iajs-3610	15	23	.	.	X
iajs-3610	15	24	introduction	introduction	NOUN
iajs-3610	15	25	one	one	NUM
iajs-3610	15	26	of	of	ADP
iajs-3610	15	27	the	the	DET
iajs-3610	15	28	dominant	dominant	ADJ
iajs-3610	15	29	and	and	CCONJ
iajs-3610	15	30	severe	severe	ADJ
iajs-3610	15	31	effects	effect	NOUN
iajs-3610	15	32	of	of	ADP
iajs-3610	15	33	diabetes	diabetes	NOUN
iajs-3610	15	34	mellitus	mellitus	NOUN
iajs-3610	15	35	(	(	PUNCT
iajs-3610	15	36	dm	dm	NOUN
iajs-3610	15	37	)	)	PUNCT
iajs-3610	15	38	is	be	AUX
iajs-3610	15	39	diabetic	diabetic	ADJ
iajs-3610	15	40	nephropathy	nephropathy	NOUN
iajs-3610	15	41	(	(	PUNCT
iajs-3610	15	42	dn	dn	NOUN
iajs-3610	15	43	)	)	PUNCT
iajs-3610	15	44	,	,	PUNCT
iajs-3610	15	45	which	which	PRON
iajs-3610	15	46	linked	link	VERB
iajs-3610	15	47	to	to	ADP
iajs-3610	15	48	higher	high	ADJ
iajs-3610	15	49	mortality	mortality	NOUN
iajs-3610	15	50	and	and	CCONJ
iajs-3610	15	51	morbidity	morbidity	NOUN
iajs-3610	15	52	rates	rate	NOUN
iajs-3610	15	53	in	in	ADP
iajs-3610	15	54	diabetic	diabetic	ADJ
iajs-3610	15	55	individuals	individual	NOUN
iajs-3610	15	56	)	)	PUNCT
iajs-3610	15	57	1	1	NUM
iajs-3610	15	58	(	(	PUNCT
iajs-3610	15	59	.	.	PUNCT
iajs-3610	16	1	up	up	ADP
iajs-3610	16	2	to	to	PART
iajs-3610	16	3	40	40	NUM
iajs-3610	16	4	%	%	NOUN
iajs-3610	16	5	of	of	ADP
iajs-3610	16	6	people	people	NOUN
iajs-3610	16	7	with	with	ADP
iajs-3610	16	8	type	type	NOUN
iajs-3610	16	9	2	2	NUM
iajs-3610	16	10	dm	dm	PROPN
iajs-3610	16	11	(	(	PUNCT
iajs-3610	16	12	t2	t2	NOUN
iajs-3610	16	13	dm	dm	NOUN
iajs-3610	16	14	)	)	PUNCT
iajs-3610	16	15	will	will	AUX
iajs-3610	16	16	progress	progress	VERB
iajs-3610	16	17	clinically	clinically	ADV
iajs-3610	16	18	obvious	obvious	ADJ
iajs-3610	16	19	renal	renal	ADJ
iajs-3610	16	20	impairment	impairment	NOUN
iajs-3610	16	21	over	over	ADP
iajs-3610	16	22	the	the	DET
iajs-3610	16	23	course	course	NOUN
iajs-3610	16	24	of	of	ADP
iajs-3610	16	25	their	their	PRON
iajs-3610	16	26	lives	life	NOUN
iajs-3610	16	27	,	,	PUNCT
iajs-3610	16	28	dn	dn	PROPN
iajs-3610	16	29	occurs	occur	VERB
iajs-3610	16	30	in	in	ADP
iajs-3610	16	31	30	30	NUM
iajs-3610	16	32	to	to	PART
iajs-3610	16	33	40	40	NUM
iajs-3610	16	34	%	%	NOUN
iajs-3610	16	35	of	of	ADP
iajs-3610	16	36	dm	dm	PROPN
iajs-3610	16	37	patients	patient	NOUN
iajs-3610	16	38	.	.	PUNCT
iajs-3610	17	1	half	half	NOUN
iajs-3610	17	2	of	of	ADP
iajs-3610	17	3	all	all	DET
iajs-3610	17	4	patients	patient	NOUN
iajs-3610	17	5	receiving	receive	VERB
iajs-3610	17	6	dialysis	dialysis	NOUN
iajs-3610	17	7	treatment	treatment	NOUN
iajs-3610	17	8	have	have	VERB
iajs-3610	17	9	dn	dn	ADP
iajs-3610	17	10	,	,	PUNCT
iajs-3610	17	11	which	which	PRON
iajs-3610	17	12	is	be	AUX
iajs-3610	17	13	a	a	DET
iajs-3610	17	14	primary	primary	ADJ
iajs-3610	17	15	leading	leading	NOUN
iajs-3610	17	16	of	of	ADP
iajs-3610	17	17	end	end	NOUN
iajs-3610	17	18	-	-	PUNCT
iajs-3610	17	19	stage	stage	NOUN
iajs-3610	17	20	renal	renal	ADJ
iajs-3610	17	21	disease	disease	NOUN
iajs-3610	17	22	(	(	PUNCT
iajs-3610	17	23	esrd	esrd	PROPN
iajs-3610	17	24	)	)	PUNCT
iajs-3610	17	25	)	)	PUNCT
iajs-3610	17	26	2(.the	2(.the	DET
iajs-3610	17	27	clinical	clinical	ADJ
iajs-3610	17	28	syndrome	syndrome	NOUN
iajs-3610	17	29	of	of	ADP
iajs-3610	17	30	dn	dn	PROPN
iajs-3610	17	31	is	be	AUX
iajs-3610	17	32	manifested	manifest	VERB
iajs-3610	17	33	by	by	ADP
iajs-3610	17	34	albuminuria	albuminuria	PROPN
iajs-3610	17	35	,	,	PUNCT
iajs-3610	17	36	higher	high	ADJ
iajs-3610	17	37	arterial	arterial	ADJ
iajs-3610	17	38	blood	blood	NOUN
iajs-3610	17	39	pressure	pressure	NOUN
iajs-3610	17	40	(	(	PUNCT
iajs-3610	17	41	bp	bp	PROPN
iajs-3610	17	42	)	)	PUNCT
iajs-3610	17	43	,	,	PUNCT
iajs-3610	17	44	and	and	CCONJ
iajs-3610	17	45	reduced	reduce	VERB
iajs-3610	17	46	in	in	ADP
iajs-3610	17	47	the	the	DET
iajs-3610	17	48	glomerular	glomerular	ADJ
iajs-3610	17	49	filtration	filtration	NOUN
iajs-3610	17	50	rate	rate	NOUN
iajs-3610	17	51	(	(	PUNCT
iajs-3610	17	52	gfr	gfr	NOUN
iajs-3610	17	53	)	)	PUNCT
iajs-3610	17	54	)	)	PUNCT
iajs-3610	18	1	3	3	NUM
iajs-3610	18	2	(	(	PUNCT
iajs-3610	18	3	.	.	PUNCT
iajs-3610	19	1	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	2	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	3	https://orcid.org/	https://orcid.org/	PRON
iajs-3610	19	4	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	PROPN
iajs-3610	19	5	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	6	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	7	https://orcid.org/	https://orcid.org/	NOUN
iajs-3610	19	8	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	NOUN
iajs-3610	19	9	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	10	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	11	https://orcid.org/	https://orcid.org/	NOUN
iajs-3610	19	12	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	NOUN
iajs-3610	19	13	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	14	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	15	https://orcid.org/	https://orcid.org/	NOUN
iajs-3610	19	16	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	NOUN
iajs-3610	19	17	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	18	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	19	https://orcid.org/	https://orcid.org/	NOUN
iajs-3610	19	20	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	NOUN
iajs-3610	19	21	https://orcid.org/0000-0003-1156-8980	https://orcid.org/0000-0003-1156-8980	PROPN
iajs-3610	19	22	mailto:sarahsattar@uotelafer.edu.iq	mailto:sarahsattar@uotelafer.edu.iq	PROPN
iajs-3610	19	23	https://orcid.org/	https://orcid.org/	PROPN
iajs-3610	19	24	mailto:dr.sanad55@yahoo.com	mailto:dr.sanad55@yahoo.com	PROPN
iajs-3610	19	25	ihjpas	ihjpas	PROPN
iajs-3610	19	26	.	.	PUNCT
iajs-3610	20	1	2025	2025	NUM
iajs-3610	20	2	,	,	PUNCT
iajs-3610	20	3	38(3	38(3	NUM
iajs-3610	20	4	)	)	PUNCT
iajs-3610	20	5	228	228	NUM
iajs-3610	20	6	due	due	ADP
iajs-3610	20	7	to	to	ADP
iajs-3610	20	8	the	the	DET
iajs-3610	20	9	multiple	multiple	ADJ
iajs-3610	20	10	chronic	chronic	ADJ
iajs-3610	20	11	problems	problem	NOUN
iajs-3610	20	12	that	that	PRON
iajs-3610	20	13	t2	t2	NOUN
iajs-3610	20	14	dm	dm	NOUN
iajs-3610	20	15	causes	cause	NOUN
iajs-3610	20	16	,	,	PUNCT
iajs-3610	20	17	dm	dm	PROPN
iajs-3610	20	18	is	be	AUX
iajs-3610	20	19	currently	currently	ADV
iajs-3610	20	20	the	the	DET
iajs-3610	20	21	9	9	NUM
iajs-3610	20	22	th	th	NUM
iajs-3610	20	23	greatest	great	ADJ
iajs-3610	20	24	cause	cause	NOUN
iajs-3610	20	25	of	of	ADP
iajs-3610	20	26	mortality	mortality	NOUN
iajs-3610	20	27	.	.	PUNCT
iajs-3610	21	1	the	the	DET
iajs-3610	21	2	albumin	albumin	NOUN
iajs-3610	21	3	to	to	PART
iajs-3610	21	4	creatinine	creatinine	NOUN
iajs-3610	21	5	ratio	ratio	NOUN
iajs-3610	21	6	(	(	PUNCT
iajs-3610	21	7	acr	acr	NOUN
iajs-3610	21	8	)	)	PUNCT
iajs-3610	21	9	is	be	AUX
iajs-3610	21	10	frequently	frequently	ADV
iajs-3610	21	11	used	use	VERB
iajs-3610	21	12	to	to	PART
iajs-3610	21	13	determine	determine	VERB
iajs-3610	21	14	the	the	DET
iajs-3610	21	15	earliest	early	ADJ
iajs-3610	21	16	signs	sign	NOUN
iajs-3610	21	17	of	of	ADP
iajs-3610	21	18	renal	renal	ADJ
iajs-3610	21	19	impairment	impairment	NOUN
iajs-3610	21	20	.	.	PUNCT
iajs-3610	22	1	compared	compare	VERB
iajs-3610	22	2	to	to	ADP
iajs-3610	22	3	albumin	albumin	ADJ
iajs-3610	22	4	levels	level	NOUN
iajs-3610	22	5	,	,	PUNCT
iajs-3610	22	6	it	it	PRON
iajs-3610	22	7	has	have	AUX
iajs-3610	22	8	been	be	AUX
iajs-3610	22	9	showed	show	VERB
iajs-3610	22	10	to	to	PART
iajs-3610	22	11	be	be	AUX
iajs-3610	22	12	a	a	DET
iajs-3610	22	13	very	very	ADV
iajs-3610	22	14	accurate	accurate	ADJ
iajs-3610	22	15	indication	indication	NOUN
iajs-3610	22	16	)	)	PUNCT
iajs-3610	22	17	4,5	4,5	NUM
iajs-3610	22	18	(	(	PUNCT
iajs-3610	22	19	.	.	PUNCT
iajs-3610	22	20	chronic	chronic	ADJ
iajs-3610	22	21	hyperglycemia	hyperglycemia	NOUN
iajs-3610	22	22	has	have	AUX
iajs-3610	22	23	been	be	AUX
iajs-3610	22	24	associated	associate	VERB
iajs-3610	22	25	with	with	ADP
iajs-3610	22	26	ketoacidosis	ketoacidosis	NOUN
iajs-3610	22	27	,	,	PUNCT
iajs-3610	22	28	dn	dn	PROPN
iajs-3610	22	29	,	,	PUNCT
iajs-3610	22	30	high	high	ADJ
iajs-3610	22	31	bp	bp	PROPN
iajs-3610	22	32	,	,	PUNCT
iajs-3610	22	33	also	also	ADV
iajs-3610	22	34	foot	foot	VERB
iajs-3610	22	35	diseases	disease	NOUN
iajs-3610	22	36	)	)	PUNCT
iajs-3610	22	37	6	6	NUM
iajs-3610	22	38	(	(	PUNCT
iajs-3610	22	39	.	.	PUNCT
iajs-3610	23	1	diabetes	diabetes	NOUN
iajs-3610	23	2	impairs	impair	VERB
iajs-3610	23	3	the	the	DET
iajs-3610	23	4	kidney	kidney	NOUN
iajs-3610	23	5	's	's	PART
iajs-3610	23	6	filtration	filtration	NOUN
iajs-3610	23	7	function	function	NOUN
iajs-3610	23	8	,	,	PUNCT
iajs-3610	23	9	initially	initially	ADV
iajs-3610	23	10	making	make	VERB
iajs-3610	23	11	it	it	PRON
iajs-3610	23	12	leaking	leak	VERB
iajs-3610	23	13	to	to	ADP
iajs-3610	23	14	greater	great	ADJ
iajs-3610	23	15	blood	blood	NOUN
iajs-3610	23	16	proteins	protein	NOUN
iajs-3610	23	17	like	like	ADP
iajs-3610	23	18	albumin	albumin	NOUN
iajs-3610	23	19	,	,	PUNCT
iajs-3610	23	20	which	which	PRON
iajs-3610	23	21	are	be	AUX
iajs-3610	23	22	subsequently	subsequently	ADV
iajs-3610	23	23	lost	lose	VERB
iajs-3610	23	24	in	in	ADP
iajs-3610	23	25	the	the	DET
iajs-3610	23	26	urine	urine	NOUN
iajs-3610	23	27	,	,	PUNCT
iajs-3610	23	28	especially	especially	ADV
iajs-3610	23	29	when	when	SCONJ
iajs-3610	23	30	the	the	DET
iajs-3610	23	31	blood	blood	NOUN
iajs-3610	23	32	sugar	sugar	NOUN
iajs-3610	23	33	is	be	AUX
iajs-3610	23	34	not	not	PART
iajs-3610	23	35	well	well	ADV
iajs-3610	23	36	regulated	regulated	ADJ
iajs-3610	23	37	)	)	PUNCT
iajs-3610	23	38	7	7	NUM
iajs-3610	23	39	(	(	PUNCT
iajs-3610	23	40	.	.	PUNCT
iajs-3610	24	1	there	there	PRON
iajs-3610	24	2	are	be	VERB
iajs-3610	24	3	several	several	ADJ
iajs-3610	24	4	disorders	disorder	NOUN
iajs-3610	24	5	may	may	AUX
iajs-3610	24	6	alter	alter	VERB
iajs-3610	24	7	on	on	ADP
iajs-3610	24	8	the	the	DET
iajs-3610	24	9	delivery	delivery	NOUN
iajs-3610	24	10	of	of	ADP
iajs-3610	24	11	blood	blood	NOUN
iajs-3610	24	12	to	to	ADP
iajs-3610	24	13	the	the	DET
iajs-3610	24	14	renal	renal	ADJ
iajs-3610	24	15	arteries	artery	NOUN
iajs-3610	24	16	.	.	PUNCT
iajs-3610	25	1	diabetes	diabetes	NOUN
iajs-3610	25	2	mellitus	mellitus	NOUN
iajs-3610	25	3	is	be	AUX
iajs-3610	25	4	one	one	NUM
iajs-3610	25	5	of	of	ADP
iajs-3610	25	6	these	these	PRON
iajs-3610	25	7	,	,	PUNCT
iajs-3610	25	8	which	which	PRON
iajs-3610	25	9	cause	cause	VERB
iajs-3610	25	10	kidney	kidney	NOUN
iajs-3610	25	11	disease	disease	NOUN
iajs-3610	25	12	and	and	CCONJ
iajs-3610	25	13	risk	risk	NOUN
iajs-3610	25	14	of	of	ADP
iajs-3610	25	15	microvascular	microvascular	ADJ
iajs-3610	25	16	complications	complication	NOUN
iajs-3610	25	17	)	)	PUNCT
iajs-3610	25	18	8	8	NUM
iajs-3610	25	19	(	(	PUNCT
iajs-3610	25	20	.	.	PUNCT
iajs-3610	26	1	because	because	SCONJ
iajs-3610	26	2	of	of	ADP
iajs-3610	26	3	deficiencies	deficiency	NOUN
iajs-3610	26	4	in	in	ADP
iajs-3610	26	5	insulin	insulin	NOUN
iajs-3610	26	6	secretion	secretion	NOUN
iajs-3610	26	7	and	and	CCONJ
iajs-3610	26	8	activities	activity	NOUN
iajs-3610	26	9	,	,	PUNCT
iajs-3610	26	10	t2	t2	NOUN
iajs-3610	26	11	dm	dm	PROPN
iajs-3610	26	12	is	be	AUX
iajs-3610	26	13	a	a	DET
iajs-3610	26	14	chronic	chronic	ADJ
iajs-3610	26	15	condition	condition	NOUN
iajs-3610	26	16	)	)	PUNCT
iajs-3610	26	17	9	9	NUM
iajs-3610	26	18	(	(	PUNCT
iajs-3610	26	19	.	.	PUNCT
iajs-3610	27	1	according	accord	VERB
iajs-3610	27	2	to	to	ADP
iajs-3610	27	3	american	american	ADJ
iajs-3610	27	4	diabetes	diabetes	PROPN
iajs-3610	27	5	association	association	NOUN
iajs-3610	27	6	,	,	PUNCT
iajs-3610	27	7	dm	dm	PROPN
iajs-3610	27	8	is	be	AUX
iajs-3610	27	9	first	first	ADV
iajs-3610	27	10	identified	identify	VERB
iajs-3610	27	11	by	by	ADP
iajs-3610	27	12	many	many	ADJ
iajs-3610	27	13	symptoms	symptom	NOUN
iajs-3610	27	14	,	,	PUNCT
iajs-3610	27	15	a	a	DET
iajs-3610	27	16	random	random	ADJ
iajs-3610	27	17	blood	blood	NOUN
iajs-3610	27	18	glucose	glucose	NOUN
iajs-3610	27	19	level	level	NOUN
iajs-3610	27	20	of	of	ADP
iajs-3610	27	21	200	200	NUM
iajs-3610	27	22	mg	mg	PROPN
iajs-3610	27	23	/	/	SYM
iajs-3610	27	24	dl	dl	PROPN
iajs-3610	27	25	,	,	PUNCT
iajs-3610	27	26	≥126	≥126	NOUN
iajs-3610	27	27	mg	mg	PROPN
iajs-3610	27	28	/	/	SYM
iajs-3610	27	29	dl	dl	PROPN
iajs-3610	27	30	for	for	ADP
iajs-3610	27	31	fasting	fast	VERB
iajs-3610	27	32	blood	blood	NOUN
iajs-3610	27	33	glucose	glucose	NOUN
iajs-3610	27	34	(	(	PUNCT
iajs-3610	27	35	fbg	fbg	PROPN
iajs-3610	27	36	)	)	PUNCT
iajs-3610	27	37	,	,	PUNCT
iajs-3610	27	38	≥	≥	NOUN
iajs-3610	27	39	200	200	NUM
iajs-3610	27	40	mg	mg	PROPN
iajs-3610	27	41	/	/	SYM
iajs-3610	27	42	dl	dl	PROPN
iajs-3610	27	43	for	for	ADP
iajs-3610	27	44	2	2	NUM
iajs-3610	27	45	-	-	PUNCT
iajs-3610	27	46	hour	hour	NOUN
iajs-3610	27	47	post	post	ADJ
iajs-3610	27	48	-	-	ADJ
iajs-3610	27	49	load	load	ADJ
iajs-3610	27	50	glucose	glucose	NOUN
iajs-3610	27	51	,	,	PUNCT
iajs-3610	27	52	or	or	CCONJ
iajs-3610	27	53	levels	level	NOUN
iajs-3610	27	54	of	of	ADP
iajs-3610	27	55	hba1c	hba1c	PROPN
iajs-3610	27	56	≥	≥	NUM
iajs-3610	27	57	6.5	6.5	NUM
iajs-3610	27	58	%	%	NOUN
iajs-3610	27	59	)	)	PUNCT
iajs-3610	27	60	10	10	NUM
iajs-3610	27	61	(	(	PUNCT
iajs-3610	27	62	.	.	PUNCT
iajs-3610	27	63	angiotensin	angiotensin	NOUN
iajs-3610	27	64	-	-	PUNCT
iajs-3610	27	65	converting	convert	VERB
iajs-3610	27	66	enzyme	enzyme	NOUN
iajs-3610	27	67	2	2	NUM
iajs-3610	27	68	(	(	PUNCT
iajs-3610	27	69	ace2	ace2	PROPN
iajs-3610	27	70	)	)	PUNCT
iajs-3610	27	71	is	be	AUX
iajs-3610	27	72	a	a	DET
iajs-3610	27	73	monocarboxypeptidase	monocarboxypeptidase	NOUN
iajs-3610	27	74	with	with	ADP
iajs-3610	27	75	a	a	DET
iajs-3610	27	76	single	single	ADJ
iajs-3610	27	77	enzymatic	enzymatic	ADJ
iajs-3610	27	78	binding	bind	VERB
iajs-3610	27	79	site	site	NOUN
iajs-3610	27	80	that	that	PRON
iajs-3610	27	81	acts	act	VERB
iajs-3610	27	82	as	as	ADP
iajs-3610	27	83	a	a	DET
iajs-3610	27	84	key	key	ADJ
iajs-3610	27	85	counter	counter	ADJ
iajs-3610	27	86	-	-	ADJ
iajs-3610	27	87	regulatory	regulatory	ADJ
iajs-3610	27	88	component	component	NOUN
iajs-3610	27	89	of	of	ADP
iajs-3610	27	90	the	the	DET
iajs-3610	27	91	renin	renin	ADJ
iajs-3610	27	92	-	-	PUNCT
iajs-3610	27	93	angiotensin	angiotensin	NOUN
iajs-3610	27	94	system	system	NOUN
iajs-3610	27	95	(	(	PUNCT
iajs-3610	27	96	ras	ras	NOUN
iajs-3610	27	97	)	)	PUNCT
iajs-3610	27	98	)	)	PUNCT
iajs-3610	27	99	11	11	NUM
iajs-3610	27	100	(	(	PUNCT
iajs-3610	27	101	.	.	PUNCT
iajs-3610	28	1	the	the	DET
iajs-3610	28	2	renin	renin	ADJ
iajs-3610	28	3	enzyme	enzyme	NOUN
iajs-3610	28	4	is	be	AUX
iajs-3610	28	5	produced	produce	VERB
iajs-3610	28	6	by	by	ADP
iajs-3610	28	7	the	the	DET
iajs-3610	28	8	kidneys	kidney	NOUN
iajs-3610	28	9	and	and	CCONJ
iajs-3610	28	10	acts	act	NOUN
iajs-3610	28	11	in	in	ADP
iajs-3610	28	12	converting	convert	VERB
iajs-3610	28	13	angiotensinogen	angiotensinogen	NOUN
iajs-3610	28	14	protein	protein	NOUN
iajs-3610	28	15	synthesis	synthesis	NOUN
iajs-3610	28	16	in	in	ADP
iajs-3610	28	17	the	the	DET
iajs-3610	28	18	liver	liver	NOUN
iajs-3610	28	19	to	to	PART
iajs-3610	28	20	angiotensin	angiotensin	VERB
iajs-3610	28	21	1	1	NUM
iajs-3610	28	22	by	by	ADP
iajs-3610	28	23	removing	remove	VERB
iajs-3610	28	24	10	10	NUM
iajs-3610	28	25	amino	amino	ADJ
iajs-3610	28	26	acids	acid	NOUN
iajs-3610	28	27	from	from	ADP
iajs-3610	28	28	the	the	DET
iajs-3610	28	29	peptide	peptide	NOUN
iajs-3610	28	30	)	)	PUNCT
iajs-3610	28	31	12	12	NUM
iajs-3610	28	32	(	(	PUNCT
iajs-3610	28	33	.	.	PUNCT
iajs-3610	29	1	lung	lung	PROPN
iajs-3610	29	2	and	and	CCONJ
iajs-3610	29	3	kidney	kidney	PROPN
iajs-3610	29	4	produce	produce	VERB
iajs-3610	29	5	ace	ace	NOUN
iajs-3610	29	6	to	to	PART
iajs-3610	29	7	convert	convert	VERB
iajs-3610	29	8	angiotensin	angiotensin	NOUN
iajs-3610	29	9	i	i	PRON
iajs-3610	29	10	to	to	PART
iajs-3610	29	11	angiotensin	angiotensin	VERB
iajs-3610	29	12	įį	įį	ADP
iajs-3610	29	13	by	by	ADP
iajs-3610	29	14	removing	remove	VERB
iajs-3610	29	15	2	2	NUM
iajs-3610	29	16	amino	amino	NOUN
iajs-3610	29	17	acids	acid	NOUN
iajs-3610	29	18	from	from	ADP
iajs-3610	29	19	peptide	peptide	NOUN
iajs-3610	29	20	at	at	ADP
iajs-3610	29	21	positions	position	NOUN
iajs-3610	29	22	14	14	NUM
iajs-3610	29	23	and	and	CCONJ
iajs-3610	29	24	15	15	NUM
iajs-3610	29	25	.	.	PUNCT
iajs-3610	30	1	the	the	DET
iajs-3610	30	2	ace2	ace2	PROPN
iajs-3610	30	3	is	be	AUX
iajs-3610	30	4	the	the	DET
iajs-3610	30	5	only	only	ADV
iajs-3610	30	6	known	know	VERB
iajs-3610	30	7	homolog	homolog	NOUN
iajs-3610	30	8	of	of	ADP
iajs-3610	30	9	ace	ace	NOUN
iajs-3610	30	10	;	;	PUNCT
iajs-3610	30	11	it	it	PRON
iajs-3610	30	12	shares	share	VERB
iajs-3610	30	13	42	42	NUM
iajs-3610	30	14	%	%	NOUN
iajs-3610	30	15	of	of	ADP
iajs-3610	30	16	sequence	sequence	NOUN
iajs-3610	30	17	identity	identity	NOUN
iajs-3610	30	18	with	with	ADP
iajs-3610	30	19	somatic	somatic	ADJ
iajs-3610	30	20	ace	ace	NOUN
iajs-3610	30	21	and	and	CCONJ
iajs-3610	30	22	61	61	NUM
iajs-3610	30	23	%	%	NOUN
iajs-3610	30	24	similarity	similarity	NOUN
iajs-3610	30	25	in	in	ADP
iajs-3610	30	26	the	the	DET
iajs-3610	30	27	area	area	NOUN
iajs-3610	30	28	surrounding	surround	VERB
iajs-3610	30	29	the	the	DET
iajs-3610	30	30	active	active	ADJ
iajs-3610	30	31	site	site	NOUN
iajs-3610	30	32	)	)	PUNCT
iajs-3610	30	33	13,14	13,14	NUM
iajs-3610	30	34	(	(	PUNCT
iajs-3610	30	35	.	.	PUNCT
iajs-3610	31	1	it	it	PRON
iajs-3610	31	2	is	be	AUX
iajs-3610	31	3	expressed	express	VERB
iajs-3610	31	4	on	on	ADP
iajs-3610	31	5	the	the	DET
iajs-3610	31	6	surfaces	surface	NOUN
iajs-3610	31	7	of	of	ADP
iajs-3610	31	8	endothelial	endothelial	ADJ
iajs-3610	31	9	and	and	CCONJ
iajs-3610	31	10	epithelial	epithelial	ADJ
iajs-3610	31	11	cells	cell	NOUN
iajs-3610	31	12	in	in	ADP
iajs-3610	31	13	a	a	DET
iajs-3610	31	14	membrane	membrane	NOUN
iajs-3610	31	15	-	-	PUNCT
iajs-3610	31	16	bound	bind	VERB
iajs-3610	31	17	form	form	NOUN
iajs-3610	31	18	)	)	PUNCT
iajs-3610	31	19	15	15	NUM
iajs-3610	31	20	(	(	PUNCT
iajs-3610	31	21	as	as	ADV
iajs-3610	31	22	well	well	ADV
iajs-3610	31	23	as	as	ADP
iajs-3610	31	24	in	in	ADP
iajs-3610	31	25	a	a	DET
iajs-3610	31	26	soluble	soluble	ADJ
iajs-3610	31	27	form	form	NOUN
iajs-3610	31	28	in	in	ADP
iajs-3610	31	29	several	several	ADJ
iajs-3610	31	30	tissues	tissue	NOUN
iajs-3610	31	31	throughout	throughout	ADP
iajs-3610	31	32	the	the	DET
iajs-3610	31	33	body	body	NOUN
iajs-3610	31	34	,	,	PUNCT
iajs-3610	31	35	including	include	VERB
iajs-3610	31	36	the	the	DET
iajs-3610	31	37	kidneys	kidney	NOUN
iajs-3610	31	38	,	,	PUNCT
iajs-3610	31	39	heart	heart	NOUN
iajs-3610	31	40	,	,	PUNCT
iajs-3610	31	41	gastrointestinal	gastrointestinal	ADJ
iajs-3610	31	42	tract	tract	NOUN
iajs-3610	31	43	,	,	PUNCT
iajs-3610	31	44	and	and	CCONJ
iajs-3610	31	45	lungs	lung	NOUN
iajs-3610	31	46	)	)	PUNCT
iajs-3610	31	47	16,17	16,17	NUM
iajs-3610	31	48	(	(	PUNCT
iajs-3610	31	49	.	.	PUNCT
iajs-3610	32	1	ace2	ace2	PROPN
iajs-3610	32	2	promotes	promote	VERB
iajs-3610	32	3	the	the	DET
iajs-3610	32	4	development	development	NOUN
iajs-3610	32	5	of	of	ADP
iajs-3610	32	6	microalbuminuria	microalbuminuria	PROPN
iajs-3610	32	7	and	and	CCONJ
iajs-3610	32	8	diabetic	diabetic	ADJ
iajs-3610	32	9	nephropathy	nephropathy	NOUN
iajs-3610	32	10	(	(	PUNCT
iajs-3610	32	11	dn	dn	NOUN
iajs-3610	32	12	)	)	PUNCT
iajs-3610	32	13	)	)	PUNCT
iajs-3610	33	1	18	18	NUM
iajs-3610	33	2	(	(	PUNCT
iajs-3610	33	3	.	.	PUNCT
iajs-3610	34	1	urea	urea	PROPN
iajs-3610	34	2	and	and	CCONJ
iajs-3610	34	3	creatinine	creatinine	NOUN
iajs-3610	34	4	are	be	AUX
iajs-3610	34	5	nitrogenous	nitrogenous	ADJ
iajs-3610	34	6	end	end	NOUN
iajs-3610	34	7	products	product	NOUN
iajs-3610	34	8	of	of	ADP
iajs-3610	34	9	metabolism	metabolism	NOUN
iajs-3610	34	10	.	.	PUNCT
iajs-3610	35	1	urea	urea	PROPN
iajs-3610	35	2	is	be	AUX
iajs-3610	35	3	the	the	DET
iajs-3610	35	4	primary	primary	ADJ
iajs-3610	35	5	metabolite	metabolite	NOUN
iajs-3610	35	6	derived	derive	VERB
iajs-3610	35	7	from	from	ADP
iajs-3610	35	8	dietary	dietary	ADJ
iajs-3610	35	9	protein	protein	NOUN
iajs-3610	35	10	and	and	CCONJ
iajs-3610	35	11	the	the	DET
iajs-3610	35	12	breakdown	breakdown	NOUN
iajs-3610	35	13	of	of	ADP
iajs-3610	35	14	tissue	tissue	NOUN
iajs-3610	35	15	protein	protein	NOUN
iajs-3610	35	16	.	.	PUNCT
iajs-3610	36	1	creatinine	creatinine	NOUN
iajs-3610	36	2	is	be	AUX
iajs-3610	36	3	the	the	DET
iajs-3610	36	4	product	product	NOUN
iajs-3610	36	5	of	of	ADP
iajs-3610	36	6	muscle	muscle	NOUN
iajs-3610	36	7	creatine	creatine	NOUN
iajs-3610	36	8	catabolism	catabolism	NOUN
iajs-3610	36	9	.	.	PUNCT
iajs-3610	37	1	both	both	PRON
iajs-3610	37	2	are	be	AUX
iajs-3610	37	3	relatively	relatively	ADV
iajs-3610	37	4	small	small	ADJ
iajs-3610	37	5	molecules	molecule	NOUN
iajs-3610	37	6	that	that	PRON
iajs-3610	37	7	distribute	distribute	VERB
iajs-3610	37	8	through	through	ADP
iajs-3610	37	9	total	total	ADJ
iajs-3610	37	10	body	body	NOUN
iajs-3610	37	11	water	water	NOUN
iajs-3610	37	12	)	)	PUNCT
iajs-3610	37	13	19,20	19,20	NOUN
iajs-3610	37	14	(	(	PUNCT
iajs-3610	37	15	.	.	PUNCT
iajs-3610	38	1	as	as	SCONJ
iajs-3610	38	2	creatinine	creatinine	NOUN
iajs-3610	38	3	is	be	AUX
iajs-3610	38	4	produced	produce	VERB
iajs-3610	38	5	,	,	PUNCT
iajs-3610	38	6	it	it	PRON
iajs-3610	38	7	is	be	AUX
iajs-3610	38	8	filtered	filter	VERB
iajs-3610	38	9	through	through	ADP
iajs-3610	38	10	the	the	DET
iajs-3610	38	11	kidneys	kidney	NOUN
iajs-3610	38	12	and	and	CCONJ
iajs-3610	38	13	excreted	excrete	VERB
iajs-3610	38	14	in	in	ADP
iajs-3610	38	15	the	the	DET
iajs-3610	38	16	urine	urine	NOUN
iajs-3610	38	17	)	)	PUNCT
iajs-3610	38	18	21	21	NUM
iajs-3610	38	19	(	(	PUNCT
iajs-3610	38	20	.	.	PUNCT
iajs-3610	39	1	dyslipidemia	dyslipidemia	NOUN
iajs-3610	39	2	is	be	AUX
iajs-3610	39	3	a	a	DET
iajs-3610	39	4	significant	significant	ADJ
iajs-3610	39	5	factor	factor	NOUN
iajs-3610	39	6	in	in	ADP
iajs-3610	39	7	dn	dn	PROPN
iajs-3610	39	8	patients	patient	NOUN
iajs-3610	39	9	,	,	PUNCT
iajs-3610	39	10	characterized	characterize	VERB
iajs-3610	39	11	by	by	ADP
iajs-3610	39	12	higher	high	ADJ
iajs-3610	39	13	levels	level	NOUN
iajs-3610	39	14	of	of	ADP
iajs-3610	39	15	serum	serum	NOUN
iajs-3610	39	16	triglycerides	triglyceride	NOUN
iajs-3610	39	17	(	(	PUNCT
iajs-3610	39	18	tg	tg	NOUN
iajs-3610	39	19	)	)	PUNCT
iajs-3610	39	20	,	,	PUNCT
iajs-3610	39	21	low	low	ADJ
iajs-3610	39	22	-	-	PUNCT
iajs-3610	39	23	density	density	NOUN
iajs-3610	39	24	lipoprotein	lipoprotein	ADJ
iajs-3610	39	25	cholesterol	cholesterol	NOUN
iajs-3610	39	26	(	(	PUNCT
iajs-3610	39	27	ldl	ldl	NOUN
iajs-3610	39	28	-	-	PUNCT
iajs-3610	39	29	c	c	NOUN
iajs-3610	39	30	)	)	PUNCT
iajs-3610	39	31	,	,	PUNCT
iajs-3610	39	32	and	and	CCONJ
iajs-3610	39	33	very	very	ADV
iajs-3610	39	34	low	low	ADJ
iajs-3610	39	35	-	-	PUNCT
iajs-3610	39	36	density	density	NOUN
iajs-3610	39	37	lipoproteins	lipoprotein	NOUN
iajs-3610	39	38	(	(	PUNCT
iajs-3610	39	39	vldl	vldl	NOUN
iajs-3610	39	40	)	)	PUNCT
iajs-3610	39	41	,	,	PUNCT
iajs-3610	39	42	with	with	ADP
iajs-3610	39	43	low	low	ADJ
iajs-3610	39	44	levels	level	NOUN
iajs-3610	39	45	of	of	ADP
iajs-3610	39	46	high	high	ADJ
iajs-3610	39	47	-	-	PUNCT
iajs-3610	39	48	density	density	NOUN
iajs-3610	39	49	lipoprotein	lipoprotein	ADJ
iajs-3610	39	50	cholesterol	cholesterol	NOUN
iajs-3610	39	51	(	(	PUNCT
iajs-3610	39	52	hdl	hdl	NOUN
iajs-3610	39	53	-	-	PUNCT
iajs-3610	39	54	c	c	NOUN
iajs-3610	39	55	)	)	PUNCT
iajs-3610	39	56	)	)	PUNCT
iajs-3610	40	1	22	22	NUM
iajs-3610	40	2	(	(	PUNCT
iajs-3610	40	3	.	.	PUNCT
iajs-3610	41	1	raised	raise	VERB
iajs-3610	41	2	cholesterol	cholesterol	NOUN
iajs-3610	41	3	levels	level	NOUN
iajs-3610	41	4	are	be	AUX
iajs-3610	41	5	linked	link	VERB
iajs-3610	41	6	to	to	ADP
iajs-3610	41	7	the	the	DET
iajs-3610	41	8	development	development	NOUN
iajs-3610	41	9	of	of	ADP
iajs-3610	41	10	severe	severe	ADJ
iajs-3610	41	11	or	or	CCONJ
iajs-3610	41	12	moderate	moderate	ADJ
iajs-3610	41	13	urine	urine	NOUN
iajs-3610	41	14	albumin	albumin	ADJ
iajs-3610	41	15	excretion	excretion	NOUN
iajs-3610	41	16	in	in	ADP
iajs-3610	41	17	t2	t2	NOUN
iajs-3610	41	18	dm	dm	PROPN
iajs-3610	41	19	patients	patient	NOUN
iajs-3610	41	20	.	.	PUNCT
iajs-3610	42	1	lowering	lower	VERB
iajs-3610	42	2	cholesterol	cholesterol	NOUN
iajs-3610	42	3	and	and	CCONJ
iajs-3610	42	4	triglyceride	triglyceride	ADJ
iajs-3610	42	5	(	(	PUNCT
iajs-3610	42	6	tg	tg	NOUN
iajs-3610	42	7	)	)	PUNCT
iajs-3610	42	8	levels	level	NOUN
iajs-3610	42	9	in	in	ADP
iajs-3610	42	10	dm	dm	PROPN
iajs-3610	42	11	patients	patient	NOUN
iajs-3610	42	12	helps	help	VERB
iajs-3610	42	13	to	to	PART
iajs-3610	42	14	reduce	reduce	VERB
iajs-3610	42	15	urine	urine	NOUN
iajs-3610	42	16	albumin	albumin	ADJ
iajs-3610	42	17	excretion	excretion	NOUN
iajs-3610	42	18	from	from	ADP
iajs-3610	42	19	a	a	DET
iajs-3610	42	20	mild	mild	NOUN
iajs-3610	42	21	to	to	ADP
iajs-3610	42	22	a	a	DET
iajs-3610	42	23	normal	normal	ADJ
iajs-3610	42	24	level	level	NOUN
iajs-3610	42	25	)	)	PUNCT
iajs-3610	42	26	23	23	NUM
iajs-3610	42	27	(	(	PUNCT
iajs-3610	42	28	.	.	PUNCT
iajs-3610	43	1	albuminuria	albuminuria	PROPN
iajs-3610	43	2	,	,	PUNCT
iajs-3610	43	3	which	which	PRON
iajs-3610	43	4	represents	represent	VERB
iajs-3610	43	5	the	the	DET
iajs-3610	43	6	degree	degree	NOUN
iajs-3610	43	7	of	of	ADP
iajs-3610	43	8	glomerular	glomerular	ADJ
iajs-3610	43	9	damage	damage	NOUN
iajs-3610	43	10	,	,	PUNCT
iajs-3610	43	11	and	and	CCONJ
iajs-3610	43	12	serum	serum	NOUN
iajs-3610	43	13	creatinine	creatinine	NOUN
iajs-3610	43	14	,	,	PUNCT
iajs-3610	43	15	which	which	PRON
iajs-3610	43	16	may	may	AUX
iajs-3610	43	17	be	be	AUX
iajs-3610	43	18	used	use	VERB
iajs-3610	43	19	to	to	PART
iajs-3610	43	20	calculate	calculate	VERB
iajs-3610	43	21	estimated	estimate	VERB
iajs-3610	43	22	glomerular	glomerular	ADJ
iajs-3610	43	23	filtration	filtration	NOUN
iajs-3610	43	24	rate	rate	NOUN
iajs-3610	43	25	(	(	PUNCT
iajs-3610	43	26	egfr	egfr	NOUN
iajs-3610	43	27	)	)	PUNCT
iajs-3610	43	28	,	,	PUNCT
iajs-3610	43	29	are	be	AUX
iajs-3610	43	30	two	two	NUM
iajs-3610	43	31	parameters	parameter	NOUN
iajs-3610	43	32	that	that	PRON
iajs-3610	43	33	can	can	AUX
iajs-3610	43	34	be	be	AUX
iajs-3610	43	35	used	use	VERB
iajs-3610	43	36	to	to	PART
iajs-3610	43	37	assess	assess	VERB
iajs-3610	43	38	the	the	DET
iajs-3610	43	39	presence	presence	NOUN
iajs-3610	43	40	of	of	ADP
iajs-3610	43	41	dn	dn	PROPN
iajs-3610	43	42	)	)	PUNCT
iajs-3610	43	43	24	24	NUM
iajs-3610	43	44	(	(	PUNCT
iajs-3610	43	45	.	.	PUNCT
iajs-3610	44	1	however	however	ADV
iajs-3610	44	2	,	,	PUNCT
iajs-3610	44	3	acr	acr	PROPN
iajs-3610	44	4	is	be	AUX
iajs-3610	44	5	thought	think	VERB
iajs-3610	44	6	to	to	PART
iajs-3610	44	7	be	be	AUX
iajs-3610	44	8	a	a	DET
iajs-3610	44	9	more	more	ADV
iajs-3610	44	10	accurate	accurate	ADJ
iajs-3610	44	11	and	and	CCONJ
iajs-3610	44	12	sensitive	sensitive	ADJ
iajs-3610	44	13	biomarker	biomarker	NOUN
iajs-3610	44	14	for	for	ADP
iajs-3610	44	15	identifying	identify	VERB
iajs-3610	44	16	patients	patient	NOUN
iajs-3610	44	17	who	who	PRON
iajs-3610	44	18	are	be	AUX
iajs-3610	44	19	at	at	ADP
iajs-3610	44	20	high	high	ADJ
iajs-3610	44	21	risk	risk	NOUN
iajs-3610	44	22	of	of	ADP
iajs-3610	44	23	developing	develop	VERB
iajs-3610	44	24	dn	dn	PROPN
iajs-3610	44	25	)	)	PUNCT
iajs-3610	44	26	25	25	NUM
iajs-3610	44	27	(	(	PUNCT
iajs-3610	44	28	.	.	PUNCT
iajs-3610	45	1	patients	patient	NOUN
iajs-3610	45	2	with	with	ADP
iajs-3610	45	3	persistent	persistent	ADJ
iajs-3610	45	4	microalbuminuria	microalbuminuria	PROPN
iajs-3610	45	5	still	still	ADV
iajs-3610	45	6	develop	develop	VERB
iajs-3610	45	7	to	to	PART
iajs-3610	45	8	dn	dn	VERB
iajs-3610	45	9	stages	stage	NOUN
iajs-3610	45	10	3	3	NUM
iajs-3610	45	11	-	-	SYM
iajs-3610	45	12	5	5	NUM
iajs-3610	45	13	)	)	PUNCT
iajs-3610	45	14	26	26	NUM
iajs-3610	45	15	(	(	PUNCT
iajs-3610	45	16	.	.	PUNCT
iajs-3610	46	1	this	this	DET
iajs-3610	46	2	study	study	NOUN
iajs-3610	46	3	aims	aim	VERB
iajs-3610	46	4	to	to	PART
iajs-3610	46	5	measure	measure	VERB
iajs-3610	46	6	the	the	DET
iajs-3610	46	7	ace2	ace2	PROPN
iajs-3610	46	8	,	,	PUNCT
iajs-3610	46	9	urine	urine	NOUN
iajs-3610	46	10	acr	acr	NOUN
iajs-3610	46	11	,	,	PUNCT
iajs-3610	46	12	and	and	CCONJ
iajs-3610	46	13	some	some	DET
iajs-3610	46	14	factors	factor	NOUN
iajs-3610	46	15	associated	associate	VERB
iajs-3610	46	16	with	with	ADP
iajs-3610	46	17	dn	dn	NOUN
iajs-3610	46	18	for	for	ADP
iajs-3610	46	19	the	the	DET
iajs-3610	46	20	early	early	ADJ
iajs-3610	46	21	detection	detection	NOUN
iajs-3610	46	22	of	of	ADP
iajs-3610	46	23	dn	dn	PROPN
iajs-3610	46	24	in	in	ADP
iajs-3610	46	25	t2	t2	NOUN
iajs-3610	46	26	dm	dm	PROPN
iajs-3610	46	27	patients	patient	NOUN
iajs-3610	46	28	.	.	PUNCT
iajs-3610	47	1	2	2	X
iajs-3610	47	2	.	.	X
iajs-3610	47	3	materials	material	NOUN
iajs-3610	47	4	and	and	CCONJ
iajs-3610	47	5	methods	method	NOUN
iajs-3610	47	6	a	a	DET
iajs-3610	47	7	total	total	NOUN
iajs-3610	47	8	of	of	ADP
iajs-3610	47	9	135	135	NUM
iajs-3610	47	10	participants	participant	NOUN
iajs-3610	47	11	aged	age	VERB
iajs-3610	47	12	32	32	NUM
iajs-3610	47	13	-	-	SYM
iajs-3610	47	14	76	76	NUM
iajs-3610	47	15	years	year	NOUN
iajs-3610	47	16	with	with	ADP
iajs-3610	47	17	t2	t2	NOUN
iajs-3610	47	18	dm	dm	PROPN
iajs-3610	47	19	and	and	CCONJ
iajs-3610	47	20	albuminuria	albuminuria	NOUN
iajs-3610	47	21	were	be	AUX
iajs-3610	47	22	included	include	VERB
iajs-3610	47	23	.	.	PUNCT
iajs-3610	48	1	ninety	ninety	NUM
iajs-3610	48	2	t2	t2	PROPN
iajs-3610	48	3	dm	dm	PROPN
iajs-3610	48	4	patients	patient	NOUN
iajs-3610	48	5	were	be	AUX
iajs-3610	48	6	involved	involve	VERB
iajs-3610	48	7	,	,	PUNCT
iajs-3610	48	8	and	and	CCONJ
iajs-3610	48	9	they	they	PRON
iajs-3610	48	10	were	be	AUX
iajs-3610	48	11	subdivided	subdivide	VERB
iajs-3610	48	12	into	into	ADP
iajs-3610	48	13	three	three	NUM
iajs-3610	48	14	groups	group	NOUN
iajs-3610	48	15	according	accord	VERB
iajs-3610	48	16	to	to	ADP
iajs-3610	48	17	their	their	PRON
iajs-3610	48	18	albuminuria	albuminuria	NOUN
iajs-3610	48	19	levels	level	NOUN
iajs-3610	48	20	:	:	PUNCT
iajs-3610	48	21	22	22	NUM
iajs-3610	48	22	patients	patient	NOUN
iajs-3610	48	23	who	who	PRON
iajs-3610	48	24	had	have	VERB
iajs-3610	48	25	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	48	26	(	(	PUNCT
iajs-3610	48	27	acr	acr	NOUN
iajs-3610	48	28	=	=	PROPN
iajs-3610	48	29	300	300	NUM
iajs-3610	48	30	mg	mg	PROPN
iajs-3610	48	31	/	/	SYM
iajs-3610	48	32	g	g	NOUN
iajs-3610	48	33	)	)	PUNCT
iajs-3610	48	34	;	;	PUNCT
iajs-3610	48	35	23	23	NUM
iajs-3610	48	36	patients	patient	NOUN
iajs-3610	48	37	had	have	VERB
iajs-3610	48	38	microalbuminuria	microalbuminuria	PROPN
iajs-3610	48	39	(	(	PUNCT
iajs-3610	48	40	acr=	acr=	NOUN
iajs-3610	48	41	30–300	30–300	NUM
iajs-3610	48	42	mg	mg	PROPN
iajs-3610	48	43	/	/	SYM
iajs-3610	48	44	g	g	NOUN
iajs-3610	48	45	)	)	PUNCT
iajs-3610	48	46	,	,	PUNCT
iajs-3610	48	47	and	and	CCONJ
iajs-3610	48	48	45	45	NUM
iajs-3610	48	49	diabetic	diabetic	ADJ
iajs-3610	48	50	patients	patient	NOUN
iajs-3610	48	51	had	have	VERB
iajs-3610	48	52	ihjpas	ihjpa	NOUN
iajs-3610	48	53	.	.	PUNCT
iajs-3610	49	1	2025	2025	NUM
iajs-3610	49	2	,	,	PUNCT
iajs-3610	49	3	38(3	38(3	NUM
iajs-3610	49	4	)	)	PUNCT
iajs-3610	49	5	229	229	NUM
iajs-3610	49	6	normoalbuminuria	normoalbuminuria	NOUN
iajs-3610	49	7	(	(	PUNCT
iajs-3610	49	8	acr	acr	NOUN
iajs-3610	49	9	=	=	SYM
iajs-3610	49	10	30	30	NUM
iajs-3610	49	11	mg	mg	PROPN
iajs-3610	49	12	/	/	SYM
iajs-3610	49	13	g	g	NOUN
iajs-3610	49	14	)	)	PUNCT
iajs-3610	49	15	.	.	PUNCT
iajs-3610	50	1	they	they	PRON
iajs-3610	50	2	were	be	AUX
iajs-3610	50	3	compared	compare	VERB
iajs-3610	50	4	with	with	ADP
iajs-3610	50	5	a	a	DET
iajs-3610	50	6	control	control	NOUN
iajs-3610	50	7	group	group	NOUN
iajs-3610	50	8	of	of	ADP
iajs-3610	50	9	45	45	NUM
iajs-3610	50	10	healthy	healthy	ADJ
iajs-3610	50	11	individuals	individual	NOUN
iajs-3610	50	12	,	,	PUNCT
iajs-3610	50	13	and	and	CCONJ
iajs-3610	50	14	their	their	PRON
iajs-3610	50	15	clinical	clinical	ADJ
iajs-3610	50	16	examination	examination	NOUN
iajs-3610	50	17	and	and	CCONJ
iajs-3610	50	18	disease	disease	NOUN
iajs-3610	50	19	history	history	NOUN
iajs-3610	50	20	were	be	AUX
iajs-3610	50	21	collected	collect	VERB
iajs-3610	50	22	.	.	PUNCT
iajs-3610	51	1	after	after	ADP
iajs-3610	51	2	a	a	PRON
iajs-3610	51	3	12	12	NUM
iajs-3610	51	4	-	-	PUNCT
iajs-3610	51	5	hour	hour	NOUN
iajs-3610	51	6	overnight	overnight	ADV
iajs-3610	51	7	fast	fast	ADV
iajs-3610	51	8	,	,	PUNCT
iajs-3610	51	9	venous	venous	ADJ
iajs-3610	51	10	blood	blood	NOUN
iajs-3610	51	11	samples	sample	NOUN
iajs-3610	51	12	were	be	AUX
iajs-3610	51	13	obtained	obtain	VERB
iajs-3610	51	14	from	from	ADP
iajs-3610	51	15	diabetic	diabetic	ADJ
iajs-3610	51	16	patients	patient	NOUN
iajs-3610	51	17	and	and	CCONJ
iajs-3610	51	18	healthy	healthy	ADJ
iajs-3610	51	19	volunteers	volunteer	NOUN
iajs-3610	51	20	and	and	CCONJ
iajs-3610	51	21	placed	place	VERB
iajs-3610	51	22	into	into	ADP
iajs-3610	51	23	three	three	NUM
iajs-3610	51	24	different	different	ADJ
iajs-3610	51	25	types	type	NOUN
iajs-3610	51	26	of	of	ADP
iajs-3610	51	27	tubes	tube	NOUN
iajs-3610	51	28	.	.	PUNCT
iajs-3610	52	1	the	the	DET
iajs-3610	52	2	samples	sample	NOUN
iajs-3610	52	3	were	be	AUX
iajs-3610	52	4	then	then	ADV
iajs-3610	52	5	processed	process	VERB
iajs-3610	52	6	as	as	SCONJ
iajs-3610	52	7	follows	follow	VERB
iajs-3610	52	8	:	:	PUNCT
iajs-3610	52	9	the	the	DET
iajs-3610	52	10	first	first	ADJ
iajs-3610	52	11	tube	tube	NOUN
iajs-3610	52	12	was	be	AUX
iajs-3610	52	13	filled	fill	VERB
iajs-3610	52	14	with	with	ADP
iajs-3610	52	15	whole	whole	ADJ
iajs-3610	52	16	blood	blood	NOUN
iajs-3610	52	17	sample	sample	NOUN
iajs-3610	52	18	and	and	CCONJ
iajs-3610	52	19	edta	edta	NOUN
iajs-3610	52	20	without	without	ADP
iajs-3610	52	21	centrifugation	centrifugation	NOUN
iajs-3610	52	22	for	for	ADP
iajs-3610	52	23	the	the	DET
iajs-3610	52	24	assay	assay	NOUN
iajs-3610	52	25	of	of	ADP
iajs-3610	52	26	glycosylated	glycosylated	ADJ
iajs-3610	52	27	hemoglobin	hemoglobin	NOUN
iajs-3610	52	28	(	(	PUNCT
iajs-3610	52	29	hba1c	hba1c	PROPN
iajs-3610	52	30	)	)	PUNCT
iajs-3610	52	31	;	;	PUNCT
iajs-3610	52	32	the	the	DET
iajs-3610	52	33	second	second	ADJ
iajs-3610	52	34	tube	tube	NOUN
iajs-3610	52	35	was	be	AUX
iajs-3610	52	36	filled	fill	VERB
iajs-3610	52	37	with	with	ADP
iajs-3610	52	38	potassium	potassium	NOUN
iajs-3610	52	39	oxalate	oxalate	NOUN
iajs-3610	52	40	and	and	CCONJ
iajs-3610	52	41	sodium	sodium	NOUN
iajs-3610	52	42	fluoride	fluoride	NOUN
iajs-3610	52	43	for	for	ADP
iajs-3610	52	44	the	the	DET
iajs-3610	52	45	simultaneous	simultaneous	ADJ
iajs-3610	52	46	assay	assay	NOUN
iajs-3610	52	47	of	of	ADP
iajs-3610	52	48	plasma	plasma	NOUN
iajs-3610	52	49	glucose	glucose	NOUN
iajs-3610	52	50	;	;	PUNCT
iajs-3610	52	51	and	and	CCONJ
iajs-3610	52	52	the	the	DET
iajs-3610	52	53	third	third	ADJ
iajs-3610	52	54	tube	tube	NOUN
iajs-3610	52	55	was	be	AUX
iajs-3610	52	56	filled	fill	VERB
iajs-3610	52	57	with	with	ADP
iajs-3610	52	58	blood	blood	NOUN
iajs-3610	52	59	,	,	PUNCT
iajs-3610	52	60	which	which	PRON
iajs-3610	52	61	was	be	AUX
iajs-3610	52	62	centrifuged	centrifuge	VERB
iajs-3610	52	63	at	at	ADP
iajs-3610	52	64	4000	4000	NUM
iajs-3610	52	65	rpm	rpm	NOUN
iajs-3610	52	66	for	for	ADP
iajs-3610	52	67	10	10	NUM
iajs-3610	52	68	minutes	minute	NOUN
iajs-3610	52	69	.	.	PUNCT
iajs-3610	53	1	aliquots	aliquot	NOUN
iajs-3610	53	2	of	of	ADP
iajs-3610	53	3	serum	serum	NOUN
iajs-3610	53	4	were	be	AUX
iajs-3610	53	5	quickly	quickly	ADV
iajs-3610	53	6	split	split	VERB
iajs-3610	53	7	and	and	CCONJ
iajs-3610	53	8	separated	separate	VERB
iajs-3610	53	9	.	.	PUNCT
iajs-3610	54	1	on	on	ADP
iajs-3610	54	2	the	the	DET
iajs-3610	54	3	same	same	ADJ
iajs-3610	54	4	day	day	NOUN
iajs-3610	54	5	that	that	SCONJ
iajs-3610	54	6	the	the	DET
iajs-3610	54	7	blood	blood	NOUN
iajs-3610	54	8	was	be	AUX
iajs-3610	54	9	drawn	draw	VERB
iajs-3610	54	10	,	,	PUNCT
iajs-3610	54	11	a	a	DET
iajs-3610	54	12	single	single	ADJ
iajs-3610	54	13	aliquot	aliquot	NOUN
iajs-3610	54	14	of	of	ADP
iajs-3610	54	15	serum	serum	NOUN
iajs-3610	54	16	was	be	AUX
iajs-3610	54	17	used	use	VERB
iajs-3610	54	18	to	to	PART
iajs-3610	54	19	test	test	VERB
iajs-3610	54	20	the	the	DET
iajs-3610	54	21	lipid	lipid	NOUN
iajs-3610	54	22	profile	profile	NOUN
iajs-3610	54	23	.	.	PUNCT
iajs-3610	55	1	also	also	ADV
iajs-3610	55	2	,	,	PUNCT
iajs-3610	55	3	it	it	PRON
iajs-3610	55	4	was	be	AUX
iajs-3610	55	5	used	use	VERB
iajs-3610	55	6	after	after	ADP
iajs-3610	55	7	being	be	AUX
iajs-3610	55	8	maintained	maintain	VERB
iajs-3610	55	9	at	at	ADP
iajs-3610	55	10	-20	-20	PROPN
iajs-3610	55	11	°	°	ADP
iajs-3610	55	12	c	c	NOUN
iajs-3610	55	13	to	to	PART
iajs-3610	55	14	assess	assess	VERB
iajs-3610	55	15	ace2	ace2	PROPN
iajs-3610	55	16	,	,	PUNCT
iajs-3610	55	17	which	which	PRON
iajs-3610	55	18	was	be	AUX
iajs-3610	55	19	evaluated	evaluate	VERB
iajs-3610	55	20	using	use	VERB
iajs-3610	55	21	the	the	DET
iajs-3610	55	22	biosource	biosource	NOUN
iajs-3610	55	23	manufacturer	manufacturer	NOUN
iajs-3610	55	24	's	's	PART
iajs-3610	55	25	enzyme	enzyme	NOUN
iajs-3610	55	26	-	-	PUNCT
iajs-3610	55	27	linked	link	VERB
iajs-3610	55	28	immunosorbent	immunosorbent	NOUN
iajs-3610	55	29	assay	assay	PROPN
iajs-3610	55	30	(	(	PUNCT
iajs-3610	55	31	elisa	elisa	NOUN
iajs-3610	55	32	)	)	PUNCT
iajs-3610	55	33	kit	kit	NOUN
iajs-3610	55	34	from	from	ADP
iajs-3610	55	35	the	the	DET
iajs-3610	55	36	usa	usa	PROPN
iajs-3610	55	37	.	.	PROPN
iajs-3610	55	38	urine	urine	NOUN
iajs-3610	55	39	samples	sample	NOUN
iajs-3610	55	40	were	be	AUX
iajs-3610	55	41	collected	collect	VERB
iajs-3610	55	42	in	in	ADP
iajs-3610	55	43	a	a	DET
iajs-3610	55	44	clean	clean	ADJ
iajs-3610	55	45	glass	glass	NOUN
iajs-3610	55	46	tube	tube	NOUN
iajs-3610	55	47	for	for	ADP
iajs-3610	55	48	determining	determine	VERB
iajs-3610	55	49	urinary	urinary	ADJ
iajs-3610	55	50	acr	acr	NOUN
iajs-3610	55	51	using	use	VERB
iajs-3610	55	52	the	the	DET
iajs-3610	55	53	fus	fus	ADJ
iajs-3610	55	54	3000	3000	NUM
iajs-3610	55	55	urinalysis	urinalysis	NOUN
iajs-3610	55	56	device	device	NOUN
iajs-3610	55	57	.	.	PUNCT
iajs-3610	56	1	the	the	DET
iajs-3610	56	2	egfr	egfr	NOUN
iajs-3610	56	3	was	be	AUX
iajs-3610	56	4	calculated	calculate	VERB
iajs-3610	56	5	using	use	VERB
iajs-3610	56	6	the	the	DET
iajs-3610	56	7	chronic	chronic	ADJ
iajs-3610	56	8	kidney	kidney	NOUN
iajs-3610	56	9	disease	disease	NOUN
iajs-3610	56	10	(	(	PUNCT
iajs-3610	56	11	ckd)epi	ckd)epi	PROPN
iajs-3610	56	12	formula	formula	NOUN
iajs-3610	56	13	(	(	PUNCT
iajs-3610	56	14	27	27	NUM
iajs-3610	56	15	)	)	PUNCT
iajs-3610	56	16	.	.	PUNCT
iajs-3610	57	1	egfr=	egfr=	NUM
iajs-3610	57	2	144	144	NUM
iajs-3610	57	3	×	×	NOUN
iajs-3610	57	4	(	(	PUNCT
iajs-3610	57	5	scr/0.7	scr/0.7	PROPN
iajs-3610	57	6	)	)	PUNCT
iajs-3610	57	7	-1.209	-1.209	PUNCT
iajs-3610	57	8	×(0.993	×(0.993	SYM
iajs-3610	57	9	)	)	PUNCT
iajs-3610	57	10	age	age	NOUN
iajs-3610	58	1	[	[	X
iajs-3610	58	2	for	for	ADP
iajs-3610	58	3	women	woman	NOUN
iajs-3610	58	4	and	and	CCONJ
iajs-3610	58	5	serum	serum	NOUN
iajs-3610	58	6	creatinine	creatinine	PROPN
iajs-3610	58	7	>	>	X
iajs-3610	58	8	0.7	0.7	NUM
iajs-3610	58	9	mg	mg	PROPN
iajs-3610	58	10	/	/	SYM
iajs-3610	58	11	dl	dl	NOUN
iajs-3610	58	12	]	]	PUNCT
iajs-3610	58	13	.	.	PUNCT
iajs-3610	59	1	egfr=	egfr=	NUM
iajs-3610	59	2	141	141	NUM
iajs-3610	59	3	×	×	NOUN
iajs-3610	59	4	(	(	PUNCT
iajs-3610	59	5	scr/0.9	scr/0.9	PROPN
iajs-3610	59	6	)	)	PUNCT
iajs-3610	59	7	-1.209	-1.209	NOUN
iajs-3610	59	8	×	×	NOUN
iajs-3610	59	9	(	(	PUNCT
iajs-3610	59	10	0.993	0.993	NUM
iajs-3610	59	11	)	)	PUNCT
iajs-3610	59	12	age	age	NOUN
iajs-3610	59	13	[	[	X
iajs-3610	59	14	for	for	ADP
iajs-3610	59	15	men	man	NOUN
iajs-3610	59	16	and	and	CCONJ
iajs-3610	59	17	serum	serum	NOUN
iajs-3610	59	18	creatinine	creatinine	PROPN
iajs-3610	59	19	>	>	X
iajs-3610	59	20	0.9	0.9	NUM
iajs-3610	59	21	mg	mg	PROPN
iajs-3610	59	22	/	/	SYM
iajs-3610	59	23	dl	dl	PROPN
iajs-3610	59	24	]	]	PUNCT
iajs-3610	59	25	.	.	PUNCT
iajs-3610	60	1	2.1	2.1	NUM
iajs-3610	60	2	.	.	PUNCT
iajs-3610	61	1	inclusion	inclusion	NOUN
iajs-3610	61	2	and	and	CCONJ
iajs-3610	61	3	exclusion	exclusion	NOUN
iajs-3610	61	4	criteria	criterion	NOUN
iajs-3610	61	5	this	this	DET
iajs-3610	61	6	study	study	NOUN
iajs-3610	61	7	included	include	VERB
iajs-3610	61	8	t2	t2	PROPN
iajs-3610	61	9	dm	dm	PROPN
iajs-3610	61	10	patients	patient	NOUN
iajs-3610	61	11	aged	age	VERB
iajs-3610	61	12	between	between	ADP
iajs-3610	61	13	32	32	NUM
iajs-3610	61	14	and	and	CCONJ
iajs-3610	61	15	76	76	NUM
iajs-3610	61	16	years	year	NOUN
iajs-3610	61	17	,	,	PUNCT
iajs-3610	61	18	who	who	PRON
iajs-3610	61	19	had	have	VERB
iajs-3610	61	20	both	both	CCONJ
iajs-3610	61	21	albuminuria	albuminuria	NOUN
iajs-3610	61	22	and	and	CCONJ
iajs-3610	61	23	normoalbuminuria	normoalbuminuria	NOUN
iajs-3610	61	24	.	.	PUNCT
iajs-3610	62	1	this	this	DET
iajs-3610	62	2	study	study	NOUN
iajs-3610	62	3	excluded	exclude	VERB
iajs-3610	62	4	patients	patient	NOUN
iajs-3610	62	5	with	with	ADP
iajs-3610	62	6	fever	fever	NOUN
iajs-3610	62	7	,	,	PUNCT
iajs-3610	62	8	polycystic	polycystic	ADJ
iajs-3610	62	9	ovaries	ovary	NOUN
iajs-3610	62	10	,	,	PUNCT
iajs-3610	62	11	nephrotic	nephrotic	ADJ
iajs-3610	62	12	syndrome	syndrome	NOUN
iajs-3610	62	13	,	,	PUNCT
iajs-3610	62	14	esrd	esrd	PROPN
iajs-3610	62	15	,	,	PUNCT
iajs-3610	62	16	osteoarthritis	osteoarthritis	NOUN
iajs-3610	62	17	,	,	PUNCT
iajs-3610	62	18	thyroid	thyroid	NOUN
iajs-3610	62	19	disease	disease	NOUN
iajs-3610	62	20	,	,	PUNCT
iajs-3610	62	21	heart	heart	NOUN
iajs-3610	62	22	failure	failure	NOUN
iajs-3610	62	23	,	,	PUNCT
iajs-3610	62	24	and	and	CCONJ
iajs-3610	62	25	liver	liver	NOUN
iajs-3610	62	26	disease	disease	NOUN
iajs-3610	62	27	.	.	PUNCT
iajs-3610	63	1	2.2	2.2	NUM
iajs-3610	63	2	.	.	PUNCT
iajs-3610	64	1	statistical	statistical	ADJ
iajs-3610	64	2	analysis	analysis	NOUN
iajs-3610	64	3	version	version	NOUN
iajs-3610	64	4	22	22	NUM
iajs-3610	64	5	was	be	AUX
iajs-3610	64	6	used	use	VERB
iajs-3610	64	7	to	to	PART
iajs-3610	64	8	statistically	statistically	ADV
iajs-3610	64	9	the	the	DET
iajs-3610	64	10	statistical	statistical	ADJ
iajs-3610	64	11	package	package	NOUN
iajs-3610	64	12	for	for	ADP
iajs-3610	64	13	the	the	DET
iajs-3610	64	14	social	social	ADJ
iajs-3610	64	15	sciences	sciences	PROPN
iajs-3610	64	16	(	(	PUNCT
iajs-3610	64	17	spss	spss	PROPN
iajs-3610	64	18	)	)	PUNCT
iajs-3610	64	19	,	,	PUNCT
iajs-3610	64	20	analyze	analyze	VERB
iajs-3610	64	21	the	the	DET
iajs-3610	64	22	data	datum	NOUN
iajs-3610	64	23	.	.	PUNCT
iajs-3610	65	1	the	the	DET
iajs-3610	65	2	variables	variable	NOUN
iajs-3610	65	3	'	'	PART
iajs-3610	65	4	means	mean	NOUN
iajs-3610	65	5	and	and	CCONJ
iajs-3610	65	6	standard	standard	ADJ
iajs-3610	65	7	deviations	deviation	NOUN
iajs-3610	65	8	were	be	AUX
iajs-3610	65	9	reported	report	VERB
iajs-3610	65	10	.	.	PUNCT
iajs-3610	66	1	to	to	PART
iajs-3610	66	2	ascertain	ascertain	VERB
iajs-3610	66	3	whether	whether	SCONJ
iajs-3610	66	4	there	there	PRON
iajs-3610	66	5	are	be	VERB
iajs-3610	66	6	statistically	statistically	ADV
iajs-3610	66	7	significant	significant	ADJ
iajs-3610	66	8	variations	variation	NOUN
iajs-3610	66	9	in	in	ADP
iajs-3610	66	10	the	the	DET
iajs-3610	66	11	means	mean	NOUN
iajs-3610	66	12	of	of	ADP
iajs-3610	66	13	the	the	DET
iajs-3610	66	14	four	four	NUM
iajs-3610	66	15	independent	independent	ADJ
iajs-3610	66	16	studied	study	VERB
iajs-3610	66	17	groups	group	NOUN
iajs-3610	66	18	.	.	PUNCT
iajs-3610	67	1	one	one	NUM
iajs-3610	67	2	-	-	PUNCT
iajs-3610	67	3	way	way	NOUN
iajs-3610	67	4	analysis	analysis	NOUN
iajs-3610	67	5	of	of	ADP
iajs-3610	67	6	variance	variance	NOUN
iajs-3610	67	7	(	(	PUNCT
iajs-3610	67	8	anova	anova	PROPN
iajs-3610	67	9	)	)	PUNCT
iajs-3610	67	10	was	be	AUX
iajs-3610	67	11	utilized	utilize	VERB
iajs-3610	67	12	for	for	ADP
iajs-3610	67	13	comparing	compare	VERB
iajs-3610	67	14	the	the	DET
iajs-3610	67	15	variables	variable	NOUN
iajs-3610	67	16	among	among	ADP
iajs-3610	67	17	the	the	DET
iajs-3610	67	18	patients	patient	NOUN
iajs-3610	67	19	(	(	PUNCT
iajs-3610	67	20	macro-	macro-	X
iajs-3610	67	21	,	,	PUNCT
iajs-3610	67	22	micro-	micro-	NOUN
iajs-3610	67	23	,	,	PUNCT
iajs-3610	67	24	normalbuminuria	normalbuminuria	PROPN
iajs-3610	67	25	)	)	PUNCT
iajs-3610	67	26	and	and	CCONJ
iajs-3610	67	27	the	the	DET
iajs-3610	67	28	control	control	NOUN
iajs-3610	67	29	group	group	NOUN
iajs-3610	67	30	.	.	PUNCT
iajs-3610	68	1	3	3	X
iajs-3610	68	2	.	.	X
iajs-3610	68	3	results	result	VERB
iajs-3610	68	4	the	the	DET
iajs-3610	68	5	demographic	demographic	ADJ
iajs-3610	68	6	characteristics	characteristic	NOUN
iajs-3610	68	7	of	of	ADP
iajs-3610	68	8	the	the	DET
iajs-3610	68	9	study	study	NOUN
iajs-3610	68	10	groups	group	NOUN
iajs-3610	68	11	are	be	AUX
iajs-3610	68	12	demonstrated	demonstrate	VERB
iajs-3610	68	13	in	in	ADP
iajs-3610	68	14	table	table	NOUN
iajs-3610	68	15	(	(	PUNCT
iajs-3610	68	16	1	1	NUM
iajs-3610	68	17	)	)	PUNCT
iajs-3610	68	18	.	.	PUNCT
iajs-3610	69	1	there	there	PRON
iajs-3610	69	2	was	be	VERB
iajs-3610	69	3	no	no	DET
iajs-3610	69	4	significant	significant	ADJ
iajs-3610	69	5	difference	difference	NOUN
iajs-3610	69	6	in	in	ADP
iajs-3610	69	7	age	age	NOUN
iajs-3610	69	8	and	and	CCONJ
iajs-3610	69	9	bmi	bmi	NOUN
iajs-3610	69	10	among	among	ADP
iajs-3610	69	11	the	the	DET
iajs-3610	69	12	groups	group	NOUN
iajs-3610	69	13	.	.	PUNCT
iajs-3610	70	1	table	table	NOUN
iajs-3610	70	2	1	1	NUM
iajs-3610	70	3	.	.	PUNCT
iajs-3610	71	1	the	the	DET
iajs-3610	71	2	demographic	demographic	ADJ
iajs-3610	71	3	characteristics	characteristic	NOUN
iajs-3610	71	4	of	of	ADP
iajs-3610	71	5	the	the	DET
iajs-3610	71	6	study	study	NOUN
iajs-3610	71	7	groups	group	NOUN
iajs-3610	71	8	p	p	NOUN
iajs-3610	71	9	-	-	PUNCT
iajs-3610	71	10	value	value	NOUN
iajs-3610	71	11	mean	mean	NOUN
iajs-3610	71	12	±	±	NUM
iajs-3610	71	13	sd	sd	ADP
iajs-3610	71	14	variables	variable	NOUN
iajs-3610	71	15	control	control	PROPN
iajs-3610	71	16	(	(	PUNCT
iajs-3610	71	17	n=	n=	ADJ
iajs-3610	71	18	45	45	NUM
iajs-3610	71	19	)	)	PUNCT
iajs-3610	71	20	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	71	21	(	(	PUNCT
iajs-3610	71	22	n=	n=	ADJ
iajs-3610	71	23	45	45	NUM
iajs-3610	71	24	)	)	PUNCT
iajs-3610	71	25	microalbuminuria	microalbuminuria	PROPN
iajs-3610	71	26	(	(	PUNCT
iajs-3610	71	27	n=	n=	ADJ
iajs-3610	71	28	23	23	NUM
iajs-3610	71	29	)	)	PUNCT
iajs-3610	71	30	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	71	31	(	(	PUNCT
iajs-3610	71	32	n=	n=	ADJ
iajs-3610	71	33	22	22	NUM
iajs-3610	71	34	)	)	PUNCT
iajs-3610	71	35	0.767	0.767	NUM
iajs-3610	71	36	52.87±	52.87±	NUM
iajs-3610	71	37	8.77	8.77	NUM
iajs-3610	71	38	53.59±	53.59±	NUM
iajs-3610	71	39	8.10	8.10	NUM
iajs-3610	71	40	55.13±	55.13±	NUM
iajs-3610	71	41	10.13	10.13	NUM
iajs-3610	71	42	54.76±	54.76±	NUM
iajs-3610	71	43	11.53	11.53	NUM
iajs-3610	71	44	age	age	NOUN
iajs-3610	71	45	(	(	PUNCT
iajs-3610	71	46	years	year	NOUN
iajs-3610	71	47	)	)	PUNCT
iajs-3610	71	48	0.620	0.620	NUM
iajs-3610	71	49	23.00±	23.00±	NUM
iajs-3610	71	50	1.95	1.95	NUM
iajs-3610	71	51	25.57±	25.57±	NUM
iajs-3610	71	52	2.33	2.33	NUM
iajs-3610	71	53	24.92±	24.92±	NUM
iajs-3610	71	54	2.57	2.57	NUM
iajs-3610	71	55	25.97±	25.97±	NUM
iajs-3610	71	56	1.90	1.90	NUM
iajs-3610	71	57	bmi	bmi	NOUN
iajs-3610	71	58	(	(	PUNCT
iajs-3610	71	59	kg	kg	NOUN
iajs-3610	71	60	/	/	SYM
iajs-3610	71	61	m	m	PROPN
iajs-3610	71	62	2	2	NUM
iajs-3610	71	63	)	)	PUNCT
iajs-3610	71	64	*	*	PUNCT
iajs-3610	71	65	the	the	DET
iajs-3610	71	66	collected	collect	VERB
iajs-3610	71	67	data	datum	NOUN
iajs-3610	71	68	were	be	AUX
iajs-3610	71	69	presented	present	VERB
iajs-3610	71	70	as	as	ADP
iajs-3610	71	71	mean	mean	NOUN
iajs-3610	71	72	±	±	NUM
iajs-3610	71	73	sd	sd	NOUN
iajs-3610	71	74	at	at	ADP
iajs-3610	71	75	the	the	DET
iajs-3610	71	76	p	p	X
iajs-3610	71	77	<	<	X
iajs-3610	71	78	0.05	0.05	NUM
iajs-3610	71	79	level	level	NOUN
iajs-3610	71	80	,	,	PUNCT
iajs-3610	71	81	bmi	bmi	PROPN
iajs-3610	71	82	:	:	PUNCT
iajs-3610	71	83	body	body	NOUN
iajs-3610	71	84	mass	mass	PROPN
iajs-3610	71	85	index	index	NOUN
iajs-3610	71	86	.	.	PUNCT
iajs-3610	72	1	the	the	DET
iajs-3610	72	2	results	result	NOUN
iajs-3610	72	3	in	in	ADP
iajs-3610	72	4	table	table	NOUN
iajs-3610	72	5	(	(	PUNCT
iajs-3610	72	6	2	2	NUM
iajs-3610	72	7	)	)	PUNCT
iajs-3610	72	8	indicate	indicate	VERB
iajs-3610	72	9	that	that	SCONJ
iajs-3610	72	10	there	there	PRON
iajs-3610	72	11	were	be	VERB
iajs-3610	72	12	substantial	substantial	ADJ
iajs-3610	72	13	(	(	PUNCT
iajs-3610	72	14	p=	p=	NOUN
iajs-3610	72	15	0.001	0.001	NUM
iajs-3610	72	16	)	)	PUNCT
iajs-3610	72	17	variances	variance	NOUN
iajs-3610	72	18	in	in	ADP
iajs-3610	72	19	fsg	fsg	PROPN
iajs-3610	72	20	among	among	ADP
iajs-3610	72	21	the	the	DET
iajs-3610	72	22	patients	patient	NOUN
iajs-3610	72	23	and	and	CCONJ
iajs-3610	72	24	control	control	NOUN
iajs-3610	72	25	groups	group	NOUN
iajs-3610	72	26	.	.	PUNCT
iajs-3610	73	1	on	on	ADP
iajs-3610	73	2	the	the	DET
iajs-3610	73	3	other	other	ADJ
iajs-3610	73	4	hand	hand	NOUN
iajs-3610	73	5	,	,	PUNCT
iajs-3610	73	6	there	there	PRON
iajs-3610	73	7	was	be	VERB
iajs-3610	73	8	a	a	DET
iajs-3610	73	9	significant	significant	ADJ
iajs-3610	73	10	increase	increase	NOUN
iajs-3610	73	11	(	(	PUNCT
iajs-3610	73	12	p=	p=	NOUN
iajs-3610	73	13	0.045	0.045	NUM
iajs-3610	73	14	)	)	PUNCT
iajs-3610	73	15	in	in	ADP
iajs-3610	73	16	hba1c	hba1c	PROPN
iajs-3610	73	17	levels	level	NOUN
iajs-3610	73	18	in	in	ADP
iajs-3610	73	19	the	the	DET
iajs-3610	73	20	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	73	21	group	group	NOUN
iajs-3610	73	22	compared	compare	VERB
iajs-3610	73	23	to	to	ADP
iajs-3610	73	24	the	the	DET
iajs-3610	73	25	control	control	NOUN
iajs-3610	73	26	group	group	NOUN
iajs-3610	73	27	.	.	PUNCT
iajs-3610	74	1	still	still	ADV
iajs-3610	74	2	,	,	PUNCT
iajs-3610	74	3	it	it	PRON
iajs-3610	74	4	was	be	AUX
iajs-3610	74	5	not	not	PART
iajs-3610	74	6	significant	significant	ADJ
iajs-3610	74	7	when	when	SCONJ
iajs-3610	74	8	compared	compare	VERB
iajs-3610	74	9	with	with	ADP
iajs-3610	74	10	the	the	DET
iajs-3610	74	11	microand	microand	ADJ
iajs-3610	74	12	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	74	13	groups	group	NOUN
iajs-3610	74	14	.	.	PUNCT
iajs-3610	75	1	the	the	DET
iajs-3610	75	2	anova	anova	PROPN
iajs-3610	75	3	results	result	NOUN
iajs-3610	75	4	showed	show	VERB
iajs-3610	75	5	a	a	DET
iajs-3610	75	6	significant	significant	ADJ
iajs-3610	75	7	increase	increase	NOUN
iajs-3610	75	8	in	in	ADP
iajs-3610	75	9	serum	serum	NOUN
iajs-3610	75	10	tc	tc	NOUN
iajs-3610	75	11	in	in	ADP
iajs-3610	75	12	the	the	DET
iajs-3610	75	13	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	75	14	group	group	NOUN
iajs-3610	75	15	compared	compare	VERB
iajs-3610	75	16	to	to	ADP
iajs-3610	75	17	the	the	DET
iajs-3610	75	18	other	other	ADJ
iajs-3610	75	19	groups	group	NOUN
iajs-3610	75	20	(	(	PUNCT
iajs-3610	75	21	p=	p=	NOUN
iajs-3610	75	22	0.001	0.001	NUM
iajs-3610	75	23	)	)	PUNCT
iajs-3610	75	24	.	.	PUNCT
iajs-3610	76	1	also	also	ADV
iajs-3610	76	2	,	,	PUNCT
iajs-3610	76	3	there	there	PRON
iajs-3610	76	4	were	be	VERB
iajs-3610	76	5	substantial	substantial	ADJ
iajs-3610	76	6	(	(	PUNCT
iajs-3610	76	7	p=	p=	NOUN
iajs-3610	76	8	0.001	0.001	NUM
iajs-3610	76	9	)	)	PUNCT
iajs-3610	76	10	variances	variance	NOUN
iajs-3610	76	11	in	in	ADP
iajs-3610	76	12	tg	tg	PROPN
iajs-3610	76	13	,	,	PUNCT
iajs-3610	76	14	vldl	vldl	NOUN
iajs-3610	76	15	,	,	PUNCT
iajs-3610	76	16	and	and	CCONJ
iajs-3610	76	17	ldl	ldl	NOUN
iajs-3610	76	18	-	-	PUNCT
iajs-3610	76	19	c	c	NOUN
iajs-3610	76	20	among	among	ADP
iajs-3610	76	21	the	the	DET
iajs-3610	76	22	groups	group	NOUN
iajs-3610	76	23	.	.	PUNCT
iajs-3610	77	1	compared	compare	VERB
iajs-3610	77	2	to	to	ADP
iajs-3610	77	3	the	the	DET
iajs-3610	77	4	hdl	hdl	PROPN
iajs-3610	77	5	-	-	PUNCT
iajs-3610	77	6	c	c	PROPN
iajs-3610	77	7	,	,	PUNCT
iajs-3610	77	8	the	the	DET
iajs-3610	77	9	means	mean	NOUN
iajs-3610	77	10	for	for	ADP
iajs-3610	77	11	the	the	DET
iajs-3610	77	12	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	77	13	group	group	NOUN
iajs-3610	77	14	were	be	AUX
iajs-3610	77	15	statistically	statistically	ADV
iajs-3610	77	16	lower	low	ADJ
iajs-3610	77	17	(	(	PUNCT
iajs-3610	77	18	p=	p=	NOUN
iajs-3610	77	19	0.001	0.001	NUM
iajs-3610	77	20	)	)	PUNCT
iajs-3610	77	21	than	than	ADP
iajs-3610	77	22	those	those	PRON
iajs-3610	77	23	for	for	ADP
iajs-3610	77	24	the	the	DET
iajs-3610	77	25	micro-	micro-	NOUN
iajs-3610	77	26	,	,	PUNCT
iajs-3610	77	27	ihjpas	ihjpas	PROPN
iajs-3610	77	28	.	.	PUNCT
iajs-3610	78	1	2025	2025	NUM
iajs-3610	78	2	,	,	PUNCT
iajs-3610	78	3	38(3	38(3	NUM
iajs-3610	78	4	)	)	PUNCT
iajs-3610	78	5	230	230	NUM
iajs-3610	78	6	normoalbuminuria	normoalbuminuria	NOUN
iajs-3610	78	7	,	,	PUNCT
iajs-3610	78	8	and	and	CCONJ
iajs-3610	78	9	control	control	NOUN
iajs-3610	78	10	groups	group	NOUN
iajs-3610	78	11	,	,	PUNCT
iajs-3610	78	12	indicating	indicate	VERB
iajs-3610	78	13	that	that	SCONJ
iajs-3610	78	14	the	the	DET
iajs-3610	78	15	serum	serum	PROPN
iajs-3610	78	16	hdl	hdl	PROPN
iajs-3610	78	17	-	-	PUNCT
iajs-3610	78	18	c	c	NOUN
iajs-3610	78	19	level	level	NOUN
iajs-3610	78	20	significantly	significantly	ADV
iajs-3610	78	21	differed	differ	VERB
iajs-3610	78	22	among	among	ADP
iajs-3610	78	23	the	the	DET
iajs-3610	78	24	groups	group	NOUN
iajs-3610	78	25	,	,	PUNCT
iajs-3610	78	26	as	as	SCONJ
iajs-3610	78	27	shown	show	VERB
iajs-3610	78	28	in	in	ADP
iajs-3610	78	29	table	table	NOUN
iajs-3610	78	30	(	(	PUNCT
iajs-3610	78	31	2	2	NUM
iajs-3610	78	32	)	)	PUNCT
iajs-3610	78	33	.	.	PUNCT
iajs-3610	79	1	table	table	NOUN
iajs-3610	79	2	2	2	NUM
iajs-3610	79	3	.	.	X
iajs-3610	79	4	serum	serum	PROPN
iajs-3610	79	5	glycemic	glycemic	ADJ
iajs-3610	79	6	and	and	CCONJ
iajs-3610	79	7	lipid	lipid	NOUN
iajs-3610	79	8	profile	profile	NOUN
iajs-3610	79	9	for	for	ADP
iajs-3610	79	10	patients	patient	NOUN
iajs-3610	79	11	and	and	CCONJ
iajs-3610	79	12	control	control	NOUN
iajs-3610	79	13	groups	group	NOUN
iajs-3610	79	14	p	p	NOUN
iajs-3610	79	15	-	-	PUNCT
iajs-3610	79	16	value	value	NOUN
iajs-3610	79	17	mean	mean	NOUN
iajs-3610	79	18	±	±	NUM
iajs-3610	79	19	sd	sd	ADP
iajs-3610	79	20	variables	variable	NOUN
iajs-3610	79	21	control	control	PROPN
iajs-3610	79	22	(	(	PUNCT
iajs-3610	79	23	n=	n=	ADJ
iajs-3610	79	24	45	45	NUM
iajs-3610	79	25	)	)	PUNCT
iajs-3610	79	26	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	79	27	(	(	PUNCT
iajs-3610	79	28	n=	n=	ADJ
iajs-3610	79	29	45	45	NUM
iajs-3610	79	30	)	)	PUNCT
iajs-3610	79	31	microalbuminuria	microalbuminuria	PROPN
iajs-3610	79	32	(	(	PUNCT
iajs-3610	79	33	n=	n=	ADJ
iajs-3610	79	34	23	23	NUM
iajs-3610	79	35	)	)	PUNCT
iajs-3610	79	36	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	79	37	(	(	PUNCT
iajs-3610	79	38	n=	n=	ADJ
iajs-3610	79	39	22	22	NUM
iajs-3610	79	40	)	)	PUNCT
iajs-3610	80	1	0.001	0.001	NUM
iajs-3610	80	2	97.67±	97.67±	NUM
iajs-3610	80	3	6.02	6.02	NUM
iajs-3610	80	4	186.39±	186.39±	NUM
iajs-3610	80	5	9.91	9.91	NUM
iajs-3610	80	6	248.29±	248.29±	NUM
iajs-3610	80	7	9.87	9.87	NUM
iajs-3610	80	8	280.65±	280.65±	NUM
iajs-3610	80	9	14.47	14.47	NUM
iajs-3610	80	10	fsg	fsg	NOUN
iajs-3610	80	11	(	(	PUNCT
iajs-3610	80	12	mg	mg	PROPN
iajs-3610	80	13	/	/	SYM
iajs-3610	80	14	dl	dl	NOUN
iajs-3610	80	15	)	)	PUNCT
iajs-3610	80	16	0.045	0.045	NUM
iajs-3610	80	17	5.06±	5.06±	NUM
iajs-3610	80	18	0.21	0.21	NUM
iajs-3610	80	19	8.49±	8.49±	NUM
iajs-3610	80	20	1.87	1.87	NUM
iajs-3610	80	21	10.43±	10.43±	NUM
iajs-3610	80	22	2.37	2.37	NUM
iajs-3610	80	23	10.49±	10.49±	NUM
iajs-3610	80	24	2.70	2.70	NUM
iajs-3610	80	25	hba1c	hba1c	PROPN
iajs-3610	80	26	(	(	PUNCT
iajs-3610	80	27	%	%	INTJ
iajs-3610	80	28	)	)	PUNCT
iajs-3610	80	29	0.001	0.001	NUM
iajs-3610	80	30	135.24±	135.24±	NUM
iajs-3610	80	31	8.87	8.87	NUM
iajs-3610	80	32	171.89±	171.89±	NUM
iajs-3610	80	33	14.13	14.13	NUM
iajs-3610	80	34	183.20±	183.20±	NUM
iajs-3610	80	35	13.75	13.75	NUM
iajs-3610	80	36	227.76±	227.76±	NUM
iajs-3610	80	37	18.95	18.95	NUM
iajs-3610	80	38	tc	tc	NOUN
iajs-3610	80	39	(	(	PUNCT
iajs-3610	80	40	mg	mg	PROPN
iajs-3610	80	41	/	/	SYM
iajs-3610	80	42	dl	dl	NOUN
iajs-3610	80	43	)	)	PUNCT
iajs-3610	80	44	0.001	0.001	NUM
iajs-3610	80	45	110.64±19.24	110.64±19.24	NUM
iajs-3610	80	46	164.78±	164.78±	NUM
iajs-3610	80	47	8.71	8.71	NUM
iajs-3610	80	48	155.65±	155.65±	NUM
iajs-3610	80	49	9.12	9.12	NUM
iajs-3610	80	50	280.48±	280.48±	NUM
iajs-3610	80	51	11.69	11.69	NUM
iajs-3610	80	52	tg	tg	PROPN
iajs-3610	80	53	(	(	PUNCT
iajs-3610	80	54	mg	mg	PROPN
iajs-3610	80	55	/	/	SYM
iajs-3610	80	56	dl	dl	PROPN
iajs-3610	80	57	)	)	PUNCT
iajs-3610	80	58	0.001	0.001	NUM
iajs-3610	80	59	49.33±	49.33±	NUM
iajs-3610	80	60	6.28	6.28	NUM
iajs-3610	80	61	39.98±	39.98±	NUM
iajs-3610	80	62	7.16	7.16	NUM
iajs-3610	80	63	40.96±	40.96±	NUM
iajs-3610	80	64	7.71	7.71	NUM
iajs-3610	80	65	36.80±	36.80±	NUM
iajs-3610	80	66	6.61	6.61	NUM
iajs-3610	80	67	hdl	hdl	PROPN
iajs-3610	80	68	-	-	PUNCT
iajs-3610	80	69	c	c	PROPN
iajs-3610	80	70	(	(	PUNCT
iajs-3610	80	71	mg	mg	PROPN
iajs-3610	80	72	/	/	SYM
iajs-3610	80	73	dl	dl	PROPN
iajs-3610	80	74	)	)	PUNCT
iajs-3610	80	75	0.001	0.001	NUM
iajs-3610	80	76	22.08±11.04	22.08±11.04	NUM
iajs-3610	80	77	32.96±10.67	32.96±10.67	NUM
iajs-3610	80	78	31.13±14.6048	31.13±14.6048	NUM
iajs-3610	80	79	56.08±13.12	56.08±13.12	NUM
iajs-3610	80	80	vldl	vldl	NOUN
iajs-3610	80	81	(	(	PUNCT
iajs-3610	80	82	mg	mg	PROPN
iajs-3610	80	83	/	/	SYM
iajs-3610	80	84	dl	dl	NOUN
iajs-3610	80	85	)	)	PUNCT
iajs-3610	80	86	0.001	0.001	NUM
iajs-3610	80	87	64.16±	64.16±	NUM
iajs-3610	80	88	28.76	28.76	NUM
iajs-3610	80	89	98.22±	98.22±	NUM
iajs-3610	80	90	13.92	13.92	NUM
iajs-3610	80	91	111.11±	111.11±	NUM
iajs-3610	80	92	37.08	37.08	NUM
iajs-3610	80	93	134.88±	134.88±	NUM
iajs-3610	80	94	26.47	26.47	NUM
iajs-3610	80	95	ldl	ldl	PROPN
iajs-3610	80	96	-	-	PUNCT
iajs-3610	80	97	c	c	NOUN
iajs-3610	80	98	(	(	PUNCT
iajs-3610	80	99	mg	mg	PROPN
iajs-3610	80	100	/	/	SYM
iajs-3610	80	101	dl	dl	NOUN
iajs-3610	80	102	)	)	PUNCT
iajs-3610	80	103	*	*	PUNCT
iajs-3610	80	104	the	the	DET
iajs-3610	80	105	collected	collect	VERB
iajs-3610	80	106	data	datum	NOUN
iajs-3610	80	107	were	be	AUX
iajs-3610	80	108	presented	present	VERB
iajs-3610	80	109	as	as	ADP
iajs-3610	80	110	mean	mean	NOUN
iajs-3610	80	111	±	±	NUM
iajs-3610	80	112	sd	sd	NOUN
iajs-3610	80	113	at	at	ADP
iajs-3610	80	114	the	the	DET
iajs-3610	80	115	p	p	X
iajs-3610	80	116	<	<	X
iajs-3610	80	117	0.05	0.05	NUM
iajs-3610	80	118	level	level	NOUN
iajs-3610	80	119	.	.	PUNCT
iajs-3610	81	1	fsg	fsg	NOUN
iajs-3610	81	2	:	:	PUNCT
iajs-3610	81	3	fasting	fast	VERB
iajs-3610	81	4	serum	serum	NOUN
iajs-3610	81	5	glucose	glucose	NOUN
iajs-3610	81	6	,	,	PUNCT
iajs-3610	81	7	hba1c	hba1c	PROPN
iajs-3610	81	8	:	:	PUNCT
iajs-3610	81	9	glycated	glycate	VERB
iajs-3610	81	10	hemoglobin	hemoglobin	NOUN
iajs-3610	81	11	,	,	PUNCT
iajs-3610	81	12	tc	tc	NUM
iajs-3610	81	13	:	:	PUNCT
iajs-3610	81	14	total	total	ADJ
iajs-3610	81	15	cholesterol	cholesterol	NOUN
iajs-3610	81	16	,	,	PUNCT
iajs-3610	81	17	tg	tg	PRON
iajs-3610	81	18	:	:	PUNCT
iajs-3610	81	19	triglycerides	triglyceride	NOUN
iajs-3610	81	20	:	:	PUNCT
iajs-3610	81	21	ldl	ldl	NOUN
iajs-3610	81	22	-	-	PUNCT
iajs-3610	81	23	c	c	NOUN
iajs-3610	81	24	:	:	PUNCT
iajs-3610	81	25	low	low	ADJ
iajs-3610	81	26	density	density	NOUN
iajs-3610	81	27	lipoprotein	lipoprotein	ADJ
iajs-3610	81	28	cholesterol	cholesterol	NOUN
iajs-3610	81	29	,	,	PUNCT
iajs-3610	81	30	hdl	hdl	PROPN
iajs-3610	81	31	-	-	PUNCT
iajs-3610	81	32	c	c	NOUN
iajs-3610	81	33	:	:	PUNCT
iajs-3610	81	34	high	high	ADJ
iajs-3610	81	35	density	density	NOUN
iajs-3610	81	36	lipoprotein	lipoprotein	ADJ
iajs-3610	81	37	cholesterol	cholesterol	NOUN
iajs-3610	81	38	,	,	PUNCT
iajs-3610	81	39	vldl	vldl	NOUN
iajs-3610	81	40	:	:	PUNCT
iajs-3610	81	41	very	very	ADV
iajs-3610	81	42	low	low	ADJ
iajs-3610	81	43	density	density	NOUN
iajs-3610	81	44	lipoprotein	lipoprotein	ADJ
iajs-3610	81	45	.	.	PUNCT
iajs-3610	82	1	the	the	DET
iajs-3610	82	2	anova	anova	PROPN
iajs-3610	82	3	results	result	NOUN
iajs-3610	82	4	indicated	indicate	VERB
iajs-3610	82	5	that	that	SCONJ
iajs-3610	82	6	there	there	PRON
iajs-3610	82	7	were	be	VERB
iajs-3610	82	8	significant	significant	ADJ
iajs-3610	82	9	differences	difference	NOUN
iajs-3610	82	10	(	(	PUNCT
iajs-3610	82	11	p	p	X
iajs-3610	82	12	<	<	X
iajs-3610	82	13	0.001	0.001	NUM
iajs-3610	82	14	)	)	PUNCT
iajs-3610	82	15	in	in	ADP
iajs-3610	82	16	serum	serum	NOUN
iajs-3610	82	17	urea	urea	NOUN
iajs-3610	82	18	and	and	CCONJ
iajs-3610	82	19	creatinine	creatinine	NOUN
iajs-3610	82	20	levels	level	NOUN
iajs-3610	82	21	among	among	ADP
iajs-3610	82	22	the	the	DET
iajs-3610	82	23	groups	group	NOUN
iajs-3610	82	24	.	.	PUNCT
iajs-3610	83	1	multiple	multiple	ADJ
iajs-3610	83	2	pairwise	pairwise	NOUN
iajs-3610	83	3	comparisons	comparison	NOUN
iajs-3610	83	4	showed	show	VERB
iajs-3610	83	5	that	that	SCONJ
iajs-3610	83	6	the	the	DET
iajs-3610	83	7	mean	mean	ADJ
iajs-3610	83	8	serum	serum	NOUN
iajs-3610	83	9	urea	urea	NOUN
iajs-3610	83	10	and	and	CCONJ
iajs-3610	83	11	creatinine	creatinine	NOUN
iajs-3610	83	12	levels	level	NOUN
iajs-3610	83	13	for	for	ADP
iajs-3610	83	14	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	83	15	were	be	AUX
iajs-3610	83	16	significantly	significantly	ADV
iajs-3610	83	17	(	(	PUNCT
iajs-3610	83	18	p=	p=	NOUN
iajs-3610	83	19	0.001	0.001	NUM
iajs-3610	83	20	)	)	PUNCT
iajs-3610	83	21	higher	high	ADJ
iajs-3610	83	22	compared	compare	VERB
iajs-3610	83	23	to	to	ADP
iajs-3610	83	24	the	the	DET
iajs-3610	83	25	microand	microand	ADJ
iajs-3610	83	26	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	83	27	groups	group	NOUN
iajs-3610	83	28	and	and	CCONJ
iajs-3610	83	29	the	the	DET
iajs-3610	83	30	control	control	NOUN
iajs-3610	83	31	group	group	NOUN
iajs-3610	83	32	.	.	PUNCT
iajs-3610	84	1	moreover	moreover	ADV
iajs-3610	84	2	,	,	PUNCT
iajs-3610	84	3	the	the	DET
iajs-3610	84	4	results	result	NOUN
iajs-3610	84	5	of	of	ADP
iajs-3610	84	6	multiple	multiple	ADJ
iajs-3610	84	7	pairwise	pairwise	NOUN
iajs-3610	84	8	comparisons	comparison	NOUN
iajs-3610	84	9	showed	show	VERB
iajs-3610	84	10	that	that	SCONJ
iajs-3610	84	11	the	the	DET
iajs-3610	84	12	mean	mean	ADJ
iajs-3610	84	13	acr	acr	PROPN
iajs-3610	84	14	for	for	ADP
iajs-3610	84	15	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	84	16	was	be	AUX
iajs-3610	84	17	significantly	significantly	ADV
iajs-3610	84	18	(	(	PUNCT
iajs-3610	84	19	p<0.001	p<0.001	PROPN
iajs-3610	84	20	)	)	PUNCT
iajs-3610	84	21	increased	increase	VERB
iajs-3610	84	22	compared	compare	VERB
iajs-3610	84	23	to	to	ADP
iajs-3610	84	24	the	the	DET
iajs-3610	84	25	microand	microand	ADJ
iajs-3610	84	26	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	84	27	groups	group	NOUN
iajs-3610	84	28	and	and	CCONJ
iajs-3610	84	29	the	the	DET
iajs-3610	84	30	control	control	NOUN
iajs-3610	84	31	group	group	NOUN
iajs-3610	84	32	.	.	PUNCT
iajs-3610	85	1	there	there	PRON
iajs-3610	85	2	were	be	VERB
iajs-3610	85	3	substantial	substantial	ADJ
iajs-3610	85	4	decreases	decrease	NOUN
iajs-3610	85	5	in	in	ADP
iajs-3610	85	6	egfr	egfr	ADJ
iajs-3610	85	7	levels	level	NOUN
iajs-3610	85	8	among	among	ADP
iajs-3610	85	9	the	the	DET
iajs-3610	85	10	groups	group	NOUN
iajs-3610	85	11	.	.	PUNCT
iajs-3610	86	1	the	the	DET
iajs-3610	86	2	results	result	NOUN
iajs-3610	86	3	of	of	ADP
iajs-3610	86	4	the	the	DET
iajs-3610	86	5	anova	anova	PROPN
iajs-3610	86	6	indicated	indicate	VERB
iajs-3610	86	7	that	that	SCONJ
iajs-3610	86	8	the	the	DET
iajs-3610	86	9	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	86	10	group	group	NOUN
iajs-3610	86	11	had	have	VERB
iajs-3610	86	12	the	the	DET
iajs-3610	86	13	lowest	low	ADJ
iajs-3610	86	14	egfr	egfr	ADJ
iajs-3610	86	15	value	value	NOUN
iajs-3610	86	16	compared	compare	VERB
iajs-3610	86	17	to	to	ADP
iajs-3610	86	18	the	the	DET
iajs-3610	86	19	other	other	ADJ
iajs-3610	86	20	groups	group	NOUN
iajs-3610	86	21	,	,	PUNCT
iajs-3610	86	22	as	as	SCONJ
iajs-3610	86	23	shown	show	VERB
iajs-3610	86	24	in	in	ADP
iajs-3610	86	25	table	table	NOUN
iajs-3610	86	26	(	(	PUNCT
iajs-3610	86	27	3	3	NUM
iajs-3610	86	28	)	)	PUNCT
iajs-3610	86	29	.	.	PUNCT
iajs-3610	87	1	table	table	NOUN
iajs-3610	87	2	3	3	NUM
iajs-3610	87	3	.	.	PUNCT
iajs-3610	87	4	descriptive	descriptive	ADJ
iajs-3610	87	5	statistics	statistic	NOUN
iajs-3610	87	6	of	of	ADP
iajs-3610	87	7	kidney	kidney	NOUN
iajs-3610	87	8	function	function	NOUN
iajs-3610	87	9	parameter	parameter	NOUN
iajs-3610	87	10	for	for	ADP
iajs-3610	87	11	pateints	pateint	NOUN
iajs-3610	87	12	and	and	CCONJ
iajs-3610	87	13	control	control	NOUN
iajs-3610	87	14	groups	group	NOUN
iajs-3610	87	15	.	.	PUNCT
iajs-3610	88	1	pvalue	pvalue	NOUN
iajs-3610	88	2	mean	mean	VERB
iajs-3610	88	3	±	±	NUM
iajs-3610	88	4	sd	sd	ADP
iajs-3610	88	5	variables	variable	NOUN
iajs-3610	88	6	control	control	PROPN
iajs-3610	88	7	(	(	PUNCT
iajs-3610	88	8	n=	n=	ADJ
iajs-3610	88	9	45	45	NUM
iajs-3610	88	10	)	)	PUNCT
iajs-3610	88	11	normoalbumi	normoalbumi	PROPN
iajs-3610	88	12	nuria	nuria	PROPN
iajs-3610	88	13	(	(	PUNCT
iajs-3610	88	14	n=	n=	ADJ
iajs-3610	88	15	45	45	NUM
iajs-3610	88	16	)	)	PUNCT
iajs-3610	88	17	microalbuminuri	microalbuminuri	NOUN
iajs-3610	88	18	a	a	DET
iajs-3610	88	19	(	(	PUNCT
iajs-3610	88	20	n=	n=	ADJ
iajs-3610	88	21	23	23	NUM
iajs-3610	88	22	)	)	PUNCT
iajs-3610	88	23	macroalbuminur	macroalbuminur	NOUN
iajs-3610	88	24	ia	ia	PROPN
iajs-3610	88	25	(	(	PUNCT
iajs-3610	88	26	n=	n=	ADJ
iajs-3610	88	27	22	22	NUM
iajs-3610	88	28	)	)	PUNCT
iajs-3610	88	29	0.001	0.001	NUM
iajs-3610	88	30	20.51±5.3412	20.51±5.3412	NOUN
iajs-3610	88	31	60.33±	60.33±	NUM
iajs-3610	88	32	19.54	19.54	NUM
iajs-3610	88	33	99.22±	99.22±	NUM
iajs-3610	88	34	40.91	40.91	NUM
iajs-3610	88	35	153.86±	153.86±	PROPN
iajs-3610	88	36	34.95	34.95	NUM
iajs-3610	88	37	urea	urea	NOUN
iajs-3610	88	38	(	(	PUNCT
iajs-3610	88	39	mg	mg	PROPN
iajs-3610	88	40	/	/	SYM
iajs-3610	88	41	dl	dl	PROPN
iajs-3610	88	42	)	)	PUNCT
iajs-3610	88	43	0.001	0.001	NUM
iajs-3610	88	44	0.6113±0.137	0.6113±0.137	NOUN
iajs-3610	88	45	0.63±	0.63±	NOUN
iajs-3610	89	1	0.196	0.196	NUM
iajs-3610	89	2	0.70±	0.70±	NOUN
iajs-3610	89	3	0.23	0.23	NUM
iajs-3610	89	4	2.485.64±	2.485.64±	NOUN
iajs-3610	89	5	865.52	865.52	NUM
iajs-3610	89	6	creatinine	creatinine	NOUN
iajs-3610	89	7	(	(	PUNCT
iajs-3610	89	8	mg	mg	PROPN
iajs-3610	89	9	/	/	SYM
iajs-3610	89	10	dl	dl	PROPN
iajs-3610	89	11	)	)	PUNCT
iajs-3610	89	12	0.001	0.001	NUM
iajs-3610	89	13	20.51±	20.51±	NUM
iajs-3610	89	14	5.34	5.34	NUM
iajs-3610	89	15	47.96±	47.96±	NUM
iajs-3610	89	16	38.34	38.34	NUM
iajs-3610	89	17	111.74±	111.74±	NUM
iajs-3610	89	18	70.39	70.39	NUM
iajs-3610	89	19	556.10±	556.10±	NUM
iajs-3610	89	20	369.20	369.20	NUM
iajs-3610	89	21	acr	acr	NOUN
iajs-3610	89	22	(	(	PUNCT
iajs-3610	89	23	mg	mg	PROPN
iajs-3610	89	24	/	/	SYM
iajs-3610	89	25	g	g	NOUN
iajs-3610	89	26	)	)	PUNCT
iajs-3610	89	27	0.001	0.001	NUM
iajs-3610	89	28	160.02±	160.02±	NUM
iajs-3610	89	29	40.49	40.49	NUM
iajs-3610	89	30	119.61±	119.61±	NUM
iajs-3610	89	31	43.98	43.98	NUM
iajs-3610	89	32	50.65±	50.65±	NUM
iajs-3610	89	33	35.11	35.11	NUM
iajs-3610	89	34	38.38±	38.38±	NUM
iajs-3610	89	35	20.95	20.95	NUM
iajs-3610	89	36	egfr(ml	egfr(ml	NOUN
iajs-3610	89	37	/	/	SYM
iajs-3610	89	38	min/1.73	min/1.73	NOUN
iajs-3610	89	39	m	m	VERB
iajs-3610	89	40	2	2	NUM
iajs-3610	89	41	)	)	PUNCT
iajs-3610	89	42	*	*	PUNCT
iajs-3610	89	43	the	the	DET
iajs-3610	89	44	collected	collect	VERB
iajs-3610	89	45	data	datum	NOUN
iajs-3610	89	46	were	be	AUX
iajs-3610	89	47	presented	present	VERB
iajs-3610	89	48	as	as	ADP
iajs-3610	89	49	mean	mean	NOUN
iajs-3610	89	50	±	±	NUM
iajs-3610	89	51	sd	sd	NOUN
iajs-3610	89	52	at	at	ADP
iajs-3610	89	53	the	the	DET
iajs-3610	89	54	p	p	X
iajs-3610	89	55	<	<	X
iajs-3610	89	56	0.05	0.05	NUM
iajs-3610	89	57	level	level	NOUN
iajs-3610	89	58	.	.	PUNCT
iajs-3610	90	1	acr	acr	NOUN
iajs-3610	90	2	:	:	PUNCT
iajs-3610	90	3	albumin	albumin	NOUN
iajs-3610	90	4	to	to	ADP
iajs-3610	90	5	creatinine	creatinine	NOUN
iajs-3610	90	6	ratio	ratio	NOUN
iajs-3610	90	7	,	,	PUNCT
iajs-3610	90	8	egfr	egfr	PROPN
iajs-3610	90	9	:	:	PUNCT
iajs-3610	90	10	estimated	estimate	VERB
iajs-3610	90	11	glomerular	glomerular	ADJ
iajs-3610	90	12	filtration	filtration	NOUN
iajs-3610	90	13	rate	rate	NOUN
iajs-3610	90	14	.	.	PUNCT
iajs-3610	91	1	table	table	NOUN
iajs-3610	91	2	4	4	NUM
iajs-3610	91	3	.	.	PUNCT
iajs-3610	91	4	serum	serum	PROPN
iajs-3610	91	5	ace2	ace2	PROPN
iajs-3610	91	6	for	for	ADP
iajs-3610	91	7	pateints	pateint	NOUN
iajs-3610	91	8	and	and	CCONJ
iajs-3610	91	9	control	control	NOUN
iajs-3610	91	10	groups	group	NOUN
iajs-3610	91	11	p	p	NOUN
iajs-3610	91	12	-	-	PUNCT
iajs-3610	91	13	value	value	NOUN
iajs-3610	91	14	mean	mean	NOUN
iajs-3610	91	15	±	±	NUM
iajs-3610	91	16	sd	sd	ADP
iajs-3610	91	17	variables	variable	NOUN
iajs-3610	91	18	control	control	PROPN
iajs-3610	91	19	(	(	PUNCT
iajs-3610	91	20	n=	n=	ADJ
iajs-3610	91	21	40	40	NUM
iajs-3610	91	22	)	)	PUNCT
iajs-3610	91	23	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	91	24	(	(	PUNCT
iajs-3610	91	25	n=	n=	ADJ
iajs-3610	91	26	45	45	NUM
iajs-3610	91	27	)	)	PUNCT
iajs-3610	91	28	microalbuminuria	microalbuminuria	PROPN
iajs-3610	91	29	(	(	PUNCT
iajs-3610	91	30	n=	n=	ADJ
iajs-3610	91	31	23	23	NUM
iajs-3610	91	32	)	)	PUNCT
iajs-3610	91	33	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	91	34	(	(	PUNCT
iajs-3610	91	35	n=	n=	ADJ
iajs-3610	91	36	22	22	NUM
iajs-3610	92	1	)	)	PUNCT
iajs-3610	92	2	0.001	0.001	NUM
iajs-3610	92	3	0.61±	0.61±	NUM
iajs-3610	92	4	0.14	0.14	NUM
iajs-3610	92	5	0.62±	0.62±	NOUN
iajs-3610	92	6	0.20	0.20	NUM
iajs-3610	92	7	2183.97±	2183.97±	NUM
iajs-3610	92	8	1,012.09	1,012.09	NUM
iajs-3610	92	9	2485.64±	2485.64±	NUM
iajs-3610	92	10	865.52	865.52	NUM
iajs-3610	92	11	ace-2	ace-2	SYM
iajs-3610	92	12	(	(	PUNCT
iajs-3610	92	13	ρg	ρg	NOUN
iajs-3610	92	14	/	/	SYM
iajs-3610	92	15	ml	ml	NOUN
iajs-3610	92	16	)	)	PUNCT
iajs-3610	92	17	*	*	PUNCT
iajs-3610	92	18	the	the	DET
iajs-3610	92	19	collected	collect	VERB
iajs-3610	92	20	data	datum	NOUN
iajs-3610	92	21	were	be	AUX
iajs-3610	92	22	presented	present	VERB
iajs-3610	92	23	as	as	ADP
iajs-3610	92	24	mean	mean	NOUN
iajs-3610	92	25	±	±	NUM
iajs-3610	92	26	sd	sd	NOUN
iajs-3610	92	27	at	at	ADP
iajs-3610	92	28	the	the	DET
iajs-3610	92	29	p	p	X
iajs-3610	92	30	<	<	X
iajs-3610	92	31	0.05	0.05	NUM
iajs-3610	92	32	level.ace2	level.ace2	NOUN
iajs-3610	92	33	:	:	PUNCT
iajs-3610	92	34	angiotensin	angiotensin	NOUN
iajs-3610	92	35	converting	convert	VERB
iajs-3610	92	36	enzyme2	enzyme2	VERB
iajs-3610	92	37	the	the	DET
iajs-3610	92	38	ace2	ace2	NOUN
iajs-3610	92	39	in	in	ADP
iajs-3610	92	40	discriminating	discriminate	VERB
iajs-3610	92	41	between	between	ADP
iajs-3610	92	42	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	92	43	and	and	CCONJ
iajs-3610	92	44	control	control	NOUN
iajs-3610	92	45	subjects	subject	NOUN
iajs-3610	92	46	had	have	VERB
iajs-3610	92	47	the	the	DET
iajs-3610	92	48	best	good	ADJ
iajs-3610	92	49	cutoff	cutoff	NOUN
iajs-3610	92	50	value	value	NOUN
iajs-3610	92	51	of	of	ADP
iajs-3610	92	52	153.85	153.85	NUM
iajs-3610	92	53	.	.	PUNCT
iajs-3610	93	1	also	also	ADV
iajs-3610	93	2	,	,	PUNCT
iajs-3610	93	3	had	have	VERB
iajs-3610	93	4	sensitivity	sensitivity	NOUN
iajs-3610	93	5	and	and	CCONJ
iajs-3610	93	6	specificity	specificity	NOUN
iajs-3610	93	7	values	value	NOUN
iajs-3610	93	8	of	of	ADP
iajs-3610	93	9	95.45	95.45	NUM
iajs-3610	93	10	%	%	NOUN
iajs-3610	93	11	and	and	CCONJ
iajs-3610	93	12	97.78	97.78	NUM
iajs-3610	93	13	%	%	NOUN
iajs-3610	93	14	at	at	ADP
iajs-3610	93	15	a	a	DET
iajs-3610	93	16	cutoff	cutoff	NOUN
iajs-3610	93	17	value	value	NOUN
iajs-3610	93	18	=	=	PUNCT
iajs-3610	93	19	1085.23	1085.23	NUM
iajs-3610	93	20	.	.	PUNCT
iajs-3610	94	1	the	the	DET
iajs-3610	94	2	ace2	ace2	PROPN
iajs-3610	94	3	had	have	VERB
iajs-3610	94	4	a	a	DET
iajs-3610	94	5	sensitivity	sensitivity	NOUN
iajs-3610	94	6	of	of	ADP
iajs-3610	94	7	100.00	100.00	NUM
iajs-3610	94	8	and	and	CCONJ
iajs-3610	94	9	a	a	DET
iajs-3610	94	10	specificity	specificity	NOUN
iajs-3610	94	11	of	of	ADP
iajs-3610	94	12	93.33	93.33	NUM
iajs-3610	94	13	at	at	ADP
iajs-3610	94	14	a	a	DET
iajs-3610	94	15	cutoff	cutoff	NOUN
iajs-3610	94	16	of	of	ADP
iajs-3610	94	17	918.349	918.349	NUM
iajs-3610	94	18	in	in	ADP
iajs-3610	94	19	discriminating	discriminate	VERB
iajs-3610	94	20	the	the	DET
iajs-3610	94	21	microalbuminuria	microalbuminuria	PROPN
iajs-3610	94	22	group	group	NOUN
iajs-3610	94	23	from	from	ADP
iajs-3610	94	24	the	the	DET
iajs-3610	94	25	control	control	NOUN
iajs-3610	94	26	.	.	PUNCT
iajs-3610	95	1	for	for	ADP
iajs-3610	95	2	ihjpas	ihjpa	NOUN
iajs-3610	95	3	.	.	PUNCT
iajs-3610	96	1	2025	2025	NUM
iajs-3610	96	2	,	,	PUNCT
iajs-3610	96	3	38(3	38(3	NUM
iajs-3610	96	4	)	)	PUNCT
iajs-3610	96	5	231	231	NUM
iajs-3610	96	6	differentiation	differentiation	NOUN
iajs-3610	96	7	of	of	ADP
iajs-3610	96	8	ace2	ace2	NOUN
iajs-3610	96	9	in	in	ADP
iajs-3610	96	10	the	the	DET
iajs-3610	96	11	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	96	12	group	group	NOUN
iajs-3610	96	13	from	from	ADP
iajs-3610	96	14	control	control	NOUN
iajs-3610	96	15	subjects	subject	NOUN
iajs-3610	96	16	,	,	PUNCT
iajs-3610	96	17	auc	auc	NOUN
iajs-3610	96	18	=	=	NUM
iajs-3610	96	19	0.704	0.704	NUM
iajs-3610	96	20	,	,	PUNCT
iajs-3610	96	21	which	which	PRON
iajs-3610	96	22	had	have	VERB
iajs-3610	96	23	sensitivity	sensitivity	NOUN
iajs-3610	96	24	and	and	CCONJ
iajs-3610	96	25	specificity	specificity	NOUN
iajs-3610	96	26	of	of	ADP
iajs-3610	96	27	57.78	57.78	NUM
iajs-3610	96	28	and	and	CCONJ
iajs-3610	96	29	95.56	95.56	NUM
iajs-3610	96	30	at	at	ADP
iajs-3610	96	31	a	a	DET
iajs-3610	96	32	cutoff	cutoff	NOUN
iajs-3610	96	33	=	=	SYM
iajs-3610	96	34	1017.43	1017.43	NUM
iajs-3610	96	35	.	.	PUNCT
iajs-3610	97	1	the	the	DET
iajs-3610	97	2	outcomes	outcome	NOUN
iajs-3610	97	3	of	of	ADP
iajs-3610	97	4	this	this	DET
iajs-3610	97	5	study	study	NOUN
iajs-3610	97	6	revealed	reveal	VERB
iajs-3610	97	7	that	that	SCONJ
iajs-3610	97	8	serum	serum	NOUN
iajs-3610	97	9	ace2	ace2	PROPN
iajs-3610	97	10	was	be	AUX
iajs-3610	97	11	higher	high	ADJ
iajs-3610	97	12	in	in	ADP
iajs-3610	97	13	dn	dn	NOUN
iajs-3610	97	14	patients	patient	NOUN
iajs-3610	97	15	,	,	PUNCT
iajs-3610	97	16	especially	especially	ADV
iajs-3610	97	17	those	those	PRON
iajs-3610	97	18	with	with	ADP
iajs-3610	97	19	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	97	20	and	and	CCONJ
iajs-3610	97	21	microalbuminuria	microalbuminuria	NOUN
iajs-3610	97	22	,	,	PUNCT
iajs-3610	97	23	as	as	SCONJ
iajs-3610	97	24	illustrated	illustrate	VERB
iajs-3610	97	25	in	in	ADP
iajs-3610	97	26	figure	figure	NOUN
iajs-3610	97	27	(	(	PUNCT
iajs-3610	97	28	1	1	NUM
iajs-3610	97	29	)	)	PUNCT
iajs-3610	97	30	and	and	CCONJ
iajs-3610	97	31	table	table	NOUN
iajs-3610	97	32	(	(	PUNCT
iajs-3610	97	33	5	5	NUM
iajs-3610	97	34	)	)	PUNCT
iajs-3610	97	35	.	.	PUNCT
iajs-3610	98	1	figure	figure	NOUN
iajs-3610	98	2	1	1	NUM
iajs-3610	98	3	.	.	PUNCT
iajs-3610	99	1	the	the	DET
iajs-3610	99	2	roc	roc	PROPN
iajs-3610	99	3	for	for	ADP
iajs-3610	99	4	ace2	ace2	NOUN
iajs-3610	99	5	as	as	SCONJ
iajs-3610	99	6	differentiate	differentiate	ADJ
iajs-3610	99	7	across	across	ADP
iajs-3610	99	8	distinct	distinct	ADJ
iajs-3610	99	9	study	study	NOUN
iajs-3610	99	10	subgroups	subgroup	NOUN
iajs-3610	99	11	table	table	VERB
iajs-3610	99	12	‎5	‎5	NOUN
iajs-3610	99	13	.	.	PUNCT
iajs-3610	100	1	comparison	comparison	NOUN
iajs-3610	100	2	of	of	ADP
iajs-3610	100	3	roc	roc	PROPN
iajs-3610	100	4	curve	curve	NOUN
iajs-3610	100	5	features	feature	VERB
iajs-3610	100	6	for	for	ADP
iajs-3610	100	7	ace2	ace2	NOUN
iajs-3610	100	8	as	as	SCONJ
iajs-3610	100	9	they	they	PRON
iajs-3610	100	10	attempt	attempt	VERB
iajs-3610	100	11	to	to	PART
iajs-3610	100	12	differentiate	differentiate	VERB
iajs-3610	100	13	across	across	ADP
iajs-3610	100	14	distinct	distinct	ADJ
iajs-3610	100	15	studied	study	VERB
iajs-3610	100	16	subgroups	subgroup	NOUN
iajs-3610	100	17	.	.	PUNCT
iajs-3610	101	1	ace2	ace2	NOUN
iajs-3610	101	2	groups	group	NOUN
iajs-3610	101	3	auc	auc	VERB
iajs-3610	101	4	se	se	PROPN
iajs-3610	101	5	95	95	NUM
iajs-3610	101	6	%	%	NOUN
iajs-3610	101	7	ci	ci	NOUN
iajs-3610	101	8	cutoff	cutoff	NOUN
iajs-3610	101	9	sense	sense	NOUN
iajs-3610	101	10	.	.	PUNCT
iajs-3610	102	1	spec	spec	PROPN
iajs-3610	102	2	.	.	PUNCT
iajs-3610	103	1	pvalue	pvalue	NOUN
iajs-3610	103	2	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	103	3	vs.	vs.	X
iajs-3610	103	4	control	control	NOUN
iajs-3610	103	5	0.98	0.98	NUM
iajs-3610	103	6	0.017	0.017	NUM
iajs-3610	103	7	0.9110.999	0.9110.999	NOUN
iajs-3610	103	8	>	>	PUNCT
iajs-3610	103	9	1085.23	1085.23	NUM
iajs-3610	103	10	95.45	95.45	NUM
iajs-3610	103	11	97.78	97.78	NUM
iajs-3610	103	12	<	<	X
iajs-3610	103	13	0.001	0.001	NUM
iajs-3610	103	14	microalbuminuria	microalbuminuria	NOUN
iajs-3610	103	15	vs.	vs.	ADP
iajs-3610	103	16	control	control	NOUN
iajs-3610	103	17	0.984	0.984	NUM
iajs-3610	103	18	0.012	0.012	NUM
iajs-3610	103	19	0.918	0.918	NUM
iajs-3610	103	20	-0.999	-0.999	NOUN
iajs-3610	103	21	>	>	X
iajs-3610	103	22	918.349	918.349	NUM
iajs-3610	103	23	100.00	100.00	NUM
iajs-3610	103	24	93.33	93.33	NUM
iajs-3610	103	25	<	<	X
iajs-3610	103	26	0.0001	0.0001	NUM
iajs-3610	103	27	normoalbuminuria	normoalbuminuria	NOUN
iajs-3610	103	28	vs.	vs.	ADP
iajs-3610	103	29	control	control	NOUN
iajs-3610	103	30	0.704	0.704	NUM
iajs-3610	103	31	0.059	0.059	NUM
iajs-3610	103	32	0.599	0.599	NUM
iajs-3610	103	33	-	-	PUNCT
iajs-3610	103	34	0.796	0.796	NUM
iajs-3610	103	35	>	>	PUNCT
iajs-3610	103	36	1017.43	1017.43	NUM
iajs-3610	103	37	57.78	57.78	NUM
iajs-3610	103	38	95.56	95.56	NUM
iajs-3610	103	39	0.0006	0.0006	NUM
iajs-3610	103	40	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	103	41	vs.	vs.	ADP
iajs-3610	103	42	microalbuminuria	microalbuminuria	PROPN
iajs-3610	103	43	0.635	0.635	NUM
iajs-3610	103	44	0.087	0.087	NUM
iajs-3610	103	45	0.479	0.479	NUM
iajs-3610	103	46	-	-	PUNCT
iajs-3610	103	47	0.774	0.774	NUM
iajs-3610	103	48	>	>	PUNCT
iajs-3610	103	49	1310.65	1310.65	NUM
iajs-3610	103	50	86.36	86.36	NUM
iajs-3610	103	51	47.83	47.83	NUM
iajs-3610	103	52	0.1200	0.1200	NUM
iajs-3610	103	53	macroalbuminuria	macroalbuminuria	NOUN
iajs-3610	103	54	vs.	vs.	ADP
iajs-3610	103	55	normoalbuminuria	normoalbuminuria	PROPN
iajs-3610	103	56	0.963	0.963	NUM
iajs-3610	103	57	0.031	0.031	NUM
iajs-3610	103	58	0.8850.994	0.8850.994	NUM
iajs-3610	103	59	>	>	X
iajs-3610	103	60	1143.02	1143.02	NUM
iajs-3610	103	61	95.45	95.45	NUM
iajs-3610	103	62	95.56	95.56	NUM
iajs-3610	103	63	<	<	X
iajs-3610	103	64	0.0001	0.0001	NUM
iajs-3610	103	65	microalbuminuria	microalbuminuria	NOUN
iajs-3610	103	66	vs.	vs.	ADP
iajs-3610	103	67	normoalbuminuria	normoalbuminuria	NOUN
iajs-3610	103	68	0.932	0.932	NUM
iajs-3610	103	69	0.031	0.031	NUM
iajs-3610	103	70	0.844	0.844	NUM
iajs-3610	103	71	-	-	SYM
iajs-3610	103	72	0.979	0.979	NUM
iajs-3610	103	73	>	>	PUNCT
iajs-3610	103	74	1143.02	1143.02	NUM
iajs-3610	103	75	78.26	78.26	NUM
iajs-3610	103	76	95.56	95.56	NUM
iajs-3610	103	77	<	<	X
iajs-3610	103	78	0.0001	0.0001	NUM
iajs-3610	103	79	auc	auc	NOUN
iajs-3610	103	80	,	,	PUNCT
iajs-3610	103	81	area	area	NOUN
iajs-3610	103	82	under	under	ADP
iajs-3610	103	83	the	the	DET
iajs-3610	103	84	curve	curve	NOUN
iajs-3610	103	85	;	;	PUNCT
iajs-3610	103	86	roc	roc	NOUN
iajs-3610	103	87	,	,	PUNCT
iajs-3610	103	88	receiver	receiver	ADV
iajs-3610	103	89	operating	operate	VERB
iajs-3610	103	90	characteristic	characteristic	ADJ
iajs-3610	103	91	curve	curve	NOUN
iajs-3610	103	92	;	;	PUNCT
iajs-3610	103	93	se	se	X
iajs-3610	103	94	,	,	PUNCT
iajs-3610	103	95	standard	standard	ADJ
iajs-3610	103	96	error	error	NOUN
iajs-3610	103	97	;	;	PUNCT
iajs-3610	103	98	95	95	NUM
iajs-3610	103	99	%	%	NOUN
iajs-3610	103	100	ci	ci	NOUN
iajs-3610	103	101	,	,	PUNCT
iajs-3610	103	102	95	95	NUM
iajs-3610	103	103	%	%	NOUN
iajs-3610	103	104	confidence	confidence	NOUN
iajs-3610	103	105	interval	interval	NOUN
iajs-3610	103	106	.	.	PUNCT
iajs-3610	104	1	ihjpas	ihjpas	PROPN
iajs-3610	104	2	.	.	PUNCT
iajs-3610	105	1	2025	2025	NUM
iajs-3610	105	2	,	,	PUNCT
iajs-3610	105	3	38(3	38(3	NUM
iajs-3610	105	4	)	)	PUNCT
iajs-3610	105	5	232	232	NUM
iajs-3610	105	6	4	4	NUM
iajs-3610	105	7	.	.	PUNCT
iajs-3610	105	8	discussion	discussion	NOUN
iajs-3610	105	9	in	in	ADP
iajs-3610	105	10	this	this	DET
iajs-3610	105	11	study	study	NOUN
iajs-3610	105	12	,	,	PUNCT
iajs-3610	105	13	there	there	PRON
iajs-3610	105	14	were	be	VERB
iajs-3610	105	15	no	no	DET
iajs-3610	105	16	substantial	substantial	ADJ
iajs-3610	105	17	variances	variance	NOUN
iajs-3610	105	18	in	in	ADP
iajs-3610	105	19	the	the	DET
iajs-3610	105	20	ages	age	NOUN
iajs-3610	105	21	and	and	CCONJ
iajs-3610	105	22	bmi	bmi	NOUN
iajs-3610	105	23	of	of	ADP
iajs-3610	105	24	different	different	ADJ
iajs-3610	105	25	groups	group	NOUN
iajs-3610	105	26	,	,	PUNCT
iajs-3610	105	27	as	as	SCONJ
iajs-3610	105	28	determined	determine	VERB
iajs-3610	105	29	by	by	ADP
iajs-3610	105	30	the	the	DET
iajs-3610	105	31	anova	anova	PROPN
iajs-3610	105	32	test	test	NOUN
iajs-3610	105	33	,	,	PUNCT
iajs-3610	105	34	compared	compare	VERB
iajs-3610	105	35	to	to	ADP
iajs-3610	105	36	the	the	DET
iajs-3610	105	37	control	control	NOUN
iajs-3610	105	38	groups	group	NOUN
iajs-3610	105	39	.	.	PUNCT
iajs-3610	106	1	this	this	DET
iajs-3610	106	2	finding	finding	NOUN
iajs-3610	106	3	agrees	agree	VERB
iajs-3610	106	4	with	with	ADP
iajs-3610	106	5	previous	previous	ADJ
iajs-3610	106	6	studies	study	NOUN
iajs-3610	106	7	,	,	PUNCT
iajs-3610	106	8	which	which	PRON
iajs-3610	106	9	showed	show	VERB
iajs-3610	106	10	no	no	DET
iajs-3610	106	11	significant	significant	ADJ
iajs-3610	106	12	difference	difference	NOUN
iajs-3610	106	13	in	in	ADP
iajs-3610	106	14	mean	mean	ADJ
iajs-3610	106	15	age	age	NOUN
iajs-3610	106	16	among	among	ADP
iajs-3610	106	17	dn	dn	PROPN
iajs-3610	106	18	patient	patient	NOUN
iajs-3610	106	19	groups	group	NOUN
iajs-3610	106	20	)	)	PUNCT
iajs-3610	106	21	28	28	NUM
iajs-3610	106	22	(	(	PUNCT
iajs-3610	106	23	.	.	PUNCT
iajs-3610	107	1	another	another	DET
iajs-3610	107	2	study	study	NOUN
iajs-3610	107	3	reported	report	VERB
iajs-3610	107	4	that	that	SCONJ
iajs-3610	107	5	the	the	DET
iajs-3610	107	6	incidence	incidence	NOUN
iajs-3610	107	7	of	of	ADP
iajs-3610	107	8	esrd	esrd	PROPN
iajs-3610	107	9	in	in	ADP
iajs-3610	107	10	t2	t2	PROPN
iajs-3610	107	11	dm	dm	NUM
iajs-3610	107	12	increased	increase	VERB
iajs-3610	107	13	with	with	ADP
iajs-3610	107	14	diabetes	diabetes	NOUN
iajs-3610	107	15	duration	duration	NOUN
iajs-3610	107	16	and	and	CCONJ
iajs-3610	107	17	age	age	NOUN
iajs-3610	107	18	)	)	PUNCT
iajs-3610	107	19	29	29	NUM
iajs-3610	107	20	(	(	PUNCT
iajs-3610	107	21	.	.	PUNCT
iajs-3610	108	1	the	the	DET
iajs-3610	108	2	current	current	ADJ
iajs-3610	108	3	study	study	NOUN
iajs-3610	108	4	was	be	AUX
iajs-3610	108	5	conducted	conduct	VERB
iajs-3610	108	6	on	on	ADP
iajs-3610	108	7	diabetic	diabetic	ADJ
iajs-3610	108	8	patients	patient	NOUN
iajs-3610	108	9	with	with	ADP
iajs-3610	108	10	nephropathy	nephropathy	NOUN
iajs-3610	108	11	,	,	PUNCT
iajs-3610	108	12	who	who	PRON
iajs-3610	108	13	had	have	VERB
iajs-3610	108	14	hyperglycemia	hyperglycemia	NOUN
iajs-3610	108	15	reflected	reflect	VERB
iajs-3610	108	16	by	by	ADP
iajs-3610	108	17	higher	high	ADJ
iajs-3610	108	18	fsg	fsg	PROPN
iajs-3610	108	19	and	and	CCONJ
iajs-3610	108	20	hba1c	hba1c	PROPN
iajs-3610	108	21	levels	level	NOUN
iajs-3610	108	22	,	,	PUNCT
iajs-3610	108	23	hyperlipidemia	hyperlipidemia	NOUN
iajs-3610	108	24	reflected	reflect	VERB
iajs-3610	108	25	by	by	ADP
iajs-3610	108	26	higher	high	ADJ
iajs-3610	108	27	tc	tc	NOUN
iajs-3610	108	28	,	,	PUNCT
iajs-3610	108	29	tg	tg	PROPN
iajs-3610	108	30	,	,	PUNCT
iajs-3610	108	31	and	and	CCONJ
iajs-3610	108	32	ldl	ldl	NOUN
iajs-3610	108	33	-	-	PUNCT
iajs-3610	108	34	c	c	NOUN
iajs-3610	108	35	levels	level	NOUN
iajs-3610	108	36	,	,	PUNCT
iajs-3610	108	37	and	and	CCONJ
iajs-3610	108	38	acr	acr	NOUN
iajs-3610	108	39	,	,	PUNCT
iajs-3610	108	40	along	along	ADP
iajs-3610	108	41	with	with	ADP
iajs-3610	108	42	lower	low	ADJ
iajs-3610	108	43	egfr	egfr	ADJ
iajs-3610	108	44	values	value	NOUN
iajs-3610	108	45	,	,	PUNCT
iajs-3610	108	46	as	as	ADP
iajs-3610	108	47	dependent	dependent	ADJ
iajs-3610	108	48	criteria	criterion	NOUN
iajs-3610	108	49	for	for	ADP
iajs-3610	108	50	classifying	classify	VERB
iajs-3610	108	51	patient	patient	ADJ
iajs-3610	108	52	groups	group	NOUN
iajs-3610	108	53	.	.	PUNCT
iajs-3610	109	1	in	in	ADP
iajs-3610	109	2	addition	addition	NOUN
iajs-3610	109	3	to	to	ADP
iajs-3610	109	4	other	other	ADJ
iajs-3610	109	5	factors	factor	NOUN
iajs-3610	109	6	such	such	ADJ
iajs-3610	109	7	as	as	ADP
iajs-3610	109	8	urea	urea	NOUN
iajs-3610	109	9	and	and	CCONJ
iajs-3610	109	10	creatinine	creatinine	NOUN
iajs-3610	109	11	,	,	PUNCT
iajs-3610	109	12	the	the	DET
iajs-3610	109	13	mentioned	mention	VERB
iajs-3610	109	14	parameters	parameter	NOUN
iajs-3610	109	15	refer	refer	VERB
iajs-3610	109	16	to	to	ADP
iajs-3610	109	17	the	the	DET
iajs-3610	109	18	progression	progression	NOUN
iajs-3610	109	19	of	of	ADP
iajs-3610	109	20	diabetic	diabetic	ADJ
iajs-3610	109	21	complications	complication	NOUN
iajs-3610	109	22	,	,	PUNCT
iajs-3610	109	23	i.e.	i.e.	X
iajs-3610	109	24	,	,	PUNCT
iajs-3610	109	25	diabetic	diabetic	ADJ
iajs-3610	109	26	kidney	kidney	NOUN
iajs-3610	109	27	disease	disease	NOUN
iajs-3610	109	28	.	.	PUNCT
iajs-3610	110	1	in	in	ADP
iajs-3610	110	2	this	this	DET
iajs-3610	110	3	study	study	NOUN
iajs-3610	110	4	,	,	PUNCT
iajs-3610	110	5	the	the	DET
iajs-3610	110	6	mean	mean	ADJ
iajs-3610	110	7	hba1c	hba1c	NOUN
iajs-3610	110	8	level	level	NOUN
iajs-3610	110	9	was	be	AUX
iajs-3610	110	10	significantly	significantly	ADV
iajs-3610	110	11	different	different	ADJ
iajs-3610	110	12	between	between	ADP
iajs-3610	110	13	the	the	DET
iajs-3610	110	14	diabetics	diabetic	NOUN
iajs-3610	110	15	and	and	CCONJ
iajs-3610	110	16	the	the	DET
iajs-3610	110	17	controls	control	NOUN
iajs-3610	110	18	.	.	PUNCT
iajs-3610	111	1	measuring	measure	VERB
iajs-3610	111	2	hba1c	hba1c	PROPN
iajs-3610	111	3	value	value	NOUN
iajs-3610	111	4	is	be	AUX
iajs-3610	111	5	commonly	commonly	ADV
iajs-3610	111	6	used	use	VERB
iajs-3610	111	7	in	in	ADP
iajs-3610	111	8	dm	dm	PROPN
iajs-3610	111	9	patients	patient	NOUN
iajs-3610	111	10	as	as	ADP
iajs-3610	111	11	a	a	DET
iajs-3610	111	12	marker	marker	NOUN
iajs-3610	111	13	of	of	ADP
iajs-3610	111	14	glycemic	glycemic	ADJ
iajs-3610	111	15	control	control	NOUN
iajs-3610	111	16	and	and	CCONJ
iajs-3610	111	17	also	also	ADV
iajs-3610	111	18	as	as	ADP
iajs-3610	111	19	a	a	DET
iajs-3610	111	20	marker	marker	NOUN
iajs-3610	111	21	for	for	ADP
iajs-3610	111	22	adjusting	adjust	VERB
iajs-3610	111	23	treatment	treatment	NOUN
iajs-3610	111	24	or	or	CCONJ
iajs-3610	111	25	even	even	ADV
iajs-3610	111	26	initiating	initiate	VERB
iajs-3610	111	27	insulin	insulin	NOUN
iajs-3610	111	28	therapy	therapy	NOUN
iajs-3610	111	29	when	when	SCONJ
iajs-3610	111	30	needed	need	VERB
iajs-3610	111	31	)	)	PUNCT
iajs-3610	111	32	30	30	NUM
iajs-3610	111	33	(	(	PUNCT
iajs-3610	111	34	.	.	PUNCT
iajs-3610	112	1	it	it	PRON
iajs-3610	112	2	has	have	AUX
iajs-3610	112	3	been	be	AUX
iajs-3610	112	4	reported	report	VERB
iajs-3610	112	5	that	that	SCONJ
iajs-3610	112	6	fsg	fsg	PROPN
iajs-3610	112	7	was	be	AUX
iajs-3610	112	8	considerably	considerably	ADV
iajs-3610	112	9	greater	great	ADJ
iajs-3610	112	10	in	in	ADP
iajs-3610	112	11	patient	patient	ADJ
iajs-3610	112	12	groups	group	NOUN
iajs-3610	112	13	than	than	ADP
iajs-3610	112	14	in	in	ADP
iajs-3610	112	15	the	the	DET
iajs-3610	112	16	control	control	NOUN
iajs-3610	112	17	group	group	NOUN
iajs-3610	112	18	in	in	ADP
iajs-3610	112	19	various	various	ADJ
iajs-3610	112	20	studies	study	NOUN
iajs-3610	112	21	,	,	PUNCT
iajs-3610	112	22	which	which	PRON
iajs-3610	112	23	is	be	AUX
iajs-3610	112	24	consistent	consistent	ADJ
iajs-3610	112	25	with	with	ADP
iajs-3610	112	26	the	the	DET
iajs-3610	112	27	results	result	NOUN
iajs-3610	112	28	of	of	ADP
iajs-3610	112	29	this	this	DET
iajs-3610	112	30	study	study	NOUN
iajs-3610	112	31	)	)	PUNCT
iajs-3610	112	32	30	30	NUM
iajs-3610	112	33	,	,	PUNCT
iajs-3610	112	34	31	31	NUM
iajs-3610	112	35	(	(	PUNCT
iajs-3610	112	36	.	.	PUNCT
iajs-3610	113	1	albuminuria	albuminuria	PROPN
iajs-3610	113	2	is	be	AUX
iajs-3610	113	3	used	use	VERB
iajs-3610	113	4	to	to	PART
iajs-3610	113	5	diagnose	diagnose	VERB
iajs-3610	113	6	and	and	CCONJ
iajs-3610	113	7	monitor	monitor	VERB
iajs-3610	113	8	kidney	kidney	NOUN
iajs-3610	113	9	disease	disease	NOUN
iajs-3610	113	10	.	.	PUNCT
iajs-3610	114	1	change	change	NOUN
iajs-3610	114	2	in	in	ADP
iajs-3610	114	3	albuminuria	albuminuria	NOUN
iajs-3610	114	4	may	may	AUX
iajs-3610	114	5	reflect	reflect	VERB
iajs-3610	114	6	response	response	NOUN
iajs-3610	114	7	to	to	ADP
iajs-3610	114	8	therapy	therapy	NOUN
iajs-3610	114	9	and	and	CCONJ
iajs-3610	114	10	risk	risk	NOUN
iajs-3610	114	11	for	for	ADP
iajs-3610	114	12	progression	progression	NOUN
iajs-3610	114	13	.	.	PUNCT
iajs-3610	115	1	a	a	DET
iajs-3610	115	2	decrease	decrease	NOUN
iajs-3610	115	3	in	in	ADP
iajs-3610	115	4	urine	urine	NOUN
iajs-3610	115	5	albumin	albumin	NOUN
iajs-3610	115	6	may	may	AUX
iajs-3610	115	7	be	be	AUX
iajs-3610	115	8	associated	associate	VERB
iajs-3610	115	9	with	with	ADP
iajs-3610	115	10	improved	improved	ADJ
iajs-3610	115	11	renal	renal	ADJ
iajs-3610	115	12	and	and	CCONJ
iajs-3610	115	13	cardiovascular	cardiovascular	ADJ
iajs-3610	115	14	outcomes	outcome	NOUN
iajs-3610	115	15	.	.	PUNCT
iajs-3610	116	1	in	in	ADP
iajs-3610	116	2	this	this	DET
iajs-3610	116	3	study	study	NOUN
iajs-3610	116	4	,	,	PUNCT
iajs-3610	116	5	the	the	DET
iajs-3610	116	6	acr	acr	PROPN
iajs-3610	116	7	increased	increase	VERB
iajs-3610	116	8	in	in	ADP
iajs-3610	116	9	diabetic	diabetic	ADJ
iajs-3610	116	10	groups	group	NOUN
iajs-3610	116	11	compared	compare	VERB
iajs-3610	116	12	to	to	ADP
iajs-3610	116	13	control	control	NOUN
iajs-3610	116	14	groups	group	NOUN
iajs-3610	116	15	,	,	PUNCT
iajs-3610	116	16	reaching	reach	VERB
iajs-3610	116	17	its	its	PRON
iajs-3610	116	18	maximum	maximum	ADJ
iajs-3610	116	19	increase	increase	NOUN
iajs-3610	116	20	in	in	ADP
iajs-3610	116	21	the	the	DET
iajs-3610	116	22	macroalbuminuria	macroalbuminuria	PROPN
iajs-3610	116	23	group	group	NOUN
iajs-3610	116	24	,	,	PUNCT
iajs-3610	116	25	which	which	PRON
iajs-3610	116	26	is	be	AUX
iajs-3610	116	27	in	in	ADP
iajs-3610	116	28	agreement	agreement	NOUN
iajs-3610	116	29	with	with	ADP
iajs-3610	116	30	a	a	DET
iajs-3610	116	31	previous	previous	ADJ
iajs-3610	116	32	study	study	NOUN
iajs-3610	116	33	)	)	PUNCT
iajs-3610	116	34	31	31	NUM
iajs-3610	116	35	(	(	PUNCT
iajs-3610	116	36	.	.	PUNCT
iajs-3610	117	1	the	the	DET
iajs-3610	117	2	two	two	NUM
iajs-3610	117	3	key	key	ADJ
iajs-3610	117	4	markers	marker	NOUN
iajs-3610	117	5	for	for	ADP
iajs-3610	117	6	ckd	ckd	PROPN
iajs-3610	117	7	are	be	AUX
iajs-3610	117	8	urine	urine	ADJ
iajs-3610	117	9	albumin	albumin	ADJ
iajs-3610	117	10	and	and	CCONJ
iajs-3610	117	11	egfr	egfr	NOUN
iajs-3610	117	12	.	.	PUNCT
iajs-3610	118	1	the	the	DET
iajs-3610	118	2	current	current	ADJ
iajs-3610	118	3	study	study	NOUN
iajs-3610	118	4	also	also	ADV
iajs-3610	118	5	found	find	VERB
iajs-3610	118	6	that	that	SCONJ
iajs-3610	118	7	the	the	DET
iajs-3610	118	8	microalbuminuria	microalbuminuria	PROPN
iajs-3610	118	9	group	group	NOUN
iajs-3610	118	10	had	have	VERB
iajs-3610	118	11	significantly	significantly	ADV
iajs-3610	118	12	higher	high	ADJ
iajs-3610	118	13	levels	level	NOUN
iajs-3610	118	14	of	of	ADP
iajs-3610	118	15	urea	urea	NOUN
iajs-3610	118	16	and	and	CCONJ
iajs-3610	118	17	creatinine	creatinine	NOUN
iajs-3610	118	18	and	and	CCONJ
iajs-3610	118	19	lower	low	ADJ
iajs-3610	118	20	egfr	egfr	NOUN
iajs-3610	118	21	compared	compare	VERB
iajs-3610	118	22	to	to	ADP
iajs-3610	118	23	other	other	ADJ
iajs-3610	118	24	diabetic	diabetic	ADJ
iajs-3610	118	25	groups	group	NOUN
iajs-3610	118	26	and	and	CCONJ
iajs-3610	118	27	controls	control	NOUN
iajs-3610	118	28	)	)	PUNCT
iajs-3610	118	29	32	32	NUM
iajs-3610	118	30	(	(	PUNCT
iajs-3610	118	31	.	.	PUNCT
iajs-3610	119	1	creatinine	creatinine	PROPN
iajs-3610	119	2	is	be	AUX
iajs-3610	119	3	a	a	DET
iajs-3610	119	4	more	more	ADV
iajs-3610	119	5	sensitive	sensitive	ADJ
iajs-3610	119	6	marker	marker	NOUN
iajs-3610	119	7	than	than	ADP
iajs-3610	119	8	urea	urea	NOUN
iajs-3610	119	9	for	for	ADP
iajs-3610	119	10	the	the	DET
iajs-3610	119	11	early	early	ADJ
iajs-3610	119	12	detection	detection	NOUN
iajs-3610	119	13	of	of	ADP
iajs-3610	119	14	renal	renal	ADJ
iajs-3610	119	15	impairment	impairment	NOUN
iajs-3610	119	16	.	.	PUNCT
iajs-3610	120	1	thus	thus	ADV
iajs-3610	120	2	,	,	PUNCT
iajs-3610	120	3	serum	serum	NOUN
iajs-3610	120	4	creatinine	creatinine	NOUN
iajs-3610	120	5	can	can	AUX
iajs-3610	120	6	be	be	AUX
iajs-3610	120	7	used	use	VERB
iajs-3610	120	8	to	to	PART
iajs-3610	120	9	calculate	calculate	VERB
iajs-3610	120	10	gfr	gfr	PROPN
iajs-3610	120	11	.	.	PUNCT
iajs-3610	121	1	various	various	ADJ
iajs-3610	121	2	studies	study	NOUN
iajs-3610	121	3	have	have	AUX
iajs-3610	121	4	found	find	VERB
iajs-3610	121	5	that	that	SCONJ
iajs-3610	121	6	higher	high	ADJ
iajs-3610	121	7	serum	serum	NOUN
iajs-3610	121	8	levels	level	NOUN
iajs-3610	121	9	of	of	ADP
iajs-3610	121	10	urea	urea	NOUN
iajs-3610	121	11	and	and	CCONJ
iajs-3610	121	12	creatinine	creatinine	NOUN
iajs-3610	121	13	are	be	AUX
iajs-3610	121	14	associated	associate	VERB
iajs-3610	121	15	with	with	ADP
iajs-3610	121	16	elevated	elevated	ADJ
iajs-3610	121	17	blood	blood	NOUN
iajs-3610	121	18	sugar	sugar	NOUN
iajs-3610	121	19	.	.	PUNCT
iajs-3610	122	1	the	the	DET
iajs-3610	122	2	present	present	ADJ
iajs-3610	122	3	data	datum	NOUN
iajs-3610	122	4	are	be	AUX
iajs-3610	122	5	consistent	consistent	ADJ
iajs-3610	122	6	with	with	ADP
iajs-3610	122	7	prior	prior	ADJ
iajs-3610	122	8	research	research	NOUN
iajs-3610	122	9	on	on	ADP
iajs-3610	122	10	diabetic	diabetic	ADJ
iajs-3610	122	11	patients	patient	NOUN
iajs-3610	122	12	,	,	PUNCT
iajs-3610	122	13	which	which	PRON
iajs-3610	122	14	demonstrated	demonstrate	VERB
iajs-3610	122	15	an	an	DET
iajs-3610	122	16	increased	increased	ADJ
iajs-3610	122	17	level	level	NOUN
iajs-3610	122	18	of	of	ADP
iajs-3610	122	19	urea	urea	NOUN
iajs-3610	122	20	and	and	CCONJ
iajs-3610	122	21	creatinine	creatinine	NOUN
iajs-3610	122	22	with	with	ADP
iajs-3610	122	23	the	the	DET
iajs-3610	122	24	development	development	NOUN
iajs-3610	122	25	of	of	ADP
iajs-3610	122	26	dn	dn	PROPN
iajs-3610	122	27	.	.	PROPN
iajs-3610	122	28	increased	increase	VERB
iajs-3610	122	29	urea	urea	NOUN
iajs-3610	122	30	and	and	CCONJ
iajs-3610	122	31	creatinine	creatinine	NOUN
iajs-3610	122	32	levels	level	NOUN
iajs-3610	122	33	have	have	AUX
iajs-3610	122	34	been	be	AUX
iajs-3610	122	35	reported	report	VERB
iajs-3610	122	36	in	in	ADP
iajs-3610	122	37	earlier	early	ADJ
iajs-3610	122	38	studies	study	NOUN
iajs-3610	122	39	)	)	PUNCT
iajs-3610	122	40	33	33	NUM
iajs-3610	122	41	(	(	PUNCT
iajs-3610	122	42	during	during	ADP
iajs-3610	122	43	diabetes	diabetes	NOUN
iajs-3610	122	44	,	,	PUNCT
iajs-3610	122	45	along	along	ADP
iajs-3610	122	46	with	with	ADP
iajs-3610	122	47	a	a	DET
iajs-3610	122	48	decreased	decreased	ADJ
iajs-3610	122	49	gfr	gfr	NOUN
iajs-3610	122	50	.	.	PUNCT
iajs-3610	123	1	an	an	DET
iajs-3610	123	2	increase	increase	NOUN
iajs-3610	123	3	in	in	ADP
iajs-3610	123	4	urea	urea	NOUN
iajs-3610	123	5	level	level	NOUN
iajs-3610	123	6	is	be	AUX
iajs-3610	123	7	seen	see	VERB
iajs-3610	123	8	when	when	SCONJ
iajs-3610	123	9	there	there	PRON
iajs-3610	123	10	is	be	VERB
iajs-3610	123	11	damage	damage	NOUN
iajs-3610	123	12	to	to	ADP
iajs-3610	123	13	the	the	DET
iajs-3610	123	14	kidneys	kidney	NOUN
iajs-3610	123	15	.	.	PUNCT
iajs-3610	124	1	a	a	DET
iajs-3610	124	2	higher	high	ADJ
iajs-3610	124	3	blood	blood	NOUN
iajs-3610	124	4	urea	urea	NOUN
iajs-3610	124	5	level	level	NOUN
iajs-3610	124	6	in	in	ADP
iajs-3610	124	7	the	the	DET
iajs-3610	124	8	presence	presence	NOUN
iajs-3610	124	9	of	of	ADP
iajs-3610	124	10	high	high	ADJ
iajs-3610	124	11	blood	blood	NOUN
iajs-3610	124	12	sugar	sugar	NOUN
iajs-3610	124	13	in	in	ADP
iajs-3610	124	14	a	a	DET
iajs-3610	124	15	diabetic	diabetic	ADJ
iajs-3610	124	16	patient	patient	NOUN
iajs-3610	124	17	indicates	indicate	VERB
iajs-3610	124	18	kidney	kidney	NOUN
iajs-3610	124	19	damage	damage	NOUN
iajs-3610	124	20	)	)	PUNCT
iajs-3610	125	1	34(.the	34(.the	DET
iajs-3610	125	2	findings	finding	NOUN
iajs-3610	125	3	of	of	ADP
iajs-3610	125	4	this	this	DET
iajs-3610	125	5	study	study	NOUN
iajs-3610	125	6	showed	show	VERB
iajs-3610	125	7	that	that	SCONJ
iajs-3610	125	8	estimating	estimate	VERB
iajs-3610	125	9	acr	acr	PROPN
iajs-3610	125	10	and	and	CCONJ
iajs-3610	125	11	gfr	gfr	NOUN
iajs-3610	125	12	could	could	AUX
iajs-3610	125	13	be	be	AUX
iajs-3610	125	14	helpful	helpful	ADJ
iajs-3610	125	15	to	to	ADP
iajs-3610	125	16	markers	marker	NOUN
iajs-3610	125	17	in	in	ADP
iajs-3610	125	18	this	this	DET
iajs-3610	125	19	situation	situation	NOUN
iajs-3610	125	20	for	for	ADP
iajs-3610	125	21	early	early	ADJ
iajs-3610	125	22	detection	detection	NOUN
iajs-3610	125	23	of	of	ADP
iajs-3610	125	24	dn	dn	PROPN
iajs-3610	125	25	,	,	PUNCT
iajs-3610	125	26	prevention	prevention	NOUN
iajs-3610	125	27	of	of	ADP
iajs-3610	125	28	overt	overt	ADJ
iajs-3610	125	29	nephropathy	nephropathy	NOUN
iajs-3610	125	30	,	,	PUNCT
iajs-3610	125	31	and	and	CCONJ
iajs-3610	125	32	progression	progression	NOUN
iajs-3610	125	33	to	to	ADP
iajs-3610	125	34	esrd	esrd	PROPN
iajs-3610	125	35	(	(	PUNCT
iajs-3610	125	36	35	35	NUM
iajs-3610	125	37	)	)	PUNCT
iajs-3610	125	38	.	.	PUNCT
iajs-3610	126	1	these	these	DET
iajs-3610	126	2	results	result	NOUN
iajs-3610	126	3	suggested	suggest	VERB
iajs-3610	126	4	that	that	SCONJ
iajs-3610	126	5	alterations	alteration	NOUN
iajs-3610	126	6	in	in	ADP
iajs-3610	126	7	egfr	egfr	NOUN
iajs-3610	126	8	and	and	CCONJ
iajs-3610	126	9	albuminuria	albuminuria	PROPN
iajs-3610	126	10	may	may	AUX
iajs-3610	126	11	contribute	contribute	VERB
iajs-3610	126	12	to	to	ADP
iajs-3610	126	13	the	the	DET
iajs-3610	126	14	development	development	NOUN
iajs-3610	126	15	of	of	ADP
iajs-3610	126	16	renal	renal	ADJ
iajs-3610	126	17	disease	disease	NOUN
iajs-3610	126	18	(	(	PUNCT
iajs-3610	126	19	36	36	NUM
iajs-3610	126	20	,	,	PUNCT
iajs-3610	126	21	37	37	NUM
iajs-3610	126	22	)	)	PUNCT
iajs-3610	126	23	.	.	PUNCT
iajs-3610	127	1	the	the	DET
iajs-3610	127	2	egfr	egfr	NOUN
iajs-3610	127	3	is	be	AUX
iajs-3610	127	4	more	more	ADV
iajs-3610	127	5	accurate	accurate	ADJ
iajs-3610	127	6	than	than	ADP
iajs-3610	127	7	serum	serum	NOUN
iajs-3610	127	8	creatinine	creatinine	NOUN
iajs-3610	127	9	alone	alone	ADV
iajs-3610	127	10	.	.	PUNCT
iajs-3610	128	1	serum	serum	NOUN
iajs-3610	128	2	creatinine	creatinine	PROPN
iajs-3610	128	3	is	be	AUX
iajs-3610	128	4	affected	affect	VERB
iajs-3610	128	5	by	by	ADP
iajs-3610	128	6	factors	factor	NOUN
iajs-3610	128	7	such	such	ADJ
iajs-3610	128	8	as	as	ADP
iajs-3610	128	9	muscle	muscle	NOUN
iajs-3610	128	10	mass	mass	PROPN
iajs-3610	128	11	,	,	PUNCT
iajs-3610	128	12	age	age	NOUN
iajs-3610	128	13	,	,	PUNCT
iajs-3610	128	14	sex	sex	NOUN
iajs-3610	128	15	,	,	PUNCT
iajs-3610	128	16	and	and	CCONJ
iajs-3610	128	17	race	race	NOUN
iajs-3610	128	18	(	(	PUNCT
iajs-3610	128	19	38	38	NUM
iajs-3610	128	20	)	)	PUNCT
iajs-3610	128	21	.	.	PUNCT
iajs-3610	129	1	the	the	DET
iajs-3610	129	2	ace2	ace2	PROPN
iajs-3610	129	3	,	,	PUNCT
iajs-3610	129	4	which	which	PRON
iajs-3610	129	5	is	be	AUX
iajs-3610	129	6	capable	capable	ADJ
iajs-3610	129	7	of	of	ADP
iajs-3610	129	8	reducing	reduce	VERB
iajs-3610	129	9	angiotensin	angiotensin	NOUN
iajs-3610	129	10	ii	ii	PROPN
iajs-3610	129	11	(	(	PUNCT
iajs-3610	129	12	ang	ang	PROPN
iajs-3610	129	13	ii	ii	PROPN
iajs-3610	129	14	)	)	PUNCT
iajs-3610	129	15	and	and	CCONJ
iajs-3610	129	16	promoting	promote	VERB
iajs-3610	129	17	ang	ang	PROPN
iajs-3610	129	18	(	(	PUNCT
iajs-3610	129	19	1–7	1–7	NUM
iajs-3610	129	20	)	)	PUNCT
iajs-3610	129	21	,	,	PUNCT
iajs-3610	129	22	serves	serve	VERB
iajs-3610	129	23	as	as	ADP
iajs-3610	129	24	a	a	DET
iajs-3610	129	25	key	key	ADJ
iajs-3610	129	26	protective	protective	ADJ
iajs-3610	129	27	enzyme	enzyme	NOUN
iajs-3610	129	28	by	by	ADP
iajs-3610	129	29	reducing	reduce	VERB
iajs-3610	129	30	oxidative	oxidative	ADJ
iajs-3610	129	31	stress	stress	NOUN
iajs-3610	129	32	,	,	PUNCT
iajs-3610	129	33	inflammation	inflammation	NOUN
iajs-3610	129	34	,	,	PUNCT
iajs-3610	129	35	and	and	CCONJ
iajs-3610	129	36	fibrosis	fibrosis	NOUN
iajs-3610	129	37	.	.	PUNCT
iajs-3610	130	1	compounds	compound	VERB
iajs-3610	130	2	that	that	PRON
iajs-3610	130	3	increase	increase	VERB
iajs-3610	130	4	ace2	ace2	NOUN
iajs-3610	130	5	catalytic	catalytic	ADJ
iajs-3610	130	6	activity	activity	NOUN
iajs-3610	130	7	offer	offer	VERB
iajs-3610	130	8	a	a	DET
iajs-3610	130	9	unique	unique	ADJ
iajs-3610	130	10	approach	approach	NOUN
iajs-3610	130	11	to	to	ADP
iajs-3610	130	12	targeting	target	VERB
iajs-3610	130	13	tubular	tubular	ADJ
iajs-3610	130	14	and	and	CCONJ
iajs-3610	130	15	glomerular	glomerular	ADJ
iajs-3610	130	16	ace2	ace2	NOUN
iajs-3610	130	17	,	,	PUNCT
iajs-3610	130	18	potentially	potentially	ADV
iajs-3610	130	19	participating	participate	VERB
iajs-3610	130	20	in	in	ADP
iajs-3610	130	21	new	new	ADJ
iajs-3610	130	22	treatment	treatment	NOUN
iajs-3610	130	23	approaches	approach	NOUN
iajs-3610	130	24	for	for	ADP
iajs-3610	130	25	dm	dm	PROPN
iajs-3610	130	26	.	.	PUNCT
iajs-3610	130	27	development	development	NOUN
iajs-3610	130	28	of	of	ADP
iajs-3610	130	29	new	new	ADJ
iajs-3610	130	30	ace2	ace2	NOUN
iajs-3610	130	31	stimulators	stimulator	NOUN
iajs-3610	130	32	with	with	ADP
iajs-3610	130	33	clinical	clinical	ADJ
iajs-3610	130	34	translational	translational	ADJ
iajs-3610	130	35	potential	potential	NOUN
iajs-3610	130	36	is	be	AUX
iajs-3610	130	37	necessary	necessary	ADJ
iajs-3610	130	38	.	.	PUNCT
iajs-3610	131	1	increased	increase	VERB
iajs-3610	131	2	levels	level	NOUN
iajs-3610	131	3	of	of	ADP
iajs-3610	131	4	ace2	ace2	PROPN
iajs-3610	131	5	in	in	ADP
iajs-3610	131	6	the	the	DET
iajs-3610	131	7	kidneys	kidney	NOUN
iajs-3610	131	8	have	have	AUX
iajs-3610	131	9	been	be	AUX
iajs-3610	131	10	associated	associate	VERB
iajs-3610	131	11	with	with	ADP
iajs-3610	131	12	elevated	elevated	ADJ
iajs-3610	131	13	levels	level	NOUN
iajs-3610	131	14	of	of	ADP
iajs-3610	131	15	renal	renal	ADJ
iajs-3610	131	16	ang	ang	PROPN
iajs-3610	131	17	ii	ii	PROPN
iajs-3610	131	18	(	(	PUNCT
iajs-3610	131	19	39	39	NUM
iajs-3610	131	20	)	)	PUNCT
iajs-3610	131	21	.	.	PUNCT
iajs-3610	132	1	the	the	DET
iajs-3610	132	2	ace2	ace2	PROPN
iajs-3610	132	3	enzyme	enzyme	NOUN
iajs-3610	132	4	plays	play	VERB
iajs-3610	132	5	a	a	DET
iajs-3610	132	6	crucial	crucial	ADJ
iajs-3610	132	7	role	role	NOUN
iajs-3610	132	8	in	in	ADP
iajs-3610	132	9	preventing	prevent	VERB
iajs-3610	132	10	progressive	progressive	ADJ
iajs-3610	132	11	renal	renal	ADJ
iajs-3610	132	12	damage	damage	NOUN
iajs-3610	132	13	by	by	ADP
iajs-3610	132	14	reducing	reduce	VERB
iajs-3610	132	15	oxidative	oxidative	ADJ
iajs-3610	132	16	stress	stress	NOUN
iajs-3610	132	17	,	,	PUNCT
iajs-3610	132	18	inflammation	inflammation	NOUN
iajs-3610	132	19	,	,	PUNCT
iajs-3610	132	20	and	and	CCONJ
iajs-3610	132	21	fibrosis	fibrosis	NOUN
iajs-3610	132	22	.	.	PUNCT
iajs-3610	133	1	the	the	DET
iajs-3610	133	2	kidney	kidney	NOUN
iajs-3610	133	3	possesses	possess	VERB
iajs-3610	133	4	a	a	DET
iajs-3610	133	5	fully	fully	ADV
iajs-3610	133	6	ihjpas	ihjpas	ADJ
iajs-3610	133	7	.	.	PUNCT
iajs-3610	134	1	2025	2025	NUM
iajs-3610	134	2	,	,	PUNCT
iajs-3610	134	3	38(3	38(3	NUM
iajs-3610	134	4	)	)	PUNCT
iajs-3610	134	5	233	233	NUM
iajs-3610	134	6	functional	functional	ADJ
iajs-3610	134	7	local	local	ADJ
iajs-3610	134	8	ras	ras	NOUN
iajs-3610	134	9	capable	capable	ADJ
iajs-3610	134	10	of	of	ADP
iajs-3610	134	11	producing	produce	VERB
iajs-3610	134	12	ang	ang	PROPN
iajs-3610	134	13	ii	ii	PROPN
iajs-3610	134	14	,	,	PUNCT
iajs-3610	134	15	a	a	DET
iajs-3610	134	16	major	major	ADJ
iajs-3610	134	17	contributor	contributor	NOUN
iajs-3610	134	18	to	to	ADP
iajs-3610	134	19	the	the	DET
iajs-3610	134	20	progression	progression	NOUN
iajs-3610	134	21	of	of	ADP
iajs-3610	134	22	ckd	ckd	PROPN
iajs-3610	134	23	.	.	PUNCT
iajs-3610	135	1	the	the	DET
iajs-3610	135	2	ace2	ace2	PROPN
iajs-3610	135	3	is	be	AUX
iajs-3610	135	4	highly	highly	ADV
iajs-3610	135	5	expressed	express	VERB
iajs-3610	135	6	in	in	ADP
iajs-3610	135	7	the	the	DET
iajs-3610	135	8	kidney	kidney	NOUN
iajs-3610	135	9	and	and	CCONJ
iajs-3610	135	10	predominantly	predominantly	ADV
iajs-3610	135	11	localized	localize	VERB
iajs-3610	135	12	to	to	ADP
iajs-3610	135	13	proximal	proximal	ADJ
iajs-3610	135	14	tubules	tubule	NOUN
iajs-3610	135	15	and	and	CCONJ
iajs-3610	135	16	glomerular	glomerular	ADJ
iajs-3610	135	17	podocytes	podocyte	NOUN
iajs-3610	135	18	(	(	PUNCT
iajs-3610	135	19	40	40	NUM
iajs-3610	135	20	)	)	PUNCT
iajs-3610	135	21	.	.	PUNCT
iajs-3610	136	1	in	in	ADP
iajs-3610	136	2	t2	t2	PROPN
iajs-3610	136	3	dm	dm	PROPN
iajs-3610	136	4	patients	patient	NOUN
iajs-3610	136	5	,	,	PUNCT
iajs-3610	136	6	increased	increase	VERB
iajs-3610	136	7	levels	level	NOUN
iajs-3610	136	8	of	of	ADP
iajs-3610	136	9	specific	specific	ADJ
iajs-3610	136	10	urinary	urinary	ADJ
iajs-3610	136	11	biomarkers	biomarker	NOUN
iajs-3610	136	12	could	could	AUX
iajs-3610	136	13	be	be	AUX
iajs-3610	136	14	detected	detect	VERB
iajs-3610	136	15	before	before	ADP
iajs-3610	136	16	the	the	DET
iajs-3610	136	17	onset	onset	NOUN
iajs-3610	136	18	of	of	ADP
iajs-3610	136	19	significant	significant	ADJ
iajs-3610	136	20	albuminuria	albuminuria	NOUN
iajs-3610	136	21	,	,	PUNCT
iajs-3610	136	22	and	and	CCONJ
iajs-3610	136	23	they	they	PRON
iajs-3610	136	24	can	can	AUX
iajs-3610	136	25	be	be	AUX
iajs-3610	136	26	used	use	VERB
iajs-3610	136	27	as	as	ADP
iajs-3610	136	28	early	early	ADJ
iajs-3610	136	29	markers	marker	NOUN
iajs-3610	136	30	of	of	ADP
iajs-3610	136	31	dn	dn	PROPN
iajs-3610	136	32	(	(	PUNCT
iajs-3610	136	33	41	41	NUM
iajs-3610	136	34	)	)	PUNCT
iajs-3610	136	35	.	.	PUNCT
iajs-3610	137	1	5	5	X
iajs-3610	137	2	.	.	X
iajs-3610	137	3	conclusion	conclusion	NOUN
iajs-3610	137	4	the	the	DET
iajs-3610	137	5	study	study	NOUN
iajs-3610	137	6	revealed	reveal	VERB
iajs-3610	137	7	a	a	DET
iajs-3610	137	8	significant	significant	ADJ
iajs-3610	137	9	association	association	NOUN
iajs-3610	137	10	between	between	ADP
iajs-3610	137	11	serum	serum	NOUN
iajs-3610	137	12	glycemic	glycemic	ADJ
iajs-3610	137	13	levels	level	NOUN
iajs-3610	137	14	,	,	PUNCT
iajs-3610	137	15	lipid	lipid	NOUN
iajs-3610	137	16	profile	profile	NOUN
iajs-3610	137	17	,	,	PUNCT
iajs-3610	137	18	kidney	kidney	NOUN
iajs-3610	137	19	function	function	NOUN
iajs-3610	137	20	tests	test	NOUN
iajs-3610	137	21	,	,	PUNCT
iajs-3610	137	22	and	and	CCONJ
iajs-3610	137	23	ace2	ace2	PROPN
iajs-3610	137	24	and	and	CCONJ
iajs-3610	137	25	dn	dn	NOUN
iajs-3610	137	26	in	in	ADP
iajs-3610	137	27	t2	t2	NOUN
iajs-3610	137	28	dm	dm	PROPN
iajs-3610	137	29	patients	patient	NOUN
iajs-3610	137	30	.	.	PUNCT
iajs-3610	138	1	from	from	ADP
iajs-3610	138	2	the	the	DET
iajs-3610	138	3	current	current	ADJ
iajs-3610	138	4	data	datum	NOUN
iajs-3610	138	5	,	,	PUNCT
iajs-3610	138	6	it	it	PRON
iajs-3610	138	7	can	can	AUX
iajs-3610	138	8	be	be	AUX
iajs-3610	138	9	concluded	conclude	VERB
iajs-3610	138	10	that	that	SCONJ
iajs-3610	138	11	acr	acr	PROPN
iajs-3610	138	12	and	and	CCONJ
iajs-3610	138	13	ace2	ace2	PROPN
iajs-3610	138	14	play	play	VERB
iajs-3610	138	15	a	a	DET
iajs-3610	138	16	key	key	ADJ
iajs-3610	138	17	protective	protective	ADJ
iajs-3610	138	18	role	role	NOUN
iajs-3610	138	19	in	in	ADP
iajs-3610	138	20	preventing	prevent	VERB
iajs-3610	138	21	progressive	progressive	ADJ
iajs-3610	138	22	renal	renal	ADJ
iajs-3610	138	23	damage	damage	NOUN
iajs-3610	138	24	,	,	PUNCT
iajs-3610	138	25	which	which	PRON
iajs-3610	138	26	is	be	AUX
iajs-3610	138	27	a	a	DET
iajs-3610	138	28	good	good	ADJ
iajs-3610	138	29	indicator	indicator	NOUN
iajs-3610	138	30	for	for	ADP
iajs-3610	138	31	early	early	ADJ
iajs-3610	138	32	detection	detection	NOUN
iajs-3610	138	33	of	of	ADP
iajs-3610	138	34	dn	dn	PROPN
iajs-3610	138	35	.	.	PROPN
iajs-3610	138	36	acknowledgment	acknowledgment	NOUN
iajs-3610	138	37	after	after	ADP
iajs-3610	138	38	completing	complete	VERB
iajs-3610	138	39	this	this	DET
iajs-3610	138	40	research	research	NOUN
iajs-3610	138	41	,	,	PUNCT
iajs-3610	138	42	the	the	DET
iajs-3610	138	43	authors	author	NOUN
iajs-3610	138	44	would	would	AUX
iajs-3610	138	45	like	like	VERB
iajs-3610	138	46	to	to	PART
iajs-3610	138	47	thank	thank	VERB
iajs-3610	138	48	their	their	PRON
iajs-3610	138	49	colleagues	colleague	NOUN
iajs-3610	138	50	at	at	ADP
iajs-3610	138	51	the	the	DET
iajs-3610	138	52	college	college	NOUN
iajs-3610	138	53	of	of	ADP
iajs-3610	138	54	science	science	NOUN
iajs-3610	138	55	for	for	ADP
iajs-3610	138	56	women	woman	NOUN
iajs-3610	138	57	,	,	PUNCT
iajs-3610	138	58	university	university	NOUN
iajs-3610	138	59	of	of	ADP
iajs-3610	138	60	baghdad	baghdad	PROPN
iajs-3610	138	61	,	,	PUNCT
iajs-3610	138	62	for	for	ADP
iajs-3610	138	63	their	their	PRON
iajs-3610	138	64	cooperation	cooperation	NOUN
iajs-3610	138	65	in	in	ADP
iajs-3610	138	66	completing	complete	VERB
iajs-3610	138	67	this	this	DET
iajs-3610	138	68	work	work	NOUN
iajs-3610	138	69	.	.	PUNCT
iajs-3610	139	1	they	they	PRON
iajs-3610	139	2	also	also	ADV
iajs-3610	139	3	appreciate	appreciate	VERB
iajs-3610	139	4	everyone	everyone	PRON
iajs-3610	139	5	who	who	PRON
iajs-3610	139	6	participated	participate	VERB
iajs-3610	139	7	in	in	ADP
iajs-3610	139	8	this	this	DET
iajs-3610	139	9	study	study	NOUN
iajs-3610	139	10	.	.	PUNCT
iajs-3610	140	1	conflict	conflict	NOUN
iajs-3610	140	2	of	of	ADP
iajs-3610	140	3	interest	interest	NOUN
iajs-3610	140	4	none	none	NOUN
iajs-3610	140	5	.	.	PUNCT
iajs-3610	141	1	funding	fund	VERB
iajs-3610	141	2	none	none	NOUN
iajs-3610	141	3	.	.	PUNCT
iajs-3610	142	1	ethical	ethical	ADJ
iajs-3610	142	2	clearance	clearance	NOUN
iajs-3610	142	3	this	this	DET
iajs-3610	142	4	research	research	NOUN
iajs-3610	142	5	was	be	AUX
iajs-3610	142	6	approved	approve	VERB
iajs-3610	142	7	by	by	ADP
iajs-3610	142	8	the	the	DET
iajs-3610	142	9	scientific	scientific	ADJ
iajs-3610	142	10	committee	committee	NOUN
iajs-3610	142	11	in	in	ADP
iajs-3610	142	12	the	the	DET
iajs-3610	142	13	college	college	NOUN
iajs-3610	142	14	of	of	ADP
iajs-3610	142	15	science	science	NOUN
iajs-3610	142	16	for	for	ADP
iajs-3610	142	17	women	woman	NOUN
iajs-3610	142	18	at	at	ADP
iajs-3610	142	19	the	the	DET
iajs-3610	142	20	university	university	NOUN
iajs-3610	142	21	of	of	ADP
iajs-3610	142	22	baghdad	baghdad	PROPN
iajs-3610	142	23	,	,	PUNCT
iajs-3610	142	24	in	in	ADP
iajs-3610	142	25	accordance	accordance	NOUN
iajs-3610	142	26	with	with	ADP
iajs-3610	142	27	the	the	DET
iajs-3610	142	28	instructions	instruction	NOUN
iajs-3610	142	29	of	of	ADP
iajs-3610	142	30	the	the	DET
iajs-3610	142	31	iraqi	iraqi	ADJ
iajs-3610	142	32	ministry	ministry	PROPN
iajs-3610	142	33	of	of	ADP
iajs-3610	142	34	health	health	PROPN
iajs-3610	142	35	and	and	CCONJ
iajs-3610	142	36	environment	environment	NOUN
iajs-3610	142	37	(	(	PUNCT
iajs-3610	142	38	no	no	INTJ
iajs-3610	142	39	.	.	NOUN
iajs-3610	142	40	313/22	313/22	NUM
iajs-3610	142	41	on	on	ADP
iajs-3610	142	42	13/12022	13/12022	NUM
iajs-3610	142	43	)	)	PUNCT
iajs-3610	142	44	.	.	PUNCT
iajs-3610	143	1	references	reference	NOUN
iajs-3610	143	2	1	1	NUM
iajs-3610	143	3	.	.	PUNCT
iajs-3610	144	1	valencia	valencia	PROPN
iajs-3610	144	2	wm	wm	PROPN
iajs-3610	144	3	,	,	PUNCT
iajs-3610	144	4	florez	florez	PROPN
iajs-3610	144	5	h.	h.	PROPN
iajs-3610	144	6	how	how	SCONJ
iajs-3610	144	7	to	to	PART
iajs-3610	144	8	prevent	prevent	VERB
iajs-3610	144	9	the	the	DET
iajs-3610	144	10	microvascular	microvascular	ADJ
iajs-3610	144	11	complications	complication	NOUN
iajs-3610	144	12	of	of	ADP
iajs-3610	144	13	type	type	NOUN
iajs-3610	144	14	2	2	NUM
iajs-3610	144	15	diabetes	diabetes	NOUN
iajs-3610	144	16	beyond	beyond	ADP
iajs-3610	144	17	glucose	glucose	NOUN
iajs-3610	144	18	control	control	NOUN
iajs-3610	144	19	.	.	PUNCT
iajs-3610	145	1	bmj	bmj	PROPN
iajs-3610	145	2	.	.	PROPN
iajs-3610	145	3	2017	2017	NUM
iajs-3610	145	4	;	;	PUNCT
iajs-3610	145	5	356	356	NUM
iajs-3610	145	6	:	:	PUNCT
iajs-3610	145	7	i6505	i6505	VERB
iajs-3610	145	8	.	.	PROPN
iajs-3610	145	9	https://doi.org/10.1136/bmj.i6505	https://doi.org/10.1136/bmj.i6505	PROPN
iajs-3610	145	10	.	.	PUNCT
iajs-3610	146	1	2	2	NUM
iajs-3610	146	2	.	.	X
iajs-3610	146	3	zhang	zhang	PROPN
iajs-3610	146	4	s	s	PROPN
iajs-3610	146	5	,	,	PUNCT
iajs-3610	146	6	li	li	PROPN
iajs-3610	146	7	x	x	PROPN
iajs-3610	146	8	,	,	PUNCT
iajs-3610	146	9	luo	luo	PROPN
iajs-3610	146	10	h	h	PROPN
iajs-3610	146	11	,	,	PUNCT
iajs-3610	146	12	fang	fang	PROPN
iajs-3610	146	13	zz	zz	PROPN
iajs-3610	146	14	,	,	PUNCT
iajs-3610	146	15	ai	ai	VERB
iajs-3610	146	16	h.	h.	PROPN
iajs-3610	146	17	role	role	NOUN
iajs-3610	146	18	of	of	ADP
iajs-3610	146	19	aromatic	aromatic	ADJ
iajs-3610	146	20	amino	amino	NOUN
iajs-3610	146	21	acids	acid	NOUN
iajs-3610	146	22	in	in	ADP
iajs-3610	146	23	the	the	DET
iajs-3610	146	24	pathogenesis	pathogenesis	NOUN
iajs-3610	146	25	of	of	ADP
iajs-3610	146	26	diabetic	diabetic	ADJ
iajs-3610	146	27	nephropathy	nephropathy	NOUN
iajs-3610	146	28	in	in	ADP
iajs-3610	146	29	chinese	chinese	ADJ
iajs-3610	146	30	patients	patient	NOUN
iajs-3610	146	31	with	with	ADP
iajs-3610	146	32	type	type	NOUN
iajs-3610	146	33	2	2	NUM
iajs-3610	146	34	diabetes	diabetes	NOUN
iajs-3610	146	35	.	.	PUNCT
iajs-3610	147	1	j	j	PROPN
iajs-3610	147	2	diabetes	diabetes	NOUN
iajs-3610	147	3	complications	complication	NOUN
iajs-3610	147	4	.	.	PUNCT
iajs-3610	148	1	2020	2020	NUM
iajs-3610	148	2	;	;	PUNCT
iajs-3610	148	3	34(10):107667	34(10):107667	NUM
iajs-3610	148	4	.	.	PUNCT
iajs-3610	149	1	https://doi.org/10.1016/j.jdiacomp.2020.107667	https://doi.org/10.1016/j.jdiacomp.2020.107667	NOUN
iajs-3610	149	2	.	.	PUNCT
iajs-3610	150	1	3	3	X
iajs-3610	150	2	.	.	X
iajs-3610	150	3	al	al	PROPN
iajs-3610	150	4	-	-	PUNCT
iajs-3610	150	5	khdhairi	khdhairi	PROPN
iajs-3610	150	6	zma	zma	PROPN
iajs-3610	150	7	,	,	PUNCT
iajs-3610	150	8	ali	ali	PROPN
iajs-3610	150	9	bh	bh	PROPN
iajs-3610	150	10	.	.	PROPN
iajs-3610	150	11	comparison	comparison	PROPN
iajs-3610	150	12	study	study	NOUN
iajs-3610	150	13	of	of	ADP
iajs-3610	150	14	the	the	DET
iajs-3610	150	15	effect	effect	NOUN
iajs-3610	150	16	of	of	ADP
iajs-3610	150	17	erlotinib	erlotinib	NOUN
iajs-3610	150	18	as	as	ADP
iajs-3610	150	19	a	a	DET
iajs-3610	150	20	tyrosine	tyrosine	NOUN
iajs-3610	150	21	kinase	kinase	NOUN
iajs-3610	150	22	inhibitor	inhibitor	NOUN
iajs-3610	150	23	on	on	ADP
iajs-3610	150	24	electrolyte	electrolyte	ADJ
iajs-3610	150	25	levels	level	NOUN
iajs-3610	150	26	in	in	ADP
iajs-3610	150	27	type	type	NOUN
iajs-3610	150	28	2	2	NUM
iajs-3610	150	29	diabetic	diabetic	ADJ
iajs-3610	150	30	and	and	CCONJ
iajs-3610	150	31	diabetic	diabetic	ADJ
iajs-3610	150	32	nephropathy	nephropathy	ADJ
iajs-3610	150	33	patients	patient	NOUN
iajs-3610	150	34	.	.	PUNCT
iajs-3610	151	1	ibn	ibn	PROPN
iajs-3610	151	2	al	al	PROPN
iajs-3610	151	3	-	-	PUNCT
iajs-3610	151	4	haitham	haitham	PROPN
iajs-3610	151	5	j	j	PROPN
iajs-3610	151	6	pure	pure	PROPN
iajs-3610	151	7	appl	appl	PROPN
iajs-3610	151	8	sci	sci	PROPN
iajs-3610	151	9	.	.	PROPN
iajs-3610	151	10	2018	2018	NUM
iajs-3610	151	11	;	;	PUNCT
iajs-3610	151	12	31(3):63	31(3):63	NUM
iajs-3610	151	13	-	-	SYM
iajs-3610	151	14	69	69	NUM
iajs-3610	151	15	.	.	PUNCT
iajs-3610	152	1	https://doi.org/10.30526/31.3.2011	https://doi.org/10.30526/31.3.2011	X
iajs-3610	152	2	.	.	PROPN
iajs-3610	152	3	4	4	NUM
iajs-3610	152	4	.	.	X
iajs-3610	152	5	bakker	bakker	PROPN
iajs-3610	152	6	aj	aj	PROPN
iajs-3610	152	7	.	.	PROPN
iajs-3610	152	8	detection	detection	NOUN
iajs-3610	152	9	of	of	ADP
iajs-3610	152	10	microalbuminuria	microalbuminuria	PROPN
iajs-3610	152	11	.	.	PUNCT
iajs-3610	153	1	receiver	receiver	ADJ
iajs-3610	153	2	operating	operate	VERB
iajs-3610	153	3	characteristic	characteristic	ADJ
iajs-3610	153	4	curve	curve	NOUN
iajs-3610	153	5	analysis	analysis	NOUN
iajs-3610	153	6	favors	favor	VERB
iajs-3610	153	7	albumin	albumin	NOUN
iajs-3610	153	8	-	-	PUNCT
iajs-3610	153	9	to	to	ADP
iajs-3610	153	10	-	-	PUNCT
iajs-3610	153	11	creatinine	creatinine	NOUN
iajs-3610	153	12	ratio	ratio	NOUN
iajs-3610	153	13	over	over	ADP
iajs-3610	153	14	albumin	albumin	ADJ
iajs-3610	153	15	concentration	concentration	NOUN
iajs-3610	153	16	.	.	PUNCT
iajs-3610	154	1	diabetes	diabetes	NOUN
iajs-3610	154	2	care	care	NOUN
iajs-3610	154	3	.	.	PUNCT
iajs-3610	155	1	1999	1999	NUM
iajs-3610	155	2	;	;	PUNCT
iajs-3610	155	3	22(2):307	22(2):307	X
iajs-3610	155	4	-	-	SYM
iajs-3610	155	5	313	313	NUM
iajs-3610	155	6	.	.	PUNCT
iajs-3610	156	1	https://doi.org/10.2337/diacare.22.2.307	https://doi.org/10.2337/diacare.22.2.307	X
iajs-3610	156	2	.	.	NOUN
iajs-3610	157	1	5	5	NUM
iajs-3610	157	2	.	.	PUNCT
iajs-3610	157	3	farhan	farhan	PROPN
iajs-3610	157	4	lo	lo	PROPN
iajs-3610	157	5	,	,	PUNCT
iajs-3610	157	6	abed	abe	VERB
iajs-3610	157	7	ba	ba	PROPN
iajs-3610	157	8	,	,	PUNCT
iajs-3610	157	9	dawood	dawood	PROPN
iajs-3610	157	10	a.	a.	PROPN
iajs-3610	157	11	comparison	comparison	PROPN
iajs-3610	157	12	study	study	NOUN
iajs-3610	157	13	between	between	ADP
iajs-3610	157	14	adipsin	adipsin	NOUN
iajs-3610	157	15	levels	level	NOUN
iajs-3610	157	16	in	in	ADP
iajs-3610	157	17	sera	sera	NOUN
iajs-3610	157	18	of	of	ADP
iajs-3610	157	19	iraqi	iraqi	ADJ
iajs-3610	157	20	patients	patient	NOUN
iajs-3610	157	21	with	with	ADP
iajs-3610	157	22	diabetes	diabetes	NOUN
iajs-3610	157	23	and	and	CCONJ
iajs-3610	157	24	neuropathy	neuropathy	ADJ
iajs-3610	157	25	.	.	PUNCT
iajs-3610	158	1	baghdad	baghdad	PROPN
iajs-3610	158	2	sci	sci	PROPN
iajs-3610	158	3	j.	j.	PROPN
iajs-3610	158	4	2023	2023	NUM
iajs-3610	158	5	;	;	PUNCT
iajs-3610	158	6	20(3):726	20(3):726	NUM
iajs-3610	158	7	-	-	SYM
iajs-3610	158	8	726	726	NUM
iajs-3610	158	9	.	.	PUNCT
iajs-3610	159	1	https://doi.org/10.21123/bsj.2022.7408	https://doi.org/10.21123/bsj.2022.7408	PROPN
iajs-3610	159	2	.	.	PUNCT
iajs-3610	160	1	6	6	NUM
iajs-3610	160	2	.	.	X
iajs-3610	160	3	jafer	jafer	PROPN
iajs-3610	160	4	aa	aa	PROPN
iajs-3610	160	5	,	,	PUNCT
iajs-3610	160	6	ali	ali	PROPN
iajs-3610	160	7	bh	bh	PROPN
iajs-3610	160	8	.	.	PROPN
iajs-3610	160	9	evaluation	evaluation	NOUN
iajs-3610	160	10	of	of	ADP
iajs-3610	160	11	osteocalcin	osteocalcin	PROPN
iajs-3610	160	12	and	and	CCONJ
iajs-3610	160	13	some	some	DET
iajs-3610	160	14	biochemical	biochemical	ADJ
iajs-3610	160	15	markers	marker	NOUN
iajs-3610	160	16	in	in	ADP
iajs-3610	160	17	iraqi	iraqi	ADJ
iajs-3610	160	18	women	woman	NOUN
iajs-3610	160	19	patients	patient	NOUN
iajs-3610	160	20	with	with	ADP
iajs-3610	160	21	diabetes	diabetes	NOUN
iajs-3610	160	22	mellitus	mellitus	NOUN
iajs-3610	160	23	and	and	CCONJ
iajs-3610	160	24	osteoporosis	osteoporosis	NOUN
iajs-3610	160	25	.	.	PUNCT
iajs-3610	161	1	ibn	ibn	PROPN
iajs-3610	161	2	al	al	PROPN
iajs-3610	161	3	-	-	PUNCT
iajs-3610	161	4	haitham	haitham	PROPN
iajs-3610	161	5	j	j	PROPN
iajs-3610	161	6	pure	pure	PROPN
iajs-3610	161	7	appl	appl	PROPN
iajs-3610	161	8	sci	sci	PROPN
iajs-3610	161	9	.	.	PROPN
iajs-3610	161	10	2023	2023	NUM
iajs-3610	161	11	;	;	PUNCT
iajs-3610	161	12	36(1):225	36(1):225	NUM
iajs-3610	161	13	-	-	SYM
iajs-3610	161	14	235	235	NUM
iajs-3610	161	15	.	.	PUNCT
iajs-3610	162	1	https://doi.org/10.30526/36.1.2984	https://doi.org/10.30526/36.1.2984	PROPN
iajs-3610	162	2	.	.	PROPN
iajs-3610	162	3	7	7	X
iajs-3610	162	4	.	.	PUNCT
iajs-3610	162	5	hameed	hameed	PROPN
iajs-3610	162	6	ase	ase	PROPN
iajs-3610	162	7	.	.	PROPN
iajs-3610	162	8	estimation	estimation	NOUN
iajs-3610	162	9	activity	activity	NOUN
iajs-3610	162	10	and	and	CCONJ
iajs-3610	162	11	partial	partial	ADJ
iajs-3610	162	12	purification	purification	NOUN
iajs-3610	162	13	of	of	ADP
iajs-3610	162	14	leucine	leucine	NOUN
iajs-3610	162	15	amino	amino	NOUN
iajs-3610	162	16	peptidase	peptidase	NOUN
iajs-3610	162	17	(	(	PUNCT
iajs-3610	162	18	lap	lap	NOUN
iajs-3610	162	19	)	)	PUNCT
iajs-3610	162	20	in	in	ADP
iajs-3610	162	21	patients	patient	NOUN
iajs-3610	162	22	with	with	ADP
iajs-3610	162	23	diabetic	diabetic	ADJ
iajs-3610	162	24	nephropathy	nephropathy	NOUN
iajs-3610	162	25	.	.	PUNCT
iajs-3610	163	1	baghdad	baghdad	PROPN
iajs-3610	163	2	sci	sci	PROPN
iajs-3610	163	3	j.	j.	PROPN
iajs-3610	163	4	2012	2012	NUM
iajs-3610	163	5	;	;	PUNCT
iajs-3610	163	6	9(4):689	9(4):689	NUM
iajs-3610	163	7	-	-	SYM
iajs-3610	163	8	694	694	NUM
iajs-3610	163	9	.	.	PUNCT
iajs-3610	164	1	https://doi.org/10.21123/bsj.2012.9.4.689-694	https://doi.org/10.21123/bsj.2012.9.4.689-694	PROPN
iajs-3610	164	2	.	.	PUNCT
iajs-3610	164	3	https://doi.org/10.1136/bmj.i6505	https://doi.org/10.1136/bmj.i6505	PROPN
iajs-3610	164	4	.	.	PUNCT
iajs-3610	165	1	https://doi.org/10.1016/j.jdiacomp.2020.107667	https://doi.org/10.1016/j.jdiacomp.2020.107667	PROPN
iajs-3610	165	2	https://doi.org/10.30526/31.3.2011	https://doi.org/10.30526/31.3.2011	PUNCT
iajs-3610	165	3	https://doi.org/10.2337/diacare.22.2.307	https://doi.org/10.2337/diacare.22.2.307	PROPN
iajs-3610	165	4	.	.	PUNCT
iajs-3610	166	1	https://doi.org/10.21123/bsj.2022.7408	https://doi.org/10.21123/bsj.2022.7408	PROPN
iajs-3610	166	2	.	.	PUNCT
iajs-3610	167	1	https://doi.org/10.30526/36.1.2984	https://doi.org/10.30526/36.1.2984	PROPN
iajs-3610	167	2	https://doi.org/10.21123/bsj.2012.9.4.689-694	https://doi.org/10.21123/bsj.2012.9.4.689-694	PROPN
iajs-3610	167	3	ihjpas	ihjpas	PROPN
iajs-3610	167	4	.	.	PUNCT
iajs-3610	168	1	2025	2025	NUM
iajs-3610	168	2	,	,	PUNCT
iajs-3610	168	3	38(3	38(3	NUM
iajs-3610	168	4	)	)	PUNCT
iajs-3610	168	5	234	234	NUM
iajs-3610	168	6	8	8	NUM
iajs-3610	168	7	.	.	PUNCT
iajs-3610	169	1	abbed	abbed	PROPN
iajs-3610	169	2	am	be	AUX
iajs-3610	169	3	.	.	PUNCT
iajs-3610	170	1	effect	effect	NOUN
iajs-3610	170	2	of	of	ADP
iajs-3610	170	3	metformin	metformin	NOUN
iajs-3610	170	4	and	and	CCONJ
iajs-3610	170	5	glimepiride	glimepiride	NOUN
iajs-3610	170	6	treatment	treatment	NOUN
iajs-3610	170	7	on	on	ADP
iajs-3610	170	8	some	some	DET
iajs-3610	170	9	biochemical	biochemical	ADJ
iajs-3610	170	10	parameters	parameter	NOUN
iajs-3610	170	11	in	in	ADP
iajs-3610	170	12	diabetic	diabetic	ADJ
iajs-3610	170	13	male	male	ADJ
iajs-3610	170	14	patients	patient	NOUN
iajs-3610	170	15	with	with	ADP
iajs-3610	170	16	chronic	chronic	ADJ
iajs-3610	170	17	renal	renal	ADJ
iajs-3610	170	18	failure	failure	NOUN
iajs-3610	170	19	.	.	PUNCT
iajs-3610	171	1	ibn	ibn	PROPN
iajs-3610	171	2	al	al	PROPN
iajs-3610	171	3	-	-	PUNCT
iajs-3610	171	4	haitham	haitham	PROPN
iajs-3610	171	5	j	j	PROPN
iajs-3610	171	6	pure	pure	PROPN
iajs-3610	171	7	appl	appl	PROPN
iajs-3610	171	8	sci	sci	PROPN
iajs-3610	171	9	.	.	PROPN
iajs-3610	171	10	2019	2019	NUM
iajs-3610	171	11	;	;	PUNCT
iajs-3610	171	12	32(2):3844	32(2):3844	NUM
iajs-3610	171	13	.	.	PUNCT
iajs-3610	171	14	https://doi.org/10.30526/32.2.2137	https://doi.org/10.30526/32.2.2137	X
iajs-3610	171	15	.	.	NOUN
iajs-3610	172	1	9	9	NUM
iajs-3610	172	2	.	.	X
iajs-3610	172	3	hameed	hameed	PROPN
iajs-3610	172	4	ek	ek	PROPN
iajs-3610	172	5	,	,	PUNCT
iajs-3610	172	6	al	al	PROPN
iajs-3610	172	7	-	-	PUNCT
iajs-3610	172	8	ameri	ameri	PROPN
iajs-3610	172	9	lt	lt	PROPN
iajs-3610	172	10	,	,	PUNCT
iajs-3610	172	11	hasan	hasan	PROPN
iajs-3610	172	12	hs	hs	PROPN
iajs-3610	172	13	,	,	PUNCT
iajs-3610	172	14	abdulqahar	abdulqahar	VERB
iajs-3610	172	15	zh	zh	PROPN
iajs-3610	172	16	.	.	PUNCT
iajs-3610	173	1	the	the	DET
iajs-3610	173	2	cut	cut	VERB
iajs-3610	173	3	-	-	PUNCT
iajs-3610	173	4	off	off	ADP
iajs-3610	173	5	values	value	NOUN
iajs-3610	173	6	of	of	ADP
iajs-3610	173	7	triglycerides	triglyceride	NOUN
iajs-3610	173	8	-	-	PUNCT
iajs-3610	173	9	glucose	glucose	NOUN
iajs-3610	173	10	index	index	NOUN
iajs-3610	173	11	for	for	ADP
iajs-3610	173	12	metabolic	metabolic	NOUN
iajs-3610	173	13	syndrome	syndrome	NOUN
iajs-3610	173	14	associated	associate	VERB
iajs-3610	173	15	with	with	ADP
iajs-3610	173	16	type	type	NOUN
iajs-3610	173	17	2	2	NUM
iajs-3610	173	18	diabetes	diabetes	NOUN
iajs-3610	173	19	mellitus	mellitus	NOUN
iajs-3610	173	20	.	.	PUNCT
iajs-3610	174	1	baghdad	baghdad	PROPN
iajs-3610	174	2	sci	sci	PROPN
iajs-3610	174	3	j.	j.	PROPN
iajs-3610	174	4	2022	2022	PROPN
iajs-3610	174	5	;	;	PUNCT
iajs-3610	174	6	19(2	19(2	NUM
iajs-3610	174	7	):	):	PUNCT
iajs-3610	174	8	340	340	NUM
iajs-3610	174	9	-	-	SYM
iajs-3610	174	10	346	346	NUM
iajs-3610	174	11	.	.	PUNCT
iajs-3610	175	1	https://doi.org/10.21123/bsj.2022.19.2.0340	https://doi.org/10.21123/bsj.2022.19.2.0340	NOUN
iajs-3610	175	2	.	.	PUNCT
iajs-3610	176	1	10	10	NUM
iajs-3610	176	2	.	.	PUNCT
iajs-3610	177	1	sadiq	sadiq	PROPN
iajs-3610	177	2	ch	ch	PROPN
iajs-3610	177	3	,	,	PUNCT
iajs-3610	177	4	hussein	hussein	PROPN
iajs-3610	177	5	rh	rh	PROPN
iajs-3610	177	6	,	,	PUNCT
iajs-3610	177	7	maulood	maulood	NOUN
iajs-3610	178	1	i	i	PRON
iajs-3610	178	2	m.	m.	NOUN
iajs-3610	178	3	ghrelin	ghrelin	NOUN
iajs-3610	178	4	and	and	CCONJ
iajs-3610	178	5	leptin	leptin	NOUN
iajs-3610	178	6	and	and	CCONJ
iajs-3610	178	7	their	their	PRON
iajs-3610	178	8	relations	relation	NOUN
iajs-3610	178	9	with	with	ADP
iajs-3610	178	10	insulin	insulin	NOUN
iajs-3610	178	11	resistance	resistance	NOUN
iajs-3610	178	12	in	in	ADP
iajs-3610	178	13	diabetes	diabetes	NOUN
iajs-3610	178	14	mellitus	mellitus	NOUN
iajs-3610	178	15	type	type	VERB
iajs-3610	178	16	2	2	NUM
iajs-3610	178	17	patients	patient	NOUN
iajs-3610	178	18	.	.	PUNCT
iajs-3610	179	1	baghdad	baghdad	PROPN
iajs-3610	179	2	sci	sci	PROPN
iajs-3610	179	3	j.	j.	PROPN
iajs-3610	179	4	2022	2022	PROPN
iajs-3610	179	5	;	;	PUNCT
iajs-3610	179	6	19(1):33	19(1):33	NUM
iajs-3610	179	7	-	-	SYM
iajs-3610	179	8	42	42	NUM
iajs-3610	179	9	.	.	PUNCT
iajs-3610	180	1	http://dx.doi.org/10.21123/bsj.2022.19.1.0033	http://dx.doi.org/10.21123/bsj.2022.19.1.0033	PROPN
iajs-3610	180	2	.	.	PROPN
iajs-3610	180	3	11	11	NUM
iajs-3610	180	4	.	.	PUNCT
iajs-3610	181	1	sarkar	sarkar	PROPN
iajs-3610	181	2	s	s	PROPN
iajs-3610	181	3	,	,	PUNCT
iajs-3610	181	4	jayachandra	jayachandra	PROPN
iajs-3610	181	5	k	k	NOUN
iajs-3610	181	6	,	,	PUNCT
iajs-3610	181	7	vishwanat	vishwanat	ADJ
iajs-3610	181	8	bs	bs	PROPN
iajs-3610	181	9	.	.	PUNCT
iajs-3610	181	10	ace	ace	PROPN
iajs-3610	181	11	2	2	NUM
iajs-3610	181	12	/	/	SYM
iajs-3610	181	13	ang	ang	NOUN
iajs-3610	181	14	(	(	PUNCT
iajs-3610	181	15	1	1	NUM
iajs-3610	181	16	-	-	PUNCT
iajs-3610	181	17	7)/mas	7)/ma	NOUN
iajs-3610	181	18	,	,	PUNCT
iajs-3610	181	19	non	non	ADJ
iajs-3610	181	20	-	-	ADJ
iajs-3610	181	21	conventional	conventional	ADJ
iajs-3610	181	22	ras	ras	NOUN
iajs-3610	181	23	axis	axis	NOUN
iajs-3610	181	24	:	:	PUNCT
iajs-3610	181	25	endogenous	endogenous	ADJ
iajs-3610	181	26	contributor	contributor	NOUN
iajs-3610	181	27	of	of	ADP
iajs-3610	181	28	cardio	cardio	NOUN
iajs-3610	181	29	,	,	PUNCT
iajs-3610	181	30	and	and	CCONJ
iajs-3610	181	31	reno	reno	PROPN
iajs-3610	181	32	-	-	PUNCT
iajs-3610	181	33	protective	protective	ADJ
iajs-3610	181	34	responses	response	NOUN
iajs-3610	181	35	.	.	PUNCT
iajs-3610	182	1	j	j	PROPN
iajs-3610	182	2	cell	cell	NOUN
iajs-3610	182	3	signal	signal	NOUN
iajs-3610	182	4	.	.	PUNCT
iajs-3610	183	1	2024	2024	NUM
iajs-3610	183	2	;	;	PUNCT
iajs-3610	184	1	5(3):149161	5(3):149161	NUM
iajs-3610	184	2	.	.	PUNCT
iajs-3610	185	1	https://doi.org/10.33696/signaling.5.121	https://doi.org/10.33696/signaling.5.121	PROPN
iajs-3610	185	2	.	.	PUNCT
iajs-3610	186	1	12	12	NUM
iajs-3610	186	2	.	.	PUNCT
iajs-3610	187	1	soler	soler	PROPN
iajs-3610	187	2	mj	mj	PROPN
iajs-3610	187	3	,	,	PUNCT
iajs-3610	187	4	wysocki	wysocki	PROPN
iajs-3610	187	5	j	j	PROPN
iajs-3610	187	6	,	,	PUNCT
iajs-3610	187	7	batlle	batlle	PROPN
iajs-3610	187	8	d.	d.	PROPN
iajs-3610	187	9	ace2	ace2	PROPN
iajs-3610	187	10	alterations	alteration	NOUN
iajs-3610	187	11	in	in	ADP
iajs-3610	187	12	kidney	kidney	NOUN
iajs-3610	187	13	disease	disease	NOUN
iajs-3610	187	14	.	.	PUNCT
iajs-3610	188	1	nephrol	nephrol	PROPN
iajs-3610	188	2	dial	dial	NOUN
iajs-3610	188	3	transplant	transplant	NOUN
iajs-3610	188	4	.	.	PUNCT
iajs-3610	189	1	2023	2023	NUM
iajs-3610	189	2	;	;	PUNCT
iajs-3610	189	3	28(11):2687	28(11):2687	NUM
iajs-3610	189	4	-	-	SYM
iajs-3610	189	5	2697	2697	NUM
iajs-3610	189	6	.	.	PUNCT
iajs-3610	190	1	https://doi.org/10.1093/ndt/gft320	https://doi.org/10.1093/ndt/gft320	NOUN
iajs-3610	190	2	.	.	PROPN
iajs-3610	190	3	13	13	NUM
iajs-3610	190	4	.	.	PUNCT
iajs-3610	190	5	guy	guy	PROPN
iajs-3610	190	6	jl	jl	PROPN
iajs-3610	190	7	,	,	PUNCT
iajs-3610	190	8	jackson	jackson	PROPN
iajs-3610	190	9	rm	rm	PROPN
iajs-3610	190	10	,	,	PUNCT
iajs-3610	190	11	acharya	acharya	PROPN
iajs-3610	190	12	kr	kr	PROPN
iajs-3610	190	13	,	,	PUNCT
iajs-3610	190	14	sturrock	sturrock	NOUN
iajs-3610	190	15	ed	ed	PROPN
iajs-3610	190	16	,	,	PUNCT
iajs-3610	190	17	hooper	hooper	PROPN
iajs-3610	190	18	nm	nm	PROPN
iajs-3610	190	19	,	,	PUNCT
iajs-3610	190	20	turner	turner	PROPN
iajs-3610	190	21	aj	aj	PROPN
iajs-3610	190	22	.	.	PROPN
iajs-3610	190	23	angiotensin	angiotensin	NOUN
iajs-3610	190	24	-	-	PUNCT
iajs-3610	190	25	converting	convert	VERB
iajs-3610	190	26	enzyme-2	enzyme-2	NUM
iajs-3610	190	27	(	(	PUNCT
iajs-3610	190	28	ace2	ace2	NOUN
iajs-3610	190	29	):	):	PUNCT
iajs-3610	190	30	comparative	comparative	ADJ
iajs-3610	190	31	modeling	modeling	NOUN
iajs-3610	190	32	of	of	ADP
iajs-3610	190	33	the	the	DET
iajs-3610	190	34	active	active	ADJ
iajs-3610	190	35	site	site	NOUN
iajs-3610	190	36	,	,	PUNCT
iajs-3610	190	37	specificity	specificity	NOUN
iajs-3610	190	38	requirements	requirement	NOUN
iajs-3610	190	39	,	,	PUNCT
iajs-3610	190	40	and	and	CCONJ
iajs-3610	190	41	chloride	chloride	NOUN
iajs-3610	190	42	dependence	dependence	NOUN
iajs-3610	190	43	.	.	PUNCT
iajs-3610	191	1	biochemistry	biochemistry	NOUN
iajs-3610	191	2	.	.	PUNCT
iajs-3610	192	1	2003	2003	NUM
iajs-3610	192	2	;	;	PUNCT
iajs-3610	192	3	42(45):13185	42(45):13185	NUM
iajs-3610	192	4	-	-	SYM
iajs-3610	192	5	13192	13192	NUM
iajs-3610	192	6	.	.	PUNCT
iajs-3610	193	1	https://doi.org/10.1021/bi035268s	https://doi.org/10.1021/bi035268s	PROPN
iajs-3610	193	2	.	.	PUNCT
iajs-3610	194	1	14	14	NUM
iajs-3610	194	2	.	.	PUNCT
iajs-3610	195	1	donoghue	donoghue	PROPN
iajs-3610	195	2	m	m	PROPN
iajs-3610	195	3	,	,	PUNCT
iajs-3610	195	4	hsieh	hsieh	PROPN
iajs-3610	195	5	f	f	PROPN
iajs-3610	195	6	,	,	PUNCT
iajs-3610	195	7	baronas	baronas	X
iajs-3610	195	8	e	e	NOUN
iajs-3610	195	9	,	,	PUNCT
iajs-3610	195	10	godbout	godbout	PROPN
iajs-3610	195	11	k	k	PROPN
iajs-3610	195	12	,	,	PUNCT
iajs-3610	195	13	gosselin	gosselin	PROPN
iajs-3610	195	14	m	m	PROPN
iajs-3610	195	15	,	,	PUNCT
iajs-3610	195	16	stagliano	stagliano	PROPN
iajs-3610	195	17	n	n	CCONJ
iajs-3610	195	18	,	,	PUNCT
iajs-3610	195	19	acton	acton	PROPN
iajs-3610	195	20	s.	s.	PROPN
iajs-3610	196	1	a	a	DET
iajs-3610	196	2	novel	novel	ADJ
iajs-3610	196	3	angiotensin	angiotensin	NOUN
iajs-3610	196	4	-	-	PUNCT
iajs-3610	196	5	converting	convert	VERB
iajs-3610	196	6	enzyme	enzyme	NOUN
iajs-3610	196	7	–	–	PUNCT
iajs-3610	196	8	related	relate	VERB
iajs-3610	196	9	carboxypeptidase	carboxypeptidase	NOUN
iajs-3610	196	10	(	(	PUNCT
iajs-3610	196	11	ace2	ace2	PROPN
iajs-3610	196	12	)	)	PUNCT
iajs-3610	196	13	converts	convert	VERB
iajs-3610	196	14	angiotensin	angiotensin	NOUN
iajs-3610	196	15	i	i	PRON
iajs-3610	196	16	to	to	PART
iajs-3610	196	17	angiotensin	angiotensin	VERB
iajs-3610	196	18	1	1	NUM
iajs-3610	196	19	-	-	SYM
iajs-3610	196	20	9	9	NUM
iajs-3610	196	21	.	.	PUNCT
iajs-3610	197	1	circ	circ	PROPN
iajs-3610	197	2	res	re	NOUN
iajs-3610	197	3	.	.	PROPN
iajs-3610	197	4	2000	2000	NUM
iajs-3610	197	5	;	;	PUNCT
iajs-3610	198	1	87(5):e1	87(5):e1	NUM
iajs-3610	198	2	-	-	SYM
iajs-3610	198	3	9	9	NUM
iajs-3610	198	4	.	.	PUNCT
iajs-3610	198	5	https://doi.org/10.1161/01.res.87.5.e1	https://doi.org/10.1161/01.res.87.5.e1	NOUN
iajs-3610	198	6	.	.	NOUN
iajs-3610	198	7	15	15	NUM
iajs-3610	198	8	.	.	PUNCT
iajs-3610	199	1	south	south	PROPN
iajs-3610	199	2	am	be	AUX
iajs-3610	199	3	,	,	PUNCT
iajs-3610	199	4	shaltout	shaltout	PROPN
iajs-3610	199	5	ha	ha	INTJ
iajs-3610	199	6	,	,	PUNCT
iajs-3610	199	7	washburn	washburn	PROPN
iajs-3610	199	8	lk	lk	PROPN
iajs-3610	199	9	,	,	PUNCT
iajs-3610	199	10	hendricks	hendrick	NOUN
iajs-3610	199	11	as	as	ADP
iajs-3610	199	12	,	,	PUNCT
iajs-3610	199	13	diz	diz	PROPN
iajs-3610	199	14	di	di	PROPN
iajs-3610	199	15	,	,	PUNCT
iajs-3610	199	16	chappell	chappell	PROPN
iajs-3610	199	17	mc	mc	PROPN
iajs-3610	199	18	.	.	PROPN
iajs-3610	199	19	fetal	fetal	ADJ
iajs-3610	199	20	programming	programming	NOUN
iajs-3610	199	21	and	and	CCONJ
iajs-3610	199	22	the	the	DET
iajs-3610	199	23	angiotensin-(1	angiotensin-(1	PROPN
iajs-3610	199	24	-	-	PUNCT
iajs-3610	199	25	7	7	NUM
iajs-3610	199	26	)	)	PUNCT
iajs-3610	199	27	axis	axis	NOUN
iajs-3610	199	28	:	:	PUNCT
iajs-3610	199	29	a	a	DET
iajs-3610	199	30	review	review	NOUN
iajs-3610	199	31	of	of	ADP
iajs-3610	199	32	the	the	DET
iajs-3610	199	33	experimental	experimental	ADJ
iajs-3610	199	34	and	and	CCONJ
iajs-3610	199	35	clinical	clinical	ADJ
iajs-3610	199	36	data	datum	NOUN
iajs-3610	199	37	.	.	PUNCT
iajs-3610	200	1	clin	clin	PROPN
iajs-3610	200	2	sci	sci	PROPN
iajs-3610	200	3	.	.	PROPN
iajs-3610	200	4	2019	2019	NUM
iajs-3610	200	5	;	;	PUNCT
iajs-3610	200	6	133(1	133(1	NUM
iajs-3610	200	7	):	):	PUNCT
iajs-3610	200	8	55	55	NUM
iajs-3610	200	9	-	-	SYM
iajs-3610	200	10	74	74	NUM
iajs-3610	200	11	.	.	PUNCT
iajs-3610	201	1	https://doi.org/10.1042/cs20171550	https://doi.org/10.1042/cs20171550	X
iajs-3610	201	2	.	.	PUNCT
iajs-3610	202	1	16	16	NUM
iajs-3610	202	2	.	.	PUNCT
iajs-3610	203	1	john	john	PROPN
iajs-3610	203	2	d	d	PROPN
iajs-3610	203	3	,	,	PUNCT
iajs-3610	203	4	mark	mark	PROPN
iajs-3610	203	5	zl	zl	PROPN
iajs-3610	203	6	.	.	PROPN
iajs-3610	203	7	osmotic	osmotic	ADJ
iajs-3610	203	8	homeostasis	homeostasis	NOUN
iajs-3610	203	9	.	.	PUNCT
iajs-3610	204	1	clin	clin	PROPN
iajs-3610	204	2	j	j	PROPN
iajs-3610	204	3	am	be	AUX
iajs-3610	204	4	soc	soc	NOUN
iajs-3610	204	5	nephrol	nephrol	NOUN
iajs-3610	204	6	.	.	PUNCT
iajs-3610	205	1	2015	2015	NUM
iajs-3610	205	2	;	;	PUNCT
iajs-3610	205	3	10(5):852	10(5):852	NOUN
iajs-3610	205	4	-	-	SYM
iajs-3610	205	5	862	862	NUM
iajs-3610	205	6	.	.	PUNCT
iajs-3610	206	1	https://doi.org/10.2215/cjn.10741013	https://doi.org/10.2215/cjn.10741013	PROPN
iajs-3610	206	2	.	.	PUNCT
iajs-3610	207	1	17	17	NUM
iajs-3610	207	2	.	.	PUNCT
iajs-3610	207	3	bamanikar	bamanikar	PROPN
iajs-3610	207	4	sa	sa	PROPN
iajs-3610	207	5	,	,	PUNCT
iajs-3610	207	6	bamanikar	bamanikar	PROPN
iajs-3610	207	7	aa	aa	PROPN
iajs-3610	207	8	,	,	PUNCT
iajs-3610	207	9	arora	arora	PROPN
iajs-3610	207	10	a.	a.	NOUN
iajs-3610	207	11	study	study	NOUN
iajs-3610	207	12	of	of	ADP
iajs-3610	207	13	serum	serum	PROPN
iajs-3610	207	14	urea	urea	NOUN
iajs-3610	207	15	and	and	CCONJ
iajs-3610	207	16	creatinine	creatinine	NOUN
iajs-3610	207	17	in	in	ADP
iajs-3610	207	18	diabetic	diabetic	ADJ
iajs-3610	207	19	and	and	CCONJ
iajs-3610	207	20	nondiabetic	nondiabetic	ADJ
iajs-3610	207	21	patients	patient	NOUN
iajs-3610	207	22	in	in	ADP
iajs-3610	207	23	a	a	DET
iajs-3610	207	24	tertiary	tertiary	ADJ
iajs-3610	207	25	teaching	teaching	NOUN
iajs-3610	207	26	hospital	hospital	NOUN
iajs-3610	207	27	.	.	PUNCT
iajs-3610	208	1	j	j	PROPN
iajs-3610	208	2	med	med	PROPN
iajs-3610	208	3	res	re	NOUN
iajs-3610	208	4	.	.	PROPN
iajs-3610	208	5	2016	2016	NUM
iajs-3610	208	6	;	;	PUNCT
iajs-3610	208	7	2(1):12	2(1):12	NUM
iajs-3610	208	8	-	-	SYM
iajs-3610	208	9	15	15	NUM
iajs-3610	208	10	.	.	NOUN
iajs-3610	208	11	18	18	NUM
iajs-3610	208	12	.	.	PUNCT
iajs-3610	209	1	khan	khan	PROPN
iajs-3610	209	2	kn	kn	PROPN
iajs-3610	209	3	,	,	PUNCT
iajs-3610	209	4	khan	khan	PROPN
iajs-3610	209	5	mh	mh	PROPN
iajs-3610	209	6	,	,	PUNCT
iajs-3610	209	7	haque	haque	PROPN
iajs-3610	209	8	mz	mz	PROPN
iajs-3610	209	9	.	.	PROPN
iajs-3610	209	10	correlation	correlation	NOUN
iajs-3610	209	11	between	between	ADP
iajs-3610	209	12	microalbuminuria	microalbuminuria	PROPN
iajs-3610	209	13	with	with	ADP
iajs-3610	209	14	complexity	complexity	NOUN
iajs-3610	209	15	of	of	ADP
iajs-3610	209	16	coronary	coronary	ADJ
iajs-3610	209	17	artery	artery	NOUN
iajs-3610	209	18	disease	disease	NOUN
iajs-3610	209	19	in	in	ADP
iajs-3610	209	20	diabetic	diabetic	ADJ
iajs-3610	209	21	patients	patient	NOUN
iajs-3610	209	22	.	.	PUNCT
iajs-3610	210	1	mymensingh	mymensingh	PROPN
iajs-3610	210	2	med	med	PROPN
iajs-3610	210	3	j.	j.	PROPN
iajs-3610	210	4	2013	2013	NUM
iajs-3610	210	5	;	;	PUNCT
iajs-3610	210	6	22(2):353	22(2):353	NOUN
iajs-3610	210	7	-	-	SYM
iajs-3610	210	8	357	357	NUM
iajs-3610	210	9	.	.	PUNCT
iajs-3610	211	1	pmid	pmid	NOUN
iajs-3610	211	2	:	:	PUNCT
iajs-3610	211	3	23715361	23715361	NUM
iajs-3610	211	4	.	.	PUNCT
iajs-3610	212	1	19	19	NUM
iajs-3610	212	2	.	.	PUNCT
iajs-3610	213	1	hirano	hirano	PROPN
iajs-3610	213	2	t.	t.	PROPN
iajs-3610	213	3	abnormal	abnormal	ADJ
iajs-3610	213	4	lipoprotein	lipoprotein	ADJ
iajs-3610	213	5	metabolism	metabolism	NOUN
iajs-3610	213	6	in	in	ADP
iajs-3610	213	7	diabetic	diabetic	ADJ
iajs-3610	213	8	nephropathy	nephropathy	NOUN
iajs-3610	213	9	.	.	PUNCT
iajs-3610	214	1	clin	clin	PROPN
iajs-3610	214	2	exp	exp	NOUN
iajs-3610	214	3	nephrol	nephrol	PROPN
iajs-3610	214	4	.	.	PUNCT
iajs-3610	215	1	2014	2014	NUM
iajs-3610	215	2	;	;	PUNCT
iajs-3610	215	3	18(2	18(2	NUM
iajs-3610	215	4	):	):	PUNCT
iajs-3610	215	5	206	206	NUM
iajs-3610	215	6	-	-	SYM
iajs-3610	215	7	209	209	NUM
iajs-3610	215	8	.	.	PUNCT
iajs-3610	216	1	https://doi.org/10.1007/s10157-013-0880-y	https://doi.org/10.1007/s10157-013-0880-y	NOUN
iajs-3610	216	2	.	.	PUNCT
iajs-3610	217	1	20	20	NUM
iajs-3610	217	2	.	.	PUNCT
iajs-3610	218	1	kachhawa	kachhawa	PROPN
iajs-3610	218	2	k	k	PROPN
iajs-3610	218	3	,	,	PUNCT
iajs-3610	218	4	agrawal	agrawal	PROPN
iajs-3610	218	5	d	d	PROPN
iajs-3610	218	6	,	,	PUNCT
iajs-3610	218	7	rath	rath	PROPN
iajs-3610	218	8	b	b	PROPN
iajs-3610	218	9	,	,	PUNCT
iajs-3610	218	10	kumar	kumar	PROPN
iajs-3610	218	11	s.	s.	PROPN
iajs-3610	218	12	association	association	PROPN
iajs-3610	218	13	of	of	ADP
iajs-3610	218	14	lipid	lipid	ADJ
iajs-3610	218	15	abnormalities	abnormality	NOUN
iajs-3610	218	16	and	and	CCONJ
iajs-3610	218	17	oxidative	oxidative	ADJ
iajs-3610	218	18	stress	stress	NOUN
iajs-3610	218	19	with	with	ADP
iajs-3610	218	20	diabetic	diabetic	ADJ
iajs-3610	218	21	nephropathy	nephropathy	NOUN
iajs-3610	218	22	.	.	PUNCT
iajs-3610	219	1	j	j	PROPN
iajs-3610	219	2	integr	integr	PROPN
iajs-3610	219	3	nephrol	nephrol	PROPN
iajs-3610	219	4	androl	androl	PROPN
iajs-3610	219	5	.	.	PROPN
iajs-3610	219	6	2017	2017	NUM
iajs-3610	219	7	;	;	PUNCT
iajs-3610	219	8	4(1):3	4(1):3	PROPN
iajs-3610	219	9	-	-	SYM
iajs-3610	219	10	9	9	NUM
iajs-3610	219	11	.	.	PUNCT
iajs-3610	220	1	https://doi.org/10.4103/jina.jina_1_17	https://doi.org/10.4103/jina.jina_1_17	NOUN
iajs-3610	220	2	.	.	PROPN
iajs-3610	220	3	21	21	NUM
iajs-3610	220	4	.	.	PUNCT
iajs-3610	221	1	li	li	PROPN
iajs-3610	221	2	m	m	PROPN
iajs-3610	221	3	,	,	PUNCT
iajs-3610	221	4	tian	tian	PROPN
iajs-3610	221	5	m	m	PROPN
iajs-3610	221	6	,	,	PUNCT
iajs-3610	221	7	jiang	jiang	PROPN
iajs-3610	221	8	x	x	PROPN
iajs-3610	221	9	,	,	PUNCT
iajs-3610	221	10	liu	liu	PROPN
iajs-3610	221	11	y	y	PROPN
iajs-3610	221	12	,	,	PUNCT
iajs-3610	221	13	wang	wang	PROPN
iajs-3610	221	14	y	y	PROPN
iajs-3610	221	15	,	,	PUNCT
iajs-3610	221	16	li	li	PROPN
iajs-3610	221	17	y.	y.	PROPN
iajs-3610	221	18	inhibition	inhibition	NOUN
iajs-3610	221	19	of	of	ADP
iajs-3610	221	20	galectin-3	galectin-3	PROPN
iajs-3610	221	21	ameliorates	ameliorate	VERB
iajs-3610	221	22	high	high	ADV
iajs-3610	221	23	-	-	PUNCT
iajs-3610	221	24	glucoseinduced	glucoseinduce	VERB
iajs-3610	221	25	oxidative	oxidative	ADJ
iajs-3610	221	26	stress	stress	NOUN
iajs-3610	221	27	and	and	CCONJ
iajs-3610	221	28	inflammation	inflammation	NOUN
iajs-3610	221	29	in	in	ADP
iajs-3610	221	30	arpe-19	arpe-19	PROPN
iajs-3610	221	31	cells	cell	NOUN
iajs-3610	221	32	.	.	PUNCT
iajs-3610	222	1	cutaneous	cutaneous	ADJ
iajs-3610	222	2	ocular	ocular	ADJ
iajs-3610	222	3	toxicol	toxicol	NOUN
iajs-3610	222	4	.	.	PUNCT
iajs-3610	223	1	2022	2022	NUM
iajs-3610	223	2	;	;	PUNCT
iajs-3610	223	3	41(2):179	41(2):179	NOUN
iajs-3610	223	4	-	-	PUNCT
iajs-3610	223	5	186	186	NUM
iajs-3610	223	6	.	.	PUNCT
iajs-3610	224	1	https://doi.org/10.1080/15569527.2022.2081701	https://doi.org/10.1080/15569527.2022.2081701	X
iajs-3610	224	2	.	.	PROPN
iajs-3610	225	1	22	22	NUM
iajs-3610	225	2	.	.	PUNCT
iajs-3610	226	1	thi	thi	AUX
iajs-3610	226	2	tnd	tnd	PROPN
iajs-3610	226	3	,	,	PUNCT
iajs-3610	226	4	gia	gia	PROPN
iajs-3610	226	5	bn	bn	PROPN
iajs-3610	226	6	,	,	PUNCT
iajs-3610	226	7	le	le	PROPN
iajs-3610	226	8	thi	thi	PROPN
iajs-3610	226	9	hl	hl	PROPN
iajs-3610	226	10	,	,	PUNCT
iajs-3610	226	11	thi	thi	PROPN
iajs-3610	226	12	tnc	tnc	PROPN
iajs-3610	226	13	,	,	PUNCT
iajs-3610	226	14	thanh	thanh	PROPN
iajs-3610	226	15	hp	hp	PROPN
iajs-3610	226	16	.	.	PROPN
iajs-3610	226	17	evaluation	evaluation	NOUN
iajs-3610	226	18	of	of	ADP
iajs-3610	226	19	urinary	urinary	ADJ
iajs-3610	226	20	l	l	NOUN
iajs-3610	226	21	-	-	NOUN
iajs-3610	226	22	fabp	fabp	PROPN
iajs-3610	226	23	as	as	ADP
iajs-3610	226	24	an	an	DET
iajs-3610	226	25	early	early	ADJ
iajs-3610	226	26	marker	marker	NOUN
iajs-3610	226	27	for	for	ADP
iajs-3610	226	28	diabetic	diabetic	ADJ
iajs-3610	226	29	nephropathy	nephropathy	NOUN
iajs-3610	226	30	in	in	ADP
iajs-3610	226	31	type	type	NOUN
iajs-3610	226	32	2	2	NUM
iajs-3610	226	33	diabetic	diabetic	ADJ
iajs-3610	226	34	patients	patient	NOUN
iajs-3610	226	35	.	.	PUNCT
iajs-3610	227	1	j	j	PROPN
iajs-3610	227	2	med	med	PROPN
iajs-3610	227	3	biochem	biochem	PROPN
iajs-3610	227	4	.	.	PUNCT
iajs-3610	228	1	2020	2020	NUM
iajs-3610	228	2	;	;	PUNCT
iajs-3610	228	3	39(2):224	39(2):224	NUM
iajs-3610	228	4	-	-	SYM
iajs-3610	228	5	230	230	NUM
iajs-3610	228	6	.	.	PUNCT
iajs-3610	229	1	https://doi.org/10.2478/jomb-2019-0037	https://doi.org/10.2478/jomb-2019-0037	NOUN
iajs-3610	229	2	.	.	NOUN
iajs-3610	230	1	23	23	NUM
iajs-3610	230	2	.	.	PUNCT
iajs-3610	231	1	sueud	sueud	PROPN
iajs-3610	231	2	t	t	PROPN
iajs-3610	231	3	,	,	PUNCT
iajs-3610	231	4	hadi	hadi	PROPN
iajs-3610	231	5	nr	nr	PROPN
iajs-3610	231	6	,	,	PUNCT
iajs-3610	231	7	abdulameer	abdulameer	NOUN
iajs-3610	231	8	r	r	NOUN
iajs-3610	231	9	,	,	PUNCT
iajs-3610	231	10	jamil	jamil	PROPN
iajs-3610	231	11	da	da	PROPN
iajs-3610	231	12	,	,	PUNCT
iajs-3610	231	13	al	al	PROPN
iajs-3610	231	14	-	-	PUNCT
iajs-3610	231	15	aubaidy	aubaidy	VERB
iajs-3610	231	16	ha	ha	INTJ
iajs-3610	231	17	.	.	PUNCT
iajs-3610	231	18	assessing	assess	VERB
iajs-3610	231	19	urinary	urinary	ADJ
iajs-3610	231	20	levels	level	NOUN
iajs-3610	231	21	of	of	ADP
iajs-3610	231	22	il-18	il-18	PRON
iajs-3610	231	23	,	,	PUNCT
iajs-3610	231	24	ngal	ngal	ADJ
iajs-3610	231	25	,	,	PUNCT
iajs-3610	231	26	and	and	CCONJ
iajs-3610	231	27	albumin	albumin	ADJ
iajs-3610	231	28	creatinine	creatinine	NOUN
iajs-3610	231	29	ratio	ratio	NOUN
iajs-3610	231	30	in	in	ADP
iajs-3610	231	31	patients	patient	NOUN
iajs-3610	231	32	with	with	ADP
iajs-3610	231	33	diabetic	diabetic	ADJ
iajs-3610	231	34	nephropathy	nephropathy	NOUN
iajs-3610	231	35	.	.	PUNCT
iajs-3610	232	1	diabetes	diabetes	NOUN
iajs-3610	232	2	metab	metab	ADJ
iajs-3610	232	3	syndr	syndr	PROPN
iajs-3610	232	4	clin	clin	PROPN
iajs-3610	232	5	res	res	PROPN
iajs-3610	232	6	rev	rev	PROPN
iajs-3610	232	7	.	.	PROPN
iajs-3610	232	8	2019	2019	NUM
iajs-3610	232	9	;	;	PUNCT
iajs-3610	232	10	13(1):564	13(1):564	NUM
iajs-3610	232	11	-	-	SYM
iajs-3610	232	12	568	568	NUM
iajs-3610	232	13	.	.	PUNCT
iajs-3610	233	1	https://doi.org/10.1016/j.dsx.2018.11.022	https://doi.org/10.1016/j.dsx.2018.11.022	PROPN
iajs-3610	233	2	.	.	PROPN
iajs-3610	234	1	24	24	NUM
iajs-3610	234	2	.	.	PUNCT
iajs-3610	234	3	ferguson	ferguson	PROPN
iajs-3610	234	4	ma	ma	PROPN
iajs-3610	234	5	,	,	PUNCT
iajs-3610	234	6	waikar	waikar	PROPN
iajs-3610	234	7	ss	ss	PROPN
iajs-3610	234	8	.	.	PROPN
iajs-3610	234	9	established	establish	VERB
iajs-3610	234	10	and	and	CCONJ
iajs-3610	234	11	emerging	emerge	VERB
iajs-3610	234	12	markers	marker	NOUN
iajs-3610	234	13	of	of	ADP
iajs-3610	234	14	kidney	kidney	NOUN
iajs-3610	234	15	function	function	NOUN
iajs-3610	234	16	.	.	PUNCT
iajs-3610	235	1	clin	clin	PROPN
iajs-3610	235	2	chem	chem	PROPN
iajs-3610	235	3	.	.	PUNCT
iajs-3610	236	1	2012	2012	NUM
iajs-3610	236	2	;	;	PUNCT
iajs-3610	236	3	58(4):680	58(4):680	PROPN
iajs-3610	236	4	-	-	PUNCT
iajs-3610	236	5	689	689	NUM
iajs-3610	236	6	.	.	PUNCT
iajs-3610	237	1	https://doi.org/10.1373/clinchem.2011.167494	https://doi.org/10.1373/clinchem.2011.167494	NOUN
iajs-3610	237	2	.	.	PROPN
iajs-3610	237	3	25	25	NUM
iajs-3610	237	4	.	.	PUNCT
iajs-3610	237	5	yassin	yassin	PROPN
iajs-3610	237	6	mm	mm	PROPN
iajs-3610	237	7	,	,	PUNCT
iajs-3610	237	8	abumustafa	abumustafa	PROPN
iajs-3610	237	9	am	am	PROPN
iajs-3610	237	10	,	,	PUNCT
iajs-3610	237	11	yassin	yassin	PROPN
iajs-3610	237	12	mm	mm	PROPN
iajs-3610	237	13	.	.	PUNCT
iajs-3610	237	14	serum	serum	PROPN
iajs-3610	237	15	leptin	leptin	NOUN
iajs-3610	237	16	in	in	ADP
iajs-3610	237	17	diabetic	diabetic	ADJ
iajs-3610	237	18	nephropathy	nephropathy	ADJ
iajs-3610	237	19	male	male	ADJ
iajs-3610	237	20	patients	patient	NOUN
iajs-3610	237	21	from	from	ADP
iajs-3610	237	22	gaza	gaza	PROPN
iajs-3610	237	23	strip	strip	PROPN
iajs-3610	237	24	.	.	PUNCT
iajs-3610	238	1	diabetes	diabete	VERB
iajs-3610	238	2	metab	metab	NOUN
iajs-3610	238	3	syndr	syndr	NOUN
iajs-3610	238	4	.	.	PUNCT
iajs-3610	239	1	2019	2019	NUM
iajs-3610	239	2	;	;	PUNCT
iajs-3610	239	3	13(2):1245	13(2):1245	NUM
iajs-3610	239	4	-	-	SYM
iajs-3610	239	5	1250	1250	NUM
iajs-3610	239	6	.	.	PUNCT
iajs-3610	240	1	https://doi.org/10.1016/j.dsx.2019.02.004	https://doi.org/10.1016/j.dsx.2019.02.004	PROPN
iajs-3610	240	2	.	.	PUNCT
iajs-3610	241	1	26	26	NUM
iajs-3610	241	2	.	.	PUNCT
iajs-3610	241	3	abbas	abbas	PROPN
iajs-3610	241	4	hs	hs	PROPN
iajs-3610	241	5	,	,	PUNCT
iajs-3610	241	6	nada	nada	PROPN
iajs-3610	241	7	sz	sz	PROPN
iajs-3610	241	8	,	,	PUNCT
iajs-3610	241	9	fadhel	fadhel	PROPN
iajs-3610	241	10	aa	aa	PROPN
iajs-3610	241	11	.	.	PUNCT
iajs-3610	242	1	assessment	assessment	NOUN
iajs-3610	242	2	of	of	ADP
iajs-3610	242	3	transforming	transform	VERB
iajs-3610	242	4	growth	growth	NOUN
iajs-3610	242	5	factor	factor	NOUN
iajs-3610	242	6	-	-	PUNCT
iajs-3610	242	7	beta	beta	NOUN
iajs-3610	242	8	(	(	PUNCT
iajs-3610	242	9	tgf	tgf	PROPN
iajs-3610	242	10	-	-	PUNCT
iajs-3610	242	11	b	b	NOUN
iajs-3610	242	12	)	)	PUNCT
iajs-3610	242	13	and	and	CCONJ
iajs-3610	242	14	albumin	albumin	NOUN
iajs-3610	242	15	to	to	ADP
iajs-3610	242	16	creatinine	creatinine	NOUN
iajs-3610	242	17	ratio	ratio	NOUN
iajs-3610	242	18	(	(	PUNCT
iajs-3610	242	19	acr	acr	PROPN
iajs-3610	242	20	)	)	PUNCT
iajs-3610	242	21	in	in	ADP
iajs-3610	242	22	patients	patient	NOUN
iajs-3610	242	23	with	with	ADP
iajs-3610	242	24	type	type	NOUN
iajs-3610	242	25	2	2	NUM
iajs-3610	242	26	diabetic	diabetic	ADJ
iajs-3610	242	27	nephropathy	nephropathy	NOUN
iajs-3610	242	28	.	.	PUNCT
iajs-3610	243	1	world	world	PROPN
iajs-3610	243	2	j	j	PROPN
iajs-3610	243	3	pharm	pharm	PROPN
iajs-3610	243	4	pharm	pharm	PROPN
iajs-3610	243	5	sci	sci	PROPN
iajs-3610	243	6	.	.	PROPN
iajs-3610	243	7	2022	2022	NUM
iajs-3610	243	8	;	;	PUNCT
iajs-3610	243	9	11(8):88	11(8):88	NUM
iajs-3610	243	10	-	-	SYM
iajs-3610	243	11	103	103	NUM
iajs-3610	243	12	.	.	PUNCT
iajs-3610	244	1	https://doi.org/10.20959/wjpps20228-22902	https://doi.org/10.20959/wjpps20228-22902	X
iajs-3610	244	2	.	.	PUNCT
iajs-3610	245	1	https://doi.org/10.30526/32.2.2137	https://doi.org/10.30526/32.2.2137	X
iajs-3610	245	2	.	.	PUNCT
iajs-3610	246	1	https://doi.org/10.21123/bsj.2022.19.2.0340	https://doi.org/10.21123/bsj.2022.19.2.0340	PROPN
iajs-3610	246	2	.	.	PUNCT
iajs-3610	247	1	http://dx.doi.org/10.21123/bsj.2022.19.1.0033	http://dx.doi.org/10.21123/bsj.2022.19.1.0033	PROPN
iajs-3610	247	2	https://doi.org/10.33696/signaling.5.121	https://doi.org/10.33696/signaling.5.121	PROPN
iajs-3610	247	3	https://doi.org/10.1093/ndt/gft320	https://doi.org/10.1093/ndt/gft320	PROPN
iajs-3610	247	4	https://doi.org/10.1021/bi035268s	https://doi.org/10.1021/bi035268s	NOUN
iajs-3610	247	5	https://doi.org/10.1161/01.res.87.5.e1	https://doi.org/10.1161/01.res.87.5.e1	PROPN
iajs-3610	247	6	https://doi.org/10.1042/cs20171550	https://doi.org/10.1042/cs20171550	NOUN
iajs-3610	247	7	https://doi.org/10.2215/cjn.10741013	https://doi.org/10.2215/cjn.10741013	PROPN
iajs-3610	247	8	.	.	PUNCT
iajs-3610	248	1	https://doi.org/10.1007/s10157-013-0880-y	https://doi.org/10.1007/s10157-013-0880-y	NOUN
iajs-3610	248	2	https://doi.org/10.4103/jina.jina_1_17	https://doi.org/10.4103/jina.jina_1_17	NOUN
iajs-3610	248	3	.	.	PUNCT
iajs-3610	249	1	https://doi.org/10.1080/15569527.2022.2081701	https://doi.org/10.1080/15569527.2022.2081701	PROPN
iajs-3610	250	1	https://doi.org/10.2478/jomb-2019-0037	https://doi.org/10.2478/jomb-2019-0037	PROPN
iajs-3610	250	2	.	.	PUNCT
iajs-3610	251	1	https://doi.org/10.1016/j.dsx.2018.11.022	https://doi.org/10.1016/j.dsx.2018.11.022	PROPN
iajs-3610	251	2	https://doi.org/10.1373/clinchem.2011.167494	https://doi.org/10.1373/clinchem.2011.167494	PROPN
iajs-3610	251	3	https://doi.org/10.1016/j.dsx.2019.02.004	https://doi.org/10.1016/j.dsx.2019.02.004	PROPN
iajs-3610	251	4	https://doi.org/10.20959/wjpps20228-22902	https://doi.org/10.20959/wjpps20228-22902	X
iajs-3610	251	5	.	.	PUNCT
iajs-3610	252	1	ihjpas	ihjpas	PROPN
iajs-3610	252	2	.	.	PUNCT
iajs-3610	253	1	2025	2025	NUM
iajs-3610	253	2	,	,	PUNCT
iajs-3610	253	3	38(3	38(3	NUM
iajs-3610	253	4	)	)	PUNCT
iajs-3610	253	5	235	235	NUM
iajs-3610	253	6	27	27	NUM
iajs-3610	253	7	.	.	PUNCT
iajs-3610	254	1	morton	morton	PROPN
iajs-3610	254	2	ji	ji	PROPN
iajs-3610	254	3	,	,	PUNCT
iajs-3610	254	4	liew	liew	PROPN
iajs-3610	254	5	d	d	PROPN
iajs-3610	254	6	,	,	PUNCT
iajs-3610	254	7	mcdonald	mcdonald	PROPN
iajs-3610	254	8	sp	sp	PROPN
iajs-3610	254	9	,	,	PUNCT
iajs-3610	254	10	shaw	shaw	PROPN
iajs-3610	254	11	je	je	PROPN
iajs-3610	254	12	,	,	PUNCT
iajs-3610	254	13	magliano	magliano	PROPN
iajs-3610	254	14	dj	dj	PROPN
iajs-3610	254	15	.	.	PUNCT
iajs-3610	255	1	the	the	DET
iajs-3610	255	2	association	association	NOUN
iajs-3610	255	3	between	between	ADP
iajs-3610	255	4	age	age	NOUN
iajs-3610	255	5	of	of	ADP
iajs-3610	255	6	onset	onset	NOUN
iajs-3610	255	7	of	of	ADP
iajs-3610	255	8	type	type	NOUN
iajs-3610	255	9	2	2	NUM
iajs-3610	255	10	diabetes	diabetes	NOUN
iajs-3610	255	11	and	and	CCONJ
iajs-3610	255	12	the	the	DET
iajs-3610	255	13	long	long	ADJ
iajs-3610	255	14	-	-	PUNCT
iajs-3610	255	15	term	term	NOUN
iajs-3610	255	16	risk	risk	NOUN
iajs-3610	255	17	of	of	ADP
iajs-3610	255	18	end	end	NOUN
iajs-3610	255	19	-	-	PUNCT
iajs-3610	255	20	stage	stage	NOUN
iajs-3610	255	21	kidney	kidney	NOUN
iajs-3610	255	22	disease	disease	NOUN
iajs-3610	255	23	:	:	PUNCT
iajs-3610	255	24	a	a	DET
iajs-3610	255	25	national	national	ADJ
iajs-3610	255	26	registry	registry	NOUN
iajs-3610	255	27	study	study	NOUN
iajs-3610	255	28	.	.	PUNCT
iajs-3610	256	1	diabetes	diabetes	NOUN
iajs-3610	256	2	care	care	NOUN
iajs-3610	256	3	.	.	PUNCT
iajs-3610	257	1	2020	2020	NUM
iajs-3610	257	2	;	;	PUNCT
iajs-3610	257	3	43(8):1788	43(8):1788	NUM
iajs-3610	257	4	-	-	SYM
iajs-3610	257	5	1795	1795	NUM
iajs-3610	257	6	.	.	PUNCT
iajs-3610	258	1	https://doi.org/10.2337/dc20-0352	https://doi.org/10.2337/dc20-0352	NOUN
iajs-3610	258	2	.	.	PROPN
iajs-3610	258	3	28	28	NUM
iajs-3610	258	4	.	.	PUNCT
iajs-3610	259	1	al	al	PROPN
iajs-3610	259	2	-	-	PUNCT
iajs-3610	259	3	bayati	bayati	PROPN
iajs-3610	259	4	haa	haa	PROPN
iajs-3610	259	5	,	,	PUNCT
iajs-3610	259	6	al	al	PROPN
iajs-3610	259	7	-	-	PUNCT
iajs-3610	259	8	khateeb	khateeb	PROPN
iajs-3610	259	9	jsm	jsm	PROPN
iajs-3610	259	10	.	.	PROPN
iajs-3610	260	1	the	the	DET
iajs-3610	260	2	association	association	NOUN
iajs-3610	260	3	between	between	ADP
iajs-3610	260	4	glycaemic	glycaemic	ADJ
iajs-3610	260	5	level	level	NOUN
iajs-3610	260	6	and	and	CCONJ
iajs-3610	260	7	lipid	lipid	NOUN
iajs-3610	260	8	profile	profile	NOUN
iajs-3610	260	9	with	with	ADP
iajs-3610	260	10	albuminuria	albuminuria	PROPN
iajs-3610	260	11	in	in	ADP
iajs-3610	260	12	iraqi	iraqi	ADJ
iajs-3610	260	13	type	type	NOUN
iajs-3610	260	14	2	2	NUM
iajs-3610	260	15	diabetes	diabetes	NOUN
iajs-3610	260	16	patients	patient	NOUN
iajs-3610	260	17	:	:	PUNCT
iajs-3610	260	18	a	a	DET
iajs-3610	260	19	cross	cross	ADJ
iajs-3610	260	20	-	-	ADJ
iajs-3610	260	21	sectional	sectional	ADJ
iajs-3610	260	22	study	study	NOUN
iajs-3610	260	23	.	.	PUNCT
iajs-3610	261	1	j	j	PROPN
iajs-3610	261	2	pak	pak	PROPN
iajs-3610	261	3	med	med	PROPN
iajs-3610	261	4	assoc	assoc	PROPN
iajs-3610	261	5	.	.	PUNCT
iajs-3610	261	6	2021	2021	NUM
iajs-3610	261	7	;	;	PUNCT
iajs-3610	261	8	(	(	PUNCT
iajs-3610	261	9	suppl	suppl	ADJ
iajs-3610	261	10	8)(12):s57	8)(12):s57	NOUN
iajs-3610	261	11	-	-	PUNCT
iajs-3610	261	12	s62	s62	NOUN
iajs-3610	261	13	.	.	PUNCT
iajs-3610	262	1	pmid	pmid	NOUN
iajs-3610	262	2	:	:	PUNCT
iajs-3610	262	3	35130220	35130220	NUM
iajs-3610	262	4	.	.	PUNCT
iajs-3610	263	1	29	29	NUM
iajs-3610	263	2	.	.	PUNCT
iajs-3610	264	1	liu	liu	PROPN
iajs-3610	264	2	lp	lp	PROPN
iajs-3610	264	3	,	,	PUNCT
iajs-3610	264	4	zhang	zhang	PROPN
iajs-3610	264	5	xl	xl	PROPN
iajs-3610	264	6	,	,	PUNCT
iajs-3610	264	7	li	li	PROPN
iajs-3610	264	8	j.	j.	PROPN
iajs-3610	264	9	new	new	PROPN
iajs-3610	264	10	perspectives	perspective	NOUN
iajs-3610	264	11	on	on	ADP
iajs-3610	264	12	angiotensin	angiotensin	NOUN
iajs-3610	264	13	-	-	PUNCT
iajs-3610	264	14	converting	convert	VERB
iajs-3610	264	15	enzyme	enzyme	NOUN
iajs-3610	264	16	2	2	NUM
iajs-3610	264	17	and	and	CCONJ
iajs-3610	264	18	its	its	PRON
iajs-3610	264	19	related	related	ADJ
iajs-3610	264	20	diseases	disease	NOUN
iajs-3610	264	21	.	.	PUNCT
iajs-3610	265	1	world	world	NOUN
iajs-3610	265	2	j	j	PROPN
iajs-3610	265	3	diabetes	diabetes	PROPN
iajs-3610	265	4	.	.	PUNCT
iajs-3610	266	1	2021	2021	NUM
iajs-3610	266	2	;	;	PUNCT
iajs-3610	266	3	12(6):839	12(6):839	NUM
iajs-3610	266	4	-	-	SYM
iajs-3610	266	5	854	854	NUM
iajs-3610	266	6	.	.	PUNCT
iajs-3610	267	1	https://doi.org/10.4239/wjd.v12.i6.839	https://doi.org/10.4239/wjd.v12.i6.839	NOUN
iajs-3610	267	2	.	.	PROPN
iajs-3610	268	1	30	30	NUM
iajs-3610	268	2	.	.	PUNCT
iajs-3610	269	1	abdullah	abdullah	PROPN
iajs-3610	269	2	bi	bi	PROPN
iajs-3610	269	3	,	,	PUNCT
iajs-3610	269	4	salih	salih	PROPN
iajs-3610	269	5	sf	sf	PROPN
iajs-3610	269	6	.	.	PUNCT
iajs-3610	270	1	lipoprotein	lipoprotein	PROPN
iajs-3610	270	2	(	(	PUNCT
iajs-3610	270	3	a	a	DET
iajs-3610	270	4	)	)	PUNCT
iajs-3610	270	5	level	level	NOUN
iajs-3610	270	6	among	among	ADP
iajs-3610	270	7	patients	patient	NOUN
iajs-3610	270	8	with	with	ADP
iajs-3610	270	9	type	type	NOUN
iajs-3610	270	10	2	2	NUM
iajs-3610	270	11	diabetes	diabetes	NOUN
iajs-3610	270	12	mellitus	mellitus	NOUN
iajs-3610	270	13	and	and	CCONJ
iajs-3610	270	14	prediabetes	prediabete	NOUN
iajs-3610	270	15	in	in	ADP
iajs-3610	270	16	comparison	comparison	NOUN
iajs-3610	270	17	with	with	ADP
iajs-3610	270	18	healthy	healthy	ADJ
iajs-3610	270	19	controls	control	NOUN
iajs-3610	270	20	.	.	PUNCT
iajs-3610	271	1	sci	sci	PROPN
iajs-3610	271	2	j	j	PROPN
iajs-3610	271	3	univ	univ	PROPN
iajs-3610	271	4	zakho	zakho	PROPN
iajs-3610	271	5	.	.	PUNCT
iajs-3610	272	1	2023	2023	NUM
iajs-3610	272	2	;	;	PUNCT
iajs-3610	272	3	11(1):30	11(1):30	NUM
iajs-3610	272	4	-	-	SYM
iajs-3610	272	5	36	36	NUM
iajs-3610	272	6	.	.	PUNCT
iajs-3610	273	1	https://doi.org/10.25271/sjuoz.2023.11.1.996	https://doi.org/10.25271/sjuoz.2023.11.1.996	NOUN
iajs-3610	273	2	.	.	PUNCT
iajs-3610	274	1	31	31	NUM
iajs-3610	274	2	.	.	PUNCT
iajs-3610	275	1	chutani	chutani	PROPN
iajs-3610	275	2	a	a	PRON
iajs-3610	275	3	,	,	PUNCT
iajs-3610	275	4	pande	pande	NOUN
iajs-3610	275	5	s.	s.	PROPN
iajs-3610	275	6	correlation	correlation	NOUN
iajs-3610	275	7	of	of	ADP
iajs-3610	275	8	serum	serum	NOUN
iajs-3610	275	9	creatinine	creatinine	NOUN
iajs-3610	275	10	and	and	CCONJ
iajs-3610	275	11	urea	urea	NOUN
iajs-3610	275	12	with	with	ADP
iajs-3610	275	13	glycemic	glycemic	ADJ
iajs-3610	275	14	index	index	NOUN
iajs-3610	275	15	and	and	CCONJ
iajs-3610	275	16	duration	duration	NOUN
iajs-3610	275	17	of	of	ADP
iajs-3610	275	18	diabetes	diabetes	NOUN
iajs-3610	275	19	in	in	ADP
iajs-3610	275	20	type	type	NOUN
iajs-3610	275	21	1	1	NUM
iajs-3610	275	22	and	and	CCONJ
iajs-3610	275	23	type	type	NOUN
iajs-3610	275	24	2	2	NUM
iajs-3610	275	25	diabetes	diabetes	NOUN
iajs-3610	275	26	mellitus	mellitus	NOUN
iajs-3610	275	27	:	:	PUNCT
iajs-3610	275	28	a	a	DET
iajs-3610	275	29	comparative	comparative	ADJ
iajs-3610	275	30	study	study	NOUN
iajs-3610	275	31	.	.	PUNCT
iajs-3610	276	1	natl	natl	PROPN
iajs-3610	276	2	j	j	PROPN
iajs-3610	276	3	physiol	physiol	PROPN
iajs-3610	276	4	pharm	pharm	PROPN
iajs-3610	276	5	pharmaco	pharmaco	PROPN
iajs-3610	276	6	.	.	PUNCT
iajs-3610	277	1	2017	2017	NUM
iajs-3610	277	2	;	;	PUNCT
iajs-3610	277	3	7(9):914	7(9):914	NUM
iajs-3610	277	4	-	-	SYM
iajs-3610	277	5	919	919	NUM
iajs-3610	277	6	.	.	PUNCT
iajs-3610	278	1	https://doi.org/10.5455/njppp.2017.7.0515606052017	https://doi.org/10.5455/njppp.2017.7.0515606052017	PROPN
iajs-3610	278	2	.	.	PUNCT
iajs-3610	279	1	32	32	NUM
iajs-3610	279	2	.	.	PUNCT
iajs-3610	280	1	celik	celik	PROPN
iajs-3610	280	2	zm	zm	PROPN
iajs-3610	280	3	,	,	PUNCT
iajs-3610	280	4	akduman	akduman	NOUN
iajs-3610	280	5	g	g	NOUN
iajs-3610	280	6	,	,	PUNCT
iajs-3610	280	7	özen	özen	NOUN
iajs-3610	280	8	h	h	NOUN
iajs-3610	280	9	,	,	PUNCT
iajs-3610	280	10	daşdemir	daşdemir	NOUN
iajs-3610	280	11	ş	ş	X
iajs-3610	280	12	,	,	PUNCT
iajs-3610	280	13	güneş	güneş	PROPN
iajs-3610	280	14	f.	f.	PROPN
iajs-3610	280	15	determining	determine	VERB
iajs-3610	280	16	the	the	DET
iajs-3610	280	17	possible	possible	ADJ
iajs-3610	280	18	effect	effect	NOUN
iajs-3610	280	19	of	of	ADP
iajs-3610	280	20	diabetes	diabetes	NOUN
iajs-3610	280	21	on	on	ADP
iajs-3610	280	22	the	the	DET
iajs-3610	280	23	nutritional	nutritional	ADJ
iajs-3610	280	24	status	status	NOUN
iajs-3610	280	25	of	of	ADP
iajs-3610	280	26	hemodialysis	hemodialysis	NOUN
iajs-3610	280	27	patients	patient	NOUN
iajs-3610	280	28	.	.	PUNCT
iajs-3610	281	1	jihsam	jihsam	NOUN
iajs-3610	281	2	.	.	PUNCT
iajs-3610	282	1	2021;7(14):34	2021;7(14):34	NUM
iajs-3610	282	2	-	-	SYM
iajs-3610	282	3	41	41	NUM
iajs-3610	282	4	.	.	PUNCT
iajs-3610	283	1	https://doi.org/10.48121/jihsam.910490	https://doi.org/10.48121/jihsam.910490	X
iajs-3610	283	2	.	.	PUNCT
iajs-3610	284	1	33	33	NUM
iajs-3610	284	2	.	.	PUNCT
iajs-3610	285	1	nazar	nazar	NOUN
iajs-3610	285	2	cmj	cmj	PROPN
iajs-3610	285	3	.	.	PUNCT
iajs-3610	286	1	diabetic	diabetic	ADJ
iajs-3610	286	2	nephropathy	nephropathy	NOUN
iajs-3610	286	3	:	:	PUNCT
iajs-3610	286	4	principles	principle	NOUN
iajs-3610	286	5	of	of	ADP
iajs-3610	286	6	diagnosis	diagnosis	NOUN
iajs-3610	286	7	and	and	CCONJ
iajs-3610	286	8	treatment	treatment	NOUN
iajs-3610	286	9	of	of	ADP
iajs-3610	286	10	diabetic	diabetic	ADJ
iajs-3610	286	11	kidney	kidney	NOUN
iajs-3610	286	12	disease	disease	NOUN
iajs-3610	286	13	.	.	PUNCT
iajs-3610	287	1	j	j	PROPN
iajs-3610	287	2	nephropharmacol	nephropharmacol	PROPN
iajs-3610	287	3	.	.	PUNCT
iajs-3610	288	1	2014	2014	NUM
iajs-3610	288	2	;	;	PUNCT
iajs-3610	288	3	3(1):15	3(1):15	NUM
iajs-3610	288	4	-	-	SYM
iajs-3610	288	5	20	20	NUM
iajs-3610	288	6	.	.	PUNCT
iajs-3610	289	1	pmid	pmid	NOUN
iajs-3610	289	2	:	:	PUNCT
iajs-3610	289	3	28197454	28197454	NUM
iajs-3610	289	4	.	.	PUNCT
iajs-3610	290	1	34	34	NUM
iajs-3610	290	2	.	.	PUNCT
iajs-3610	291	1	wang	wang	PROPN
iajs-3610	291	2	w.	w.	PROPN
iajs-3610	291	3	different	different	ADJ
iajs-3610	291	4	doses	dose	NOUN
iajs-3610	291	5	of	of	ADP
iajs-3610	291	6	tripterygium	tripterygium	NOUN
iajs-3610	291	7	glycosides	glycoside	NOUN
iajs-3610	291	8	in	in	ADP
iajs-3610	291	9	the	the	DET
iajs-3610	291	10	treatment	treatment	NOUN
iajs-3610	291	11	of	of	ADP
iajs-3610	291	12	diabetic	diabetic	ADJ
iajs-3610	291	13	nephropathy	nephropathy	NOUN
iajs-3610	291	14	:	:	PUNCT
iajs-3610	291	15	effects	effect	NOUN
iajs-3610	291	16	on	on	ADP
iajs-3610	291	17	blood	blood	NOUN
iajs-3610	291	18	lipids	lipids	NOUN
iajs-3610	291	19	.	.	PUNCT
iajs-3610	292	1	kidney	kidney	NOUN
iajs-3610	292	2	blood	blood	NOUN
iajs-3610	292	3	press	press	NOUN
iajs-3610	292	4	res	re	NOUN
iajs-3610	292	5	.	.	PUNCT
iajs-3610	292	6	2018	2018	NUM
iajs-3610	292	7	;	;	PUNCT
iajs-3610	292	8	43(3):931	43(3):931	PROPN
iajs-3610	292	9	-	-	PUNCT
iajs-3610	292	10	937	937	NUM
iajs-3610	292	11	.	.	PUNCT
iajs-3610	293	1	https://doi.org/10.1159/000490472	https://doi.org/10.1159/000490472	NOUN
iajs-3610	293	2	.	.	PUNCT
iajs-3610	294	1	35	35	NUM
iajs-3610	294	2	.	.	PUNCT
iajs-3610	295	1	benzing	benze	VERB
iajs-3610	295	2	t	t	PROPN
iajs-3610	295	3	,	,	PUNCT
iajs-3610	295	4	salant	salant	PROPN
iajs-3610	295	5	d.	d.	PROPN
iajs-3610	295	6	insights	insight	NOUN
iajs-3610	295	7	into	into	ADP
iajs-3610	295	8	glomerular	glomerular	ADJ
iajs-3610	295	9	filtration	filtration	NOUN
iajs-3610	295	10	and	and	CCONJ
iajs-3610	295	11	albuminuria	albuminuria	NOUN
iajs-3610	295	12	.	.	PUNCT
iajs-3610	296	1	n	n	PROPN
iajs-3610	296	2	engl	engl	PROPN
iajs-3610	296	3	j	j	PROPN
iajs-3610	296	4	med	med	PROPN
iajs-3610	296	5	.	.	PROPN
iajs-3610	296	6	2021	2021	NUM
iajs-3610	296	7	;	;	PUNCT
iajs-3610	297	1	384(15):1437	384(15):1437	NUM
iajs-3610	297	2	-	-	SYM
iajs-3610	297	3	1446	1446	NUM
iajs-3610	297	4	.	.	PUNCT
iajs-3610	298	1	https://doi.org/10.1056/nejmra1808786	https://doi.org/10.1056/nejmra1808786	PROPN
iajs-3610	298	2	.	.	PUNCT
iajs-3610	299	1	36	36	NUM
iajs-3610	299	2	.	.	X
iajs-3610	300	1	akpotaire	akpotaire	ADP
iajs-3610	300	2	pa	pa	PROPN
iajs-3610	300	3	,	,	PUNCT
iajs-3610	300	4	seriki	seriki	PROPN
iajs-3610	300	5	sa	sa	PROPN
iajs-3610	300	6	.	.	PUNCT
iajs-3610	300	7	assessment	assessment	NOUN
iajs-3610	300	8	and	and	CCONJ
iajs-3610	300	9	correlation	correlation	NOUN
iajs-3610	300	10	of	of	ADP
iajs-3610	300	11	serum	serum	NOUN
iajs-3610	300	12	urea	urea	NOUN
iajs-3610	300	13	and	and	CCONJ
iajs-3610	300	14	creatinine	creatinine	NOUN
iajs-3610	300	15	levels	level	NOUN
iajs-3610	300	16	in	in	ADP
iajs-3610	300	17	normal	normal	ADJ
iajs-3610	300	18	,	,	PUNCT
iajs-3610	300	19	hypertensive	hypertensive	ADJ
iajs-3610	300	20	,	,	PUNCT
iajs-3610	300	21	and	and	CCONJ
iajs-3610	300	22	diabetic	diabetic	ADJ
iajs-3610	300	23	persons	person	NOUN
iajs-3610	300	24	in	in	ADP
iajs-3610	300	25	auchi	auchi	PROPN
iajs-3610	300	26	,	,	PUNCT
iajs-3610	300	27	nigeria	nigeria	PROPN
iajs-3610	300	28	.	.	PUNCT
iajs-3610	301	1	arch	arch	PROPN
iajs-3610	301	2	pathol	pathol	PROPN
iajs-3610	301	3	clin	clin	PROPN
iajs-3610	301	4	res	re	NOUN
iajs-3610	301	5	.	.	PUNCT
iajs-3610	301	6	2023	2023	NUM
iajs-3610	301	7	;	;	PUNCT
iajs-3610	301	8	7:7	7:7	NUM
iajs-3610	301	9	-	-	SYM
iajs-3610	301	10	16	16	NUM
iajs-3610	301	11	.	.	PUNCT
iajs-3610	302	1	https://doi.org/10.29328/journal.apcr.1001035	https://doi.org/10.29328/journal.apcr.1001035	PROPN
iajs-3610	302	2	.	.	PUNCT
iajs-3610	303	1	37	37	NUM
iajs-3610	303	2	.	.	PUNCT
iajs-3610	304	1	cai	cai	PROPN
iajs-3610	305	1	z	z	PROPN
iajs-3610	305	2	,	,	PUNCT
iajs-3610	305	3	yang	yang	PROPN
iajs-3610	305	4	y	y	PROPN
iajs-3610	305	5	,	,	PUNCT
iajs-3610	305	6	zhang	zhang	PROPN
iajs-3610	305	7	j.	j.	PROPN
iajs-3610	305	8	a	a	DET
iajs-3610	305	9	systematic	systematic	ADJ
iajs-3610	305	10	review	review	NOUN
iajs-3610	305	11	and	and	CCONJ
iajs-3610	305	12	meta	meta	NOUN
iajs-3610	305	13	-	-	PUNCT
iajs-3610	305	14	analysis	analysis	NOUN
iajs-3610	305	15	of	of	ADP
iajs-3610	305	16	the	the	DET
iajs-3610	305	17	serum	serum	NOUN
iajs-3610	305	18	lipid	lipid	NOUN
iajs-3610	305	19	profile	profile	NOUN
iajs-3610	305	20	in	in	ADP
iajs-3610	305	21	prediction	prediction	NOUN
iajs-3610	305	22	of	of	ADP
iajs-3610	305	23	diabetic	diabetic	NOUN
iajs-3610	305	24	neuropathy	neuropathy	ADJ
iajs-3610	305	25	.	.	PUNCT
iajs-3610	306	1	sci	sci	PROPN
iajs-3610	306	2	rep	rep	PROPN
iajs-3610	306	3	.	.	PROPN
iajs-3610	306	4	2021	2021	NUM
iajs-3610	306	5	;	;	PUNCT
iajs-3610	306	6	11(1):499	11(1):499	NUM
iajs-3610	306	7	.	.	PUNCT
iajs-3610	307	1	https://doi.org/10.1038/s41598-02079276-0	https://doi.org/10.1038/s41598-02079276-0	ADJ
iajs-3610	307	2	.	.	PUNCT
iajs-3610	308	1	38	38	NUM
iajs-3610	308	2	.	.	PUNCT
iajs-3610	309	1	timar	timar	PROPN
iajs-3610	309	2	b	b	PROPN
iajs-3610	309	3	,	,	PUNCT
iajs-3610	309	4	albai	albai	PROPN
iajs-3610	310	1	o.	o.	NOUN
iajs-3610	310	2	the	the	DET
iajs-3610	310	3	relationship	relationship	NOUN
iajs-3610	310	4	between	between	ADP
iajs-3610	310	5	hemoglobin	hemoglobin	NOUN
iajs-3610	310	6	a1c	a1c	PROPN
iajs-3610	310	7	and	and	CCONJ
iajs-3610	310	8	chronic	chronic	ADJ
iajs-3610	310	9	complications	complication	NOUN
iajs-3610	310	10	in	in	ADP
iajs-3610	310	11	diabetes	diabetes	NOUN
iajs-3610	310	12	mellitus	mellitus	NOUN
iajs-3610	310	13	.	.	PUNCT
iajs-3610	311	1	romanian	romanian	PROPN
iajs-3610	311	2	j	j	PROPN
iajs-3610	311	3	diabetes	diabetes	PROPN
iajs-3610	311	4	nutr	nutr	PROPN
iajs-3610	311	5	metab	metab	PROPN
iajs-3610	311	6	dis	dis	PROPN
iajs-3610	311	7	.	.	PUNCT
iajs-3610	312	1	2012	2012	NUM
iajs-3610	312	2	;	;	PUNCT
iajs-3610	313	1	19(2):115	19(2):115	PROPN
iajs-3610	313	2	-	-	SYM
iajs-3610	313	3	122	122	NUM
iajs-3610	313	4	.	.	PUNCT
iajs-3610	314	1	https://doi.org/10.2478/v10255-012-0015-3	https://doi.org/10.2478/v10255-012-0015-3	X
iajs-3610	314	2	.	.	PUNCT
iajs-3610	315	1	39	39	NUM
iajs-3610	315	2	.	.	PUNCT
iajs-3610	316	1	pagliaro	pagliaro	NOUN
iajs-3610	316	2	p	p	NOUN
iajs-3610	316	3	,	,	PUNCT
iajs-3610	316	4	thairi	thairi	NOUN
iajs-3610	316	5	c	c	NOUN
iajs-3610	316	6	,	,	PUNCT
iajs-3610	316	7	alloatti	alloatti	NOUN
iajs-3610	316	8	g	g	PROPN
iajs-3610	316	9	,	,	PUNCT
iajs-3610	316	10	penna	penna	PROPN
iajs-3610	316	11	c.	c.	PROPN
iajs-3610	316	12	angiotensin	angiotensin	PROPN
iajs-3610	316	13	-	-	PUNCT
iajs-3610	316	14	converting	convert	VERB
iajs-3610	316	15	enzyme	enzyme	NOUN
iajs-3610	316	16	2	2	NUM
iajs-3610	316	17	:	:	PUNCT
iajs-3610	316	18	a	a	DET
iajs-3610	316	19	key	key	ADJ
iajs-3610	316	20	enzyme	enzyme	NOUN
iajs-3610	316	21	in	in	ADP
iajs-3610	316	22	key	key	ADJ
iajs-3610	316	23	organs	organ	NOUN
iajs-3610	316	24	.	.	PUNCT
iajs-3610	317	1	j	j	PROPN
iajs-3610	317	2	cardiovasc	cardiovasc	PROPN
iajs-3610	317	3	med	me	VERB
iajs-3610	317	4	.	.	PUNCT
iajs-3610	317	5	2022	2022	NUM
iajs-3610	317	6	;	;	PUNCT
iajs-3610	317	7	23(1):1	23(1):1	NUM
iajs-3610	317	8	-	-	SYM
iajs-3610	317	9	11	11	NUM
iajs-3610	317	10	.	.	PUNCT
iajs-3610	318	1	https://doi.org/10.2459/jcm.0000000000001218	https://doi.org/10.2459/jcm.0000000000001218	NOUN
iajs-3610	318	2	.	.	PROPN
iajs-3610	319	1	40	40	NUM
iajs-3610	319	2	.	.	PUNCT
iajs-3610	320	1	berhane	berhane	NOUN
iajs-3610	320	2	am	am	PROPN
iajs-3610	320	3	,	,	PUNCT
iajs-3610	320	4	weil	weil	PROPN
iajs-3610	320	5	ej	ej	PROPN
iajs-3610	320	6	,	,	PUNCT
iajs-3610	320	7	knowler	knowler	PROPN
iajs-3610	320	8	wc	wc	PROPN
iajs-3610	320	9	,	,	PUNCT
iajs-3610	320	10	nelson	nelson	PROPN
iajs-3610	320	11	rg	rg	PROPN
iajs-3610	320	12	,	,	PUNCT
iajs-3610	320	13	hanson	hanson	PROPN
iajs-3610	320	14	rl	rl	PROPN
iajs-3610	320	15	.	.	PROPN
iajs-3610	320	16	albuminuria	albuminuria	PROPN
iajs-3610	320	17	and	and	CCONJ
iajs-3610	320	18	estimated	estimate	VERB
iajs-3610	320	19	glomerular	glomerular	ADJ
iajs-3610	320	20	filtration	filtration	NOUN
iajs-3610	320	21	rate	rate	NOUN
iajs-3610	320	22	as	as	ADP
iajs-3610	320	23	predictors	predictor	NOUN
iajs-3610	320	24	of	of	ADP
iajs-3610	320	25	diabetic	diabetic	ADJ
iajs-3610	320	26	end	end	NOUN
iajs-3610	320	27	-	-	PUNCT
iajs-3610	320	28	stage	stage	NOUN
iajs-3610	320	29	renal	renal	ADJ
iajs-3610	320	30	disease	disease	NOUN
iajs-3610	320	31	and	and	CCONJ
iajs-3610	320	32	death	death	NOUN
iajs-3610	320	33	.	.	PUNCT
iajs-3610	321	1	clin	clin	PROPN
iajs-3610	321	2	j	j	PROPN
iajs-3610	321	3	am	be	AUX
iajs-3610	321	4	soc	soc	NOUN
iajs-3610	321	5	nephrol	nephrol	NOUN
iajs-3610	321	6	.	.	PUNCT
iajs-3610	322	1	2011	2011	NUM
iajs-3610	322	2	;	;	PUNCT
iajs-3610	322	3	6(10):2444	6(10):2444	NUM
iajs-3610	322	4	-	-	PUNCT
iajs-3610	322	5	2451	2451	NUM
iajs-3610	322	6	.	.	PUNCT
iajs-3610	323	1	https://doi.org/10.2215/cjn.00580111	https://doi.org/10.2215/cjn.00580111	PROPN
iajs-3610	323	2	.	.	PROPN
iajs-3610	323	3	41	41	NUM
iajs-3610	323	4	.	.	PUNCT
iajs-3610	323	5	fiseha	fiseha	PROPN
iajs-3610	323	6	t	t	PROPN
iajs-3610	323	7	,	,	PUNCT
iajs-3610	323	8	ahmed	ahmed	PROPN
iajs-3610	323	9	e	e	PROPN
iajs-3610	323	10	,	,	PUNCT
iajs-3610	323	11	chalie	chalie	PROPN
iajs-3610	323	12	s	s	PROPN
iajs-3610	323	13	,	,	PUNCT
iajs-3610	323	14	gebreweld	gebreweld	ADJ
iajs-3610	323	15	a.	a.	NOUN
iajs-3610	323	16	prevalence	prevalence	NOUN
iajs-3610	323	17	and	and	CCONJ
iajs-3610	323	18	associated	associated	ADJ
iajs-3610	323	19	factors	factor	NOUN
iajs-3610	323	20	of	of	ADP
iajs-3610	323	21	impaired	impaired	ADJ
iajs-3610	323	22	renal	renal	ADJ
iajs-3610	323	23	function	function	NOUN
iajs-3610	323	24	and	and	CCONJ
iajs-3610	323	25	albuminuria	albuminuria	NOUN
iajs-3610	323	26	among	among	ADP
iajs-3610	323	27	adult	adult	NOUN
iajs-3610	323	28	patients	patient	NOUN
iajs-3610	323	29	admitted	admit	VERB
iajs-3610	323	30	to	to	ADP
iajs-3610	323	31	a	a	DET
iajs-3610	323	32	hospital	hospital	NOUN
iajs-3610	323	33	in	in	ADP
iajs-3610	323	34	northeast	northeast	ADJ
iajs-3610	323	35	ethiopia	ethiopia	PROPN
iajs-3610	323	36	.	.	PUNCT
iajs-3610	324	1	plos	plos	PROPN
iajs-3610	324	2	one	one	NUM
iajs-3610	324	3	.	.	PUNCT
iajs-3610	324	4	2021	2021	NUM
iajs-3610	324	5	;	;	PUNCT
iajs-3610	324	6	16(2):e0246509	16(2):e0246509	X
iajs-3610	324	7	.	.	PUNCT
iajs-3610	325	1	https://doi.org/10.1371/journal.pone.0246509	https://doi.org/10.1371/journal.pone.0246509	NOUN
iajs-3610	325	2	.	.	PUNCT
iajs-3610	325	3	https://doi.org/10.2337/dc20-0352	https://doi.org/10.2337/dc20-0352	PROPN
iajs-3610	325	4	https://doi.org/10.4239/wjd.v12.i6.839	https://doi.org/10.4239/wjd.v12.i6.839	PROPN
iajs-3610	325	5	.	.	PUNCT
iajs-3610	326	1	https://doi.org/10.25271/sjuoz.2023.11.1.996	https://doi.org/10.25271/sjuoz.2023.11.1.996	NOUN
iajs-3610	326	2	https://doi.org/10.5455/njppp.2017.7.0515606052017	https://doi.org/10.5455/njppp.2017.7.0515606052017	PROPN
iajs-3610	326	3	.	.	PUNCT
iajs-3610	327	1	https://doi.org/10.48121/jihsam.910490	https://doi.org/10.48121/jihsam.910490	NOUN
iajs-3610	327	2	https://doi.org/10.1159/000490472	https://doi.org/10.1159/000490472	ADJ
iajs-3610	327	3	https://doi.org/10.1056/nejmra1808786	https://doi.org/10.1056/nejmra1808786	NOUN
iajs-3610	327	4	.	.	PUNCT
iajs-3610	328	1	https://doi.org/10.29328/journal.apcr.1001035	https://doi.org/10.29328/journal.apcr.1001035	PROPN
iajs-3610	328	2	https://doi.org/10.1038/s41598-020-79276-0	https://doi.org/10.1038/s41598-020-79276-0	NUM
iajs-3610	328	3	https://doi.org/10.1038/s41598-020-79276-0	https://doi.org/10.1038/s41598-020-79276-0	NUM
iajs-3610	328	4	https://doi.org/10.2478/v10255-012-0015-3	https://doi.org/10.2478/v10255-012-0015-3	NOUN
iajs-3610	328	5	https://doi.org/10.2459/jcm.0000000000001218	https://doi.org/10.2459/jcm.0000000000001218	NOUN
iajs-3610	328	6	.	.	PUNCT
iajs-3610	329	1	https://doi.org/10.2215/cjn.00580111	https://doi.org/10.2215/cjn.00580111	PROPN
iajs-3610	329	2	.	.	PUNCT
iajs-3610	330	1	https://doi.org/10.1371/journal.pone.0246509	https://doi.org/10.1371/journal.pone.0246509	VERB